data_1hp2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hp2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.6 pt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.181 0.515 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' ALA . 10.5 p30 -67.67 -13.91 62.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 110.389 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.484 ' CB ' HG13 ' A' ' 3' ' ' ILE . . . -44.25 104.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.02 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.27 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 5' ' ' ALA . 26.3 p -75.57 153.58 37.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -128.8 -9.54 4.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.039 -1.038 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.98 131.0 4.72 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -49.4 -49.23 72.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 110.952 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.63 -21.02 70.19 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.303 1.159 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -75.63 -30.94 59.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 109.599 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -68.0 -22.0 65.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.579 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -64.14 -58.9 12.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.8 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.76 -32.19 96.53 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.362 1.191 . . . . 0.0 109.354 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -56.14 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.494 -0.754 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' HD12 ' A' ' 21' ' ' ILE . 94.5 m -50.33 -47.38 55.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -58.75 -34.47 71.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.245 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.8 tm-20 -82.36 -16.12 50.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 109.363 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 21' ' ' ILE . . . -88.1 -58.42 2.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.189 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -105.3 -28.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.274 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 -15.27 5.07 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.037 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 8.7 mmmt -118.81 144.6 46.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.235 . . . . 0.0 110.508 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 14' ' ' LEU . . . -90.09 64.22 6.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.39 103.99 7.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.83 178.38 45.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.34 -175.64 4.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -1.178 . . . . 0.0 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.2 t -126.55 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.421 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 13.1 mtp -150.15 160.82 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 110.308 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 51.05 24.78 2.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.314 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 69.16 41.57 79.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 26.4 mttm -156.98 161.65 39.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -1.135 . . . . 0.0 110.023 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -99.36 134.0 42.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.179 -0.95 . . . . 0.0 110.194 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 29' ' ' MET . 8.6 mtpt -107.0 86.07 2.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.9 m -91.54 135.65 33.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.85 113.8 65.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.229 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.268 1.141 . . . . 0.0 110.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.308 0.575 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' ALA . 21.8 p30 -106.89 -10.58 15.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.33 116.07 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.833 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.65 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 0.0 110.378 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 27.3 p -60.35 151.67 27.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -110.64 -22.21 11.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.962 . . . . 0.0 110.595 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.37 153.51 24.49 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.07 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.609 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -65.18 -48.24 69.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.474 -1.015 . . . . 0.0 111.207 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.77 -20.92 72.44 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.34 1.179 . . . . 0.0 111.103 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 tt0 -75.18 -37.13 61.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 109.807 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -67.48 -23.32 65.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.854 . . . . 0.0 110.132 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.1 mm? -59.38 -59.06 15.06 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.993 . . . . 0.0 109.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.4 -47.95 15.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.277 1.146 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 1.7 mtpt -64.53 -53.5 46.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -0.801 . . . . 0.0 110.176 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 13' ' ' CYS . 38.4 t -55.16 -36.49 65.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -62.87 -42.93 99.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.38 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -74.39 -15.85 60.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -0.998 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 19' ' ' GLU . . . -93.64 -34.52 13.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.504 ' CG2' ' O ' ' A' ' 17' ' ' CYS . 9.3 tt -110.91 -15.17 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 110.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 99.22 -14.71 60.99 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' ALA . 4.3 tptt -138.84 125.8 21.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.129 -1.218 . . . . 0.0 110.378 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.53 77.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -131.79 67.23 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -159.6 -173.65 28.35 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -162.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.5 t -130.96 118.35 20.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.66 162.55 40.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 48.77 23.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 69.32 26.52 74.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 15.7 mtpt -136.34 175.2 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.987 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -112.81 116.98 30.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.015 . . . . 0.0 110.381 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -96.9 151.07 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 109.499 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 34' ' ' LYS . 97.1 m -149.88 154.49 38.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 110.654 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.53 129.79 21.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.367 1.193 . . . . 0.0 110.588 -179.82 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.1 pt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.36 0.6 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.7 p30 -76.31 1.95 14.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.307 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.0 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.237 -0.914 . . . . 0.0 110.095 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -47.57 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.32 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 5' ' ' ALA . 12.1 p -78.72 -173.43 3.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.171 -0.956 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB2' ' OE1' ' A' ' 12' ' ' GLU . 3.0 mmt180 -112.04 -27.1 8.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.2 -173.62 33.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.603 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -70.27 -46.94 20.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.521 -0.988 . . . . 0.0 111.866 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.72 -9.92 15.34 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.127 1.067 . . . . 0.0 111.493 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -87.06 -20.41 27.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.981 -1.074 . . . . 0.0 109.536 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -36.97 83.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.441 -0.787 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.587 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -47.56 -58.71 6.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.13 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.63 -42.25 55.95 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.352 1.185 . . . . 0.0 109.918 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 16' ' ' LYS . 6.2 mptt -65.21 -51.18 62.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.3 m -57.06 -45.84 82.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.182 -0.949 . . . . 0.0 109.893 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.5 ttpt -61.96 -33.0 73.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.8 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.02 -11.62 43.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.56 -49.44 8.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.069 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 pt -125.61 -33.96 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.75 27.09 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HD2' ' OXT' ' A' ' 37' ' ' PRO . 4.0 mmtm -126.97 -156.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.378 -1.072 . . . . 0.0 109.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.88 44.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 110.066 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.37 101.01 6.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 176.72 171.91 40.84 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -138.72 -176.44 4.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.564 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -132.24 134.12 44.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.051 -1.03 . . . . 0.0 110.411 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -144.06 146.39 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 29' ' ' MET . 78.6 m-20 57.61 14.06 2.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 89.29 32.27 10.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.6 OUTLIER -141.69 143.9 33.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -1.22 . . . . 0.0 109.767 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.531 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.9 t -94.36 147.78 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.852 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -132.85 99.9 4.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.205 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 6.4 m -101.5 174.88 5.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.132 -0.98 . . . . 0.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 21.2 m-85 -141.98 161.49 50.89 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' OXT' ' HD2' ' A' ' 23' ' ' LYS . 3.0 Cg_endo . . . . . 0 C--N 1.31 -1.462 0 O-C-N 123.701 1.369 . . . . 0.0 110.497 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.456 HG13 ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.573 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.465 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 50.2 p30 -118.91 68.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 110.389 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . . . -79.78 6.2 11.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 65.98 51.25 1.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.4 p -71.48 166.88 20.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.83 -8.44 5.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 110.478 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.67 170.2 31.79 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.147 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -66.12 -48.29 59.86 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.946 . . . . 0.0 111.465 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.4 -10.64 16.64 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.321 1.169 . . . . 0.0 111.157 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -84.3 -47.12 11.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.128 -0.982 . . . . 0.0 109.631 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 53.2 t -67.93 -23.84 65.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.787 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.84 -59.44 11.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 109.566 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -58.98 -43.51 42.42 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.364 1.192 . . . . 0.0 109.359 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -57.15 -39.8 75.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 109.779 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 52.2 m -69.31 -42.93 74.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 -35.99 49.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 109.723 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -12.26 32.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 17' ' ' CYS . . . -81.09 -64.06 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.477 HD13 HG23 ' A' ' 21' ' ' ILE . 13.4 pt -109.97 -33.09 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.26 1.93 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' HD12 ' A' ' 21' ' ' ILE . 28.1 mmtm -142.29 114.34 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.69 62.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.404 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.01 102.57 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 110.11 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.93 -176.77 43.51 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -145.83 -170.58 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.063 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.1 t -128.8 111.8 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.441 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -133.13 150.58 52.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.31 26.04 2.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.31 40.76 80.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 17.1 mtpp -141.68 159.3 42.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.136 . . . . 0.0 110.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HB3' HG13 ' A' ' 3' ' ' ILE . 48.6 t -101.97 115.47 30.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 0.0 110.506 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -102.2 123.83 46.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.709 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -107.14 148.39 28.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.967 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 47.8 m-85 -133.11 149.3 72.35 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.523 -0.736 . . . . 0.0 109.808 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 O-C-N 123.661 1.348 . . . . 0.0 110.548 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.387 0.613 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ALA . 9.5 p30 -72.69 0.87 9.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.887 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.97 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.26 -164.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -40.08 1.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.337 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -156.86 -53.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.568 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 170.32 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.194 . . . . 0.0 110.7 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -59.85 -13.07 20.8 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.26 1.137 . . . . 0.0 110.709 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 26.1 mt-10 -92.5 -19.99 21.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -38.31 71.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.385 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.565 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -50.04 -56.0 20.61 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.67 -38.12 74.16 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.291 1.153 . . . . 0.0 109.781 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -64.41 -53.77 43.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' O ' HG21 ' A' ' 21' ' ' ILE . 85.4 m -53.95 -38.87 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.451 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -56.56 -44.94 81.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.863 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -78.32 -8.88 58.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.98 -51.18 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.378 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 22' ' ' GLY . 16.1 tt -99.66 -26.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 122.53 -28.64 5.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.95 147.68 52.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.82 95.17 6.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.23 50.85 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 110.153 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -143.76 -178.88 19.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 39.0 mtmt -139.44 179.73 6.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.444 -1.033 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 t -107.98 118.36 36.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.775 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.463 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.34 152.96 39.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.465 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.432 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 14.6 m-20 50.45 23.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.79 79.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -132.83 166.05 23.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 t -101.61 121.12 41.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 6.8 mtpm? -97.63 90.34 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.953 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 13.2 m -87.48 139.3 30.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 3.3 m-30 -88.45 150.36 46.42 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.162 -0.962 . . . . 0.0 110.397 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 O-C-N 123.686 1.361 . . . . 0.0 110.532 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 15.7 pt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.27 0.557 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.72 75.44 9.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 110.47 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.4 15.21 20.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.907 . . . . 0.0 109.992 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 48.81 59.3 4.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 110.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 12.1 p -56.56 147.82 21.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 3.9 mmt-85 -99.03 -30.06 12.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.11 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.15 149.46 20.86 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.568 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -51.76 -54.56 38.66 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.231 -1.158 . . . . 0.0 110.656 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.93 -40.16 64.81 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.384 1.202 . . . . 0.0 110.312 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.2 mm-40 -64.94 -24.69 67.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.458 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.31 -31.23 70.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.1 mp -51.95 -58.68 10.35 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.65 -48.62 14.32 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.398 1.21 . . . . 0.0 110.034 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -60.58 -41.07 93.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 t -55.66 -39.71 71.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -44.53 80.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.991 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 7.5 tp10 -67.03 -14.01 62.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.1 -65.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 110.283 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.37 -25.08 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.93 13.23 10.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -119.1 111.69 18.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.157 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.2 55.92 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.164 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.75 108.69 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -179.16 152.22 10.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.9 -162.09 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 110.145 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 27.9 t -143.34 131.88 22.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.111 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtt -148.23 137.11 21.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.493 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.86 17.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.503 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 94.95 -1.06 64.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 38.3 mmtt -105.66 159.77 15.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.0 t -107.53 134.62 50.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.698 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -99.14 83.66 2.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.51 137.53 37.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.421 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -109.25 117.99 52.0 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.271 1.143 . . . . 0.0 110.534 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.468 HG12 ' HB3' ' A' ' 33' ' ' CYS . 29.6 pt . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.331 0.586 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -82.7 71.02 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.843 . . . . 0.0 110.364 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -110.97 23.65 13.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 5' ' ' ALA . 3.3 pttm 33.18 62.63 0.37 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.59 0.709 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 28.2 p -57.6 168.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.717 -0.614 . . . . 0.0 110.422 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HB2' ' OE2' ' A' ' 12' ' ' GLU . 3.3 mmt-85 -122.77 -25.11 4.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -150.67 148.66 20.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.582 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -45.82 -50.95 32.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 111.137 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -62.06 -17.86 58.55 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.327 1.172 . . . . 0.0 110.934 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 3.1 tt0 -70.68 -26.21 63.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.126 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -75.17 -27.64 59.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.16 -54.54 49.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.81 -1.181 . . . . 0.0 109.595 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.6 Cg_endo -64.41 -49.36 3.52 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.344 1.181 . . . . 0.0 110.54 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -69.34 -52.45 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.0 111.062 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' CYS . 32.9 t -55.26 -48.17 74.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 110.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -58.96 -35.38 73.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.987 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.32 9.01 42.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.59 -17.69 7.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 17' ' ' CYS . 8.4 tt -130.02 -26.02 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.053 -1.03 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 110.82 3.12 28.54 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 133.49 28.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.0 110.239 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . . . -73.99 55.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.63 96.52 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.91 156.53 28.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -129.73 -176.17 3.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.381 -1.07 . . . . 0.0 110.003 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -132.89 116.25 16.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.972 -1.08 . . . . 0.0 110.828 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 43.6 tpp -150.36 152.0 33.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.84 . . . . 0.0 110.121 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' MET . 3.7 m-80 61.19 13.01 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.04 23.71 56.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 49.7 mttt -132.33 161.46 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -1.141 . . . . 0.0 109.925 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.468 ' HB3' HG12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -104.44 122.61 45.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.748 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -89.63 155.11 19.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.4 m -147.62 162.28 39.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 110.534 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.87 159.73 49.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.816 . . . . 0.0 109.89 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 O-C-N 123.729 1.384 . . . . 0.0 110.611 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.171 0.51 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -113.71 59.31 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.98 . . . . 0.0 109.85 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.53 10.69 26.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 110.6 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 54.06 44.12 29.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.08 -1.012 . . . . 0.0 110.099 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 6' ' ' LYS . 16.6 p -44.14 170.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.466 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.41 -22.03 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -0.839 . . . . 0.0 110.253 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.65 166.46 26.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.17 -50.0 1.41 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.331 -1.099 . . . . 0.0 111.058 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.7 -25.41 68.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.355 1.187 . . . . 0.0 110.704 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -70.88 -34.87 72.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.035 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -25.82 67.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.599 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.42 -59.9 9.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.92 . . . . 0.0 109.928 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.22 -49.04 13.49 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.311 1.164 . . . . 0.0 109.53 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.97 -37.67 74.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 24.7 t -70.37 -36.82 74.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.935 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 2.5 tttp -56.59 -44.16 80.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.942 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -17.89 48.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 110.184 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . . . -77.03 -54.03 7.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 110.426 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.424 HD13 ' SG ' ' A' ' 17' ' ' CYS . 12.1 pt -112.41 -34.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -0.918 . . . . 0.0 110.387 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 116.87 26.35 3.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -123.53 -147.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -1.09 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.56 48.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.235 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.81 68.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.106 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -126.12 161.85 20.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 -165.0 1.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -1.165 . . . . 0.0 110.345 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 29' ' ' MET . 43.3 t -137.98 114.09 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.451 ' HA ' ' HE3' ' A' ' 29' ' ' MET . 1.2 mmt -146.92 145.51 29.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.038 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.35 33.43 23.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.129 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.55 35.2 88.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 31' ' ' GLY . 10.5 mttt -142.09 159.19 42.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.59 122.54 37.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.131 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 3.1 mtmt -99.38 94.09 6.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.827 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.5 m -84.5 147.17 27.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 110.652 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -136.7 91.47 15.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.309 -1.51 0 O-C-N 123.689 1.363 . . . . 0.0 110.606 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 5' ' ' ALA . 25.3 pt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.255 0.55 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 5' ' ' ALA . 1.2 p-10 -75.17 -0.65 20.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -42.5 116.86 0.91 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.099 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.6 ttmm -64.35 69.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 4.2 p -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -76.43 -15.57 59.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . 152.64 -23.96 0.83 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.67 -55.83 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.27 . . . . 0.0 110.927 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.13 -14.25 18.64 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.283 1.149 . . . . 0.0 110.652 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.48 -29.56 13.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.765 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.4 t -74.34 -33.58 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -59.95 -57.68 25.0 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.7 -50.53 9.04 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 109.464 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -52.87 -34.38 54.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.101 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 5.0 t -68.22 -43.57 77.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -54.63 -32.59 59.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.666 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.49 -16.08 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.782 . . . . 0.0 109.961 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.18 -50.6 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.389 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.48 -9.29 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 82.69 32.17 27.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -144.63 103.99 3.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 110.064 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 65.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -134.44 88.75 2.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 177.52 -175.64 47.67 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 20.2 mttp -151.14 177.02 10.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.6 t -112.16 139.28 47.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.288 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 29' ' ' MET . 3.9 ppp? -150.86 131.56 14.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 t30 58.1 41.65 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.747 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.62 30.07 76.57 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -137.39 155.8 48.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -1.214 . . . . 0.0 109.784 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.8 t -110.86 129.94 55.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.492 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.3 mtpt -100.88 144.81 29.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.346 -0.846 . . . . 0.0 109.751 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m -149.38 143.2 25.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.364 -0.835 . . . . 0.0 110.55 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -89.52 123.87 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 O-C-N 123.313 1.165 . . . . 0.0 110.529 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.34 0.59 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 5' ' ' ALA . 2.8 p-10 -74.57 -10.11 59.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -43.95 110.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.3 tttp -59.85 94.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -71.04 152.38 43.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.687 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -8.1 8.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.031 . . . . 0.0 110.74 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -155.7 135.39 4.56 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.188 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.6 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -52.45 -50.2 81.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -1.083 . . . . 0.0 110.698 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.79 -16.29 48.01 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.427 1.225 . . . . 0.0 110.576 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 11.9 tt0 -82.48 -39.43 22.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 0.0 109.726 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.96 -20.31 65.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.833 . . . . 0.0 109.993 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.589 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.8 mp -63.64 -59.65 11.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -59.84 -32.67 95.73 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.369 1.194 . . . . 0.0 109.92 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -64.07 -54.95 26.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 110.351 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 85.9 m -56.8 -39.88 74.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.053 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.9 tttt -59.22 -46.23 89.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.23 -16.74 62.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.93 -43.58 10.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 4.1 pt -115.83 -34.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 131.03 -14.0 5.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -126.65 145.11 50.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.242 . . . . 0.0 110.466 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.49 60.61 4.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.82 84.35 2.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -165.84 179.56 40.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 177.03 8.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -1.131 . . . . 0.0 110.298 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 29' ' ' MET . 1.5 t -123.27 114.04 19.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.833 . . . . 0.0 109.637 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -144.26 157.71 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.92 24.53 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.369 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 68.87 39.31 85.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -145.81 167.99 21.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -1.157 . . . . 0.0 110.035 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.4 t -109.88 123.4 49.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.696 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -107.49 91.88 3.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.364 -0.835 . . . . 0.0 110.202 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 18.4 m -91.48 141.22 28.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.11 -0.994 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.415 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 4.5 m-85 -113.32 138.13 22.31 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.514 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.473 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.1 pt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.083 0.468 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 19.4 p-10 -86.33 30.2 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -75.08 101.91 4.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 0.0 109.959 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 7.1 ptpp? -39.56 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.757 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' ALA . 25.4 p -78.42 146.33 34.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.912 . . . . 0.0 110.1 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -20.58 13.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -167.14 154.85 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -46.39 -50.23 40.6 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.4 -1.059 . . . . 0.0 111.03 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.35 -20.43 68.22 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.346 1.182 . . . . 0.0 110.968 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 tp10 -78.59 -39.67 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.944 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.1 t -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.046 -1.034 . . . . 0.0 110.143 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.589 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.1 mp -49.32 -59.09 7.16 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.026 -1.046 . . . . 0.0 109.768 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.45 -40.57 65.68 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.418 1.22 . . . . 0.0 109.898 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.1 mmtp -57.8 -46.04 85.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.965 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.43 -45.61 83.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -23.76 62.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.041 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.26 -12.17 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -103.41 -65.65 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 35' ' ' CYS . 11.8 pt -86.47 -21.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.95 18.5 26.96 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.58 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 110.158 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 64.71 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.32 76.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.938 . . . . 0.0 110.207 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -166.28 168.31 39.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 19.2 mtmt -132.7 -175.31 3.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -1.082 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 7' ' ' CYS . 11.3 t -100.97 147.33 26.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 0.0 109.791 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.43 93.9 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.002 -1.061 . . . . 0.0 110.814 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.4 m120 61.56 9.54 2.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.45 -0.781 . . . . 0.0 111.097 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 122.66 10.38 5.94 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 6.3 mttt -121.23 154.73 35.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.258 . . . . 0.0 110.227 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.473 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -96.43 120.22 36.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 22.3 mtmt -97.49 78.14 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.932 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 53.8 m -80.71 156.12 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.363 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.56 75.45 68.97 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.852 . . . . 0.0 110.153 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 O-C-N 123.611 1.322 . . . . 0.0 110.553 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.188 0.518 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -87.16 67.53 9.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.476 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -93.94 28.72 2.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 36.4 48.8 0.62 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.0 110.95 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 27.4 p -53.44 138.55 33.15 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.518 -0.739 . . . . 0.0 109.966 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -9.72 13.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.63 147.16 15.92 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.09 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -61.22 -43.97 91.92 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 111.613 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.0 -21.85 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 122.875 0.934 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 tt0 -78.64 -34.03 46.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.6 -26.62 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -57.19 -57.71 22.98 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 109.898 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.58 -41.37 48.39 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.38 1.2 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -62.49 -50.97 69.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.5 m -54.76 -36.52 64.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 109.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -67.11 -51.43 54.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.709 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.13 -5.09 33.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.719 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -57.01 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.15 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 pt -116.91 -32.5 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.61 17.16 2.16 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.233 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -144.68 125.43 14.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.974 -1.309 . . . . 0.0 110.058 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.34 81.32 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.442 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -146.9 119.46 8.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 150.35 177.95 24.79 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -148.13 -170.02 3.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.158 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.5 132.51 55.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.228 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 30' ' ' ASN . 6.3 tpt -149.64 143.95 25.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' N ' ' HG3' ' A' ' 29' ' ' MET . 1.0 OUTLIER 50.2 30.42 4.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 70.68 24.97 76.47 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 mttt -127.48 155.46 43.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 110.298 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 t -105.42 123.1 47.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.1 mtpm? -109.49 105.8 15.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.48 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 36.0 m -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.493 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -125.59 158.82 63.45 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 109.994 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.389 0 O-C-N 123.707 1.372 . . . . 0.0 110.587 -179.751 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.477 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.4 pt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.195 0.521 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -88.84 65.54 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.647 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 6' ' ' LYS . . . -81.54 1.1 35.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 68.46 52.47 0.61 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 28.8 p -55.54 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.393 -0.817 . . . . 0.0 109.952 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -141.45 -33.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 110.663 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -159.97 -40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.556 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 168.11 -53.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.267 -1.137 . . . . 0.0 110.473 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.53 -11.1 18.53 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.281 1.148 . . . . 0.0 110.507 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 tp10 -91.86 -47.47 7.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.913 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -67.03 -16.02 64.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 mt -72.83 -58.37 2.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.46 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -59.49 -46.55 20.43 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.314 1.166 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -38.46 85.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 31.9 t -65.22 -44.96 86.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -54.97 -41.89 71.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.04 -16.87 59.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.96 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.57 -55.14 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 110.333 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 1.5 tt -86.58 -17.7 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.71 -33.8 5.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.05 133.19 35.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -1.196 . . . . 0.0 110.159 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -67.3 91.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.182 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 66.59 1.39 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -158.56 -168.23 20.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.26 171.58 13.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -1.187 . . . . 0.0 110.117 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -110.57 142.51 42.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.95 . . . . 0.0 109.883 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.473 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -150.32 117.0 5.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.68 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' MET . 25.8 m-20 57.26 35.04 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.971 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 80.5 24.04 59.44 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.349 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.52 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -126.18 152.68 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.181 -1.188 . . . . 0.0 109.835 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.4 t -107.74 119.21 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 110.234 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 11.4 mtmt -108.39 117.23 33.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HA ' ' CA ' ' A' ' 26' ' ' GLY . 97.3 m -120.56 141.57 50.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.542 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 m-85 -79.39 -53.16 1.08 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 110.939 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 36' ' ' TYR . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.327 0 O-C-N 123.25 1.131 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 33' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.189 0.518 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -90.81 46.78 1.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.57 8.1 8.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 34.5 mmtt 51.77 51.3 16.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 27.1 p -55.87 150.72 12.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.838 . . . . 0.0 110.234 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -111.49 -24.13 10.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 150.79 22.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.36 -47.93 95.19 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.074 . . . . 0.0 111.241 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -64.5 -39.44 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.301 1.159 . . . . 0.0 110.72 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -60.38 -26.48 66.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.145 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -29.62 68.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.578 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.5 mp -54.0 -58.94 11.26 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.73 -47.27 19.24 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.346 1.182 . . . . 0.0 110.017 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -60.85 -47.83 84.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 109.89 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.1 t -59.75 -37.21 78.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -58.21 -47.87 82.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.13 -25.67 60.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.42 60.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.68 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -124.31 -31.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 0.0 110.58 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 113.43 18.62 7.01 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' CE ' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -145.12 125.29 13.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.147 . . . . 0.0 110.181 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.7 7.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.35 68.19 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.336 -0.852 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -156.54 152.04 23.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.3 mtmt -114.52 179.84 3.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -1.178 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 32.0 t -120.75 138.88 53.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.454 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -148.06 116.36 6.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.94 . . . . 0.0 110.489 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 66.33 7.23 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.623 179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 106.76 16.0 15.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 24.0 mmtt -123.24 142.66 50.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -1.194 . . . . 0.0 109.894 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.9 t -93.34 127.54 38.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.373 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 24.2 mtpt -101.08 80.93 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -86.28 147.5 26.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.044 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.4 m-85 -79.26 -60.32 0.55 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 110.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 36' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.366 0 O-C-N 123.213 1.112 . . . . 0.0 110.52 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.47 HD13 ' HB1' ' A' ' 5' ' ' ALA . 20.7 pt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.225 0.536 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -79.43 16.1 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 111.244 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HB1' HD13 ' A' ' 3' ' ' ILE . . . -46.88 171.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.93 -1.106 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 2.7 tppt? -116.32 69.3 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.564 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LYS . 5.0 p -49.12 175.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 109.703 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.48 -10.02 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.116 -0.99 . . . . 0.0 110.777 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -161.42 -74.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 175.88 -58.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 110.545 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 3.0 Cg_endo -57.94 -15.63 22.98 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.293 1.154 . . . . 0.0 110.287 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 mt-10 -87.55 -15.55 37.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.08 -40.41 68.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 tp -50.09 -54.29 34.8 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -60.5 -55.86 1.29 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.396 1.208 . . . . 0.0 110.254 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -62.11 -31.62 72.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' CYS . 35.8 t -71.89 -46.11 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -58.11 -45.14 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.71 -21.41 60.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.424 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.96 -51.39 8.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 21' ' ' ILE . 2.5 tt -101.94 -24.19 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 104.2 -6.74 46.93 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.39 115.34 25.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 18' ' ' LYS . . . -70.8 67.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.68 103.51 3.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 170.66 178.67 41.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -147.78 -176.12 5.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -1.076 . . . . 0.0 110.124 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 6.6 t -107.91 128.62 54.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -145.95 126.9 14.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.47 -0.769 . . . . 0.0 109.788 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.2 m120 62.68 42.58 8.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 62.43 23.88 65.14 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 20.2 mttm -134.03 175.99 8.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -1.183 . . . . 0.0 109.922 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB3' HG12 ' A' ' 3' ' ' ILE . 1.9 t -118.47 129.25 55.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 1.9 mmmm -99.92 92.47 5.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 110.148 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.87 142.81 27.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.394 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -96.47 133.92 24.1 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.451 1.237 . . . . 0.0 110.548 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 1.3 pt . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.87 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.362 0.601 . . . . 0.0 111.074 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -144.55 88.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.214 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 6.3 mmtp -36.01 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.373 0.606 . . . . 0.0 110.897 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 5' ' ' ALA . 23.8 p -78.71 139.57 38.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.349 -0.845 . . . . 0.0 110.352 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 -15.19 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.265 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -154.27 151.4 23.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.579 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -60.09 -50.98 83.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -1.149 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.16 -11.98 21.21 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.422 1.222 . . . . 0.0 110.841 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -80.51 -34.82 35.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 2.0 t -67.1 -27.19 67.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -53.72 -59.08 10.51 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 0.0 109.723 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.21 -41.97 54.73 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.362 1.19 . . . . 0.0 109.785 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -50.31 64.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 59.6 m -56.48 -45.93 80.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.112 -0.992 . . . . 0.0 109.822 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -39.78 69.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.712 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -78.97 -13.42 59.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.53 -15.69 25.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -148.52 -37.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.352 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -9.13 10.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 126.55 52.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 110.263 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' O ' HD11 ' A' ' 14' ' ' LEU . . . -76.57 74.11 3.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.361 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 110.12 4.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 109.865 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 177.6 171.16 40.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -145.37 -168.73 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -1.118 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.77 133.04 55.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.27 141.62 23.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.0 110.968 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.14 22.3 0.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.33 -0.856 . . . . 0.0 110.621 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 82.2 13.84 78.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 7.6 mttt -117.69 160.17 21.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -1.174 . . . . 0.0 109.618 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -97.04 128.16 43.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.856 -1.152 . . . . 0.0 110.146 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 36.7 mtpt -96.88 117.38 30.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -123.34 134.98 53.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' OH ' ' CE ' ' A' ' 34' ' ' LYS . 23.6 m-85 -108.38 151.28 41.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 O-C-N 123.655 1.345 . . . . 0.0 110.359 179.911 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.0 pt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.237 0.541 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.444 ' HA ' ' CE ' ' A' ' 32' ' ' LYS . 27.9 p-10 -79.34 48.09 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.399 -0.813 . . . . 0.0 110.47 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -95.09 90.77 6.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -0.952 . . . . 0.0 109.81 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -45.76 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.437 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 10.3 p -73.11 -167.68 0.42 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.135 -0.978 . . . . 0.0 110.367 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.31 -17.38 6.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.213 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.69 150.29 22.35 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -58.84 -51.0 84.96 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -1.093 . . . . 0.0 111.163 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.44 -24.73 78.84 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.39 1.205 . . . . 0.0 111.217 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.444 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 39.4 tp10 -58.88 -26.51 64.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -70.96 -23.05 62.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -58.05 -57.39 26.22 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.4 -45.0 19.94 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.424 1.223 . . . . 0.0 109.864 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -49.05 79.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 m -61.78 -42.55 99.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.726 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 12.2 ttpp -55.99 -30.1 61.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.04 -20.11 23.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.55 -57.88 2.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.521 ' CG1' ' N ' ' A' ' 22' ' ' GLY . 10.0 pt -100.9 -41.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.09 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 103.01 32.79 4.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 19.9 mmtt -129.69 -2.27 4.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -1.178 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.62 60.33 1.64 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.742 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 36' ' ' TYR . . . -150.22 82.37 1.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.0 -175.2 33.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 5.3 mttp -150.0 -176.92 5.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -1.068 . . . . 0.0 109.948 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.1 t -121.97 127.54 50.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 110.585 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.512 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -144.11 155.27 43.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 109.823 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.87 18.21 1.54 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.127 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' C ' ' CG ' ' A' ' 32' ' ' LYS . . . 78.06 43.3 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 3.9 mttt -153.07 160.33 42.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.132 -1.216 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -91.26 134.2 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 0.0 109.96 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' CD ' ' HB2' ' A' ' 29' ' ' MET . 0.4 OUTLIER -120.89 99.68 6.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.547 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 57.1 m -87.74 156.4 19.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.101 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' ALA . 32.6 m-85 -140.33 141.24 25.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 0.0 110.23 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.313 -1.314 0 O-C-N 123.508 1.268 . . . . 0.0 110.451 179.853 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.8 pt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.348 0.594 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 6' ' ' LYS . 12.3 p-10 -62.6 -9.77 10.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.464 -0.773 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.463 ' CB ' HD12 ' A' ' 3' ' ' ILE . . . -41.2 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.86 . . . . 0.0 110.265 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' ASN . 10.5 mmtm -49.04 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 110.345 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . 16.9 p -76.07 149.36 37.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -122.38 -10.67 8.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.01 143.84 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -49.75 -50.26 68.37 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.338 -1.095 . . . . 0.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.14 -9.35 16.88 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.368 1.194 . . . . 0.0 110.776 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -87.8 -35.63 17.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 8.4 t -73.24 -39.92 65.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.584 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -44.56 -55.65 9.89 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.059 -1.026 . . . . 0.0 109.845 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -62.54 -47.76 8.77 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.367 1.193 . . . . 0.0 110.119 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -54.01 -44.14 70.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.873 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 60.6 m -62.65 -39.34 93.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.856 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 10.6 tttt -61.92 -26.96 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -32.49 21.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.475 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.63 -18.02 21.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.119 -0.988 . . . . 0.0 110.325 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.593 ' CD1' ' CB ' ' A' ' 35' ' ' CYS . 37.0 mt -128.92 -45.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 97.18 35.76 5.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -134.78 1.39 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -1.226 . . . . 0.0 110.338 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.16 46.28 1.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.463 -0.773 . . . . 0.0 110.442 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.84 106.85 7.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 110.237 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 173.49 178.99 43.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -146.58 -165.36 2.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.011 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 t -126.71 122.56 35.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 tpt -150.02 134.96 17.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 62.15 31.01 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.261 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.76 33.88 88.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 18.3 mttt -136.36 150.87 49.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.221 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.45 118.16 30.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 109.846 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -101.22 103.73 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.454 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.593 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 9.8 m -111.76 166.74 10.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.89 157.4 42.0 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.423 0 O-C-N 123.69 1.363 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 3' ' ' ILE . 17.9 pt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.434 0.635 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.506 ' CB ' ' HD3' ' A' ' 32' ' ' LYS . 14.6 p-10 -101.34 60.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.283 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.71 4.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 47.65 79.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.51 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -70.42 -165.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 0.0 109.982 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -126.45 -18.0 4.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.01 . . . . 0.0 110.63 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -154.3 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 168.65 -55.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.095 -1.238 . . . . 0.0 111.309 -179.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.9 Cg_exo -56.15 -11.95 6.76 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.309 1.163 . . . . 0.0 111.69 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.85 -31.2 64.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 109.533 179.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.1 t -69.12 -28.65 66.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.506 -0.746 . . . . 0.0 110.633 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.562 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 tp -59.36 -56.5 35.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.581 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.26 -46.44 18.41 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.405 1.213 . . . . 0.0 110.291 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -62.58 -32.6 73.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 21' ' ' ILE . 20.0 m -64.24 -52.33 59.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 ttpt -57.94 -35.84 71.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 mm-40 -76.05 -18.17 59.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.95 -9.94 12.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.8 tt -131.06 -28.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.504 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 116.65 -38.0 3.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -124.0 132.92 53.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.339 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.85 90.61 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' TYR . . . -141.42 89.55 2.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 27' ' ' LYS . . . 177.7 -175.42 47.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 15.1 mtmm -150.15 175.03 12.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -1.094 . . . . 0.0 109.584 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 18.4 t -109.44 130.71 55.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.927 -1.108 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.527 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 1.6 ttt -130.51 138.6 50.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 61.24 11.93 3.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 95.63 17.48 35.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HD3' ' CB ' ' A' ' 4' ' ' ASN . 2.1 mttt -131.24 143.29 50.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.917 -1.343 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.7 t -84.47 145.51 28.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 0.0 110.638 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' HE2' ' CB ' ' A' ' 29' ' ' MET . 2.4 mtmp? -133.24 100.84 4.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.742 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.6 m -81.93 168.4 17.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.519 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 5.4 m-85 -122.08 159.6 51.07 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.004 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 0.0 110.554 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.293 0.568 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -108.14 42.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -96.15 27.78 3.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.581 -0.699 . . . . 0.0 110.278 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 3.1 ptmm? 36.06 72.57 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.582 0.706 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.9 p -51.82 134.46 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.63 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -94.26 -15.58 24.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 0.0 109.845 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -160.1 156.98 28.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.43 -50.02 89.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.13 -11.44 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.425 1.224 . . . . 0.0 110.857 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 8.5 mm-40 -81.7 -33.72 31.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.3 t -67.03 -21.01 65.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -59.65 -59.36 14.1 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.068 -1.02 . . . . 0.0 109.314 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -57.94 -37.98 94.01 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.3 1.158 . . . . 0.0 109.697 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 18.5 mttp -69.81 -38.31 76.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' O ' HG12 ' A' ' 21' ' ' ILE . 62.6 m -75.65 -34.82 60.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.902 . . . . 0.0 109.703 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -67.78 -36.24 80.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.83 -18.29 27.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.188 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -75.04 -55.33 5.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.338 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 17' ' ' CYS . 18.1 pt -108.34 -35.03 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.14 11.02 3.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -135.52 135.92 40.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.281 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.471 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -85.73 76.64 9.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 93.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -164.79 178.45 39.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 3.6 mtmp? -142.71 -175.16 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -1.107 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 5.8 t -132.18 119.7 21.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 110.168 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.449 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.13 145.35 30.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.829 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.83 28.28 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.817 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.82 75.7 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -126.57 159.39 33.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -1.154 . . . . 0.0 110.344 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.5 119.78 40.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.974 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.3 mtmt -105.36 125.78 51.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' SG ' HD12 ' A' ' 3' ' ' ILE . 40.0 m -119.11 142.14 48.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -110.2 125.1 31.73 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 110.148 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.401 1.211 . . . . 0.0 110.516 179.983 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 33' ' ' CYS . 1.7 pt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.317 0.58 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.467 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 31.5 p-10 -101.0 68.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.86 11.16 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 4' ' ' ASN . 4.4 mttt 50.64 60.86 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 23.7 p -71.97 159.07 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 110.409 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.54 -17.13 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.01 151.78 22.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -52.9 -48.0 93.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.392 -1.063 . . . . 0.0 111.529 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.01 -25.9 78.09 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.201 1.106 . . . . 0.0 111.684 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.3 tp10 -52.33 -29.58 24.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.806 -1.184 . . . . 0.0 110.095 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 5.6 t -69.35 -35.59 76.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.499 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.589 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -44.62 -57.5 6.63 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.947 -1.096 . . . . 0.0 109.816 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -61.49 -48.4 9.51 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.392 1.206 . . . . 0.0 109.323 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.779 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 5.1 t -61.6 -48.73 79.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.429 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 4.5 ttmt -66.16 -19.81 65.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.885 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.54 -12.98 30.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.98 -69.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.365 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 23' ' ' LYS . 6.2 pt -84.78 -29.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 110.204 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 112.67 18.1 7.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -149.99 122.88 8.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -1.225 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 14' ' ' LEU . . . -81.48 82.33 7.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.84 92.17 2.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . 171.13 -159.36 31.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.5 mtmp? -147.73 -163.37 1.75 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -1.092 . . . . 0.0 109.859 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' CB ' ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -138.86 127.71 23.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.884 -1.135 . . . . 0.0 110.682 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 29.5 ttm -141.91 166.19 25.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 109.657 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 48.92 22.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.965 . . . . 0.0 109.892 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.401 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 73.6 34.97 56.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.2 mttp -148.19 147.05 28.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.485 ' HB3' HD12 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -83.4 139.44 32.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -115.55 149.57 37.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.845 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.05 147.83 37.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.566 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -123.13 104.05 35.62 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.024 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 O-C-N 123.457 1.241 . . . . 0.0 110.594 -179.715 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.537 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.9 pt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.148 0.499 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 24.8 p-10 -100.24 55.31 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.817 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.79 15.15 17.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 4.7 mmtp 46.63 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.343 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 8' ' ' ARG . 19.6 p -69.7 -168.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 3.5 mmt85 -140.37 -34.89 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -138.45 -65.19 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.105 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER 169.9 -55.85 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.119 -1.224 . . . . 0.0 110.88 -179.691 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -57.92 -26.67 75.55 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.377 1.199 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt-10 -61.2 -23.12 65.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -69.64 -31.01 68.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.941 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.575 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -53.58 -58.43 12.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.072 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.66 -51.93 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.367 1.193 . . . . 0.0 109.976 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -60.27 -46.65 89.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.1 t -62.61 -44.43 96.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -58.54 -28.3 65.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -105.25 1.58 28.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.17 -62.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.488 HG21 ' N ' ' A' ' 22' ' ' GLY . 4.4 tt -90.34 -39.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 110.03 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 109.38 26.68 5.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 127.66 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.539 -0.977 . . . . 0.0 109.828 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.28 50.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 110.779 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -137.16 110.97 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.046 -1.034 . . . . 0.0 109.837 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 179.26 173.36 44.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -150.04 -172.39 4.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.136 . . . . 0.0 110.302 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t -122.54 122.12 38.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 3.6 tmm? -146.91 137.07 23.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 63.94 10.75 5.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 110.343 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.79 22.8 37.97 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -124.97 162.44 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -1.153 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.537 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -108.64 106.81 17.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 108.726 179.736 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.9 mtpm? -89.4 152.96 21.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.018 . . . . 0.0 111.003 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 23.7 m -144.23 136.71 26.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.689 . . . . 0.0 109.751 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -97.22 154.03 38.24 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.942 . . . . 0.0 110.464 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.732 1.385 . . . . 0.0 110.639 179.862 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.8 pt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.181 0.515 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 4' ' ' ASN . 16.0 p-10 -79.84 75.44 6.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 0.0 110.087 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -108.36 15.95 23.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' CA ' ' O ' ' A' ' 31' ' ' GLY . 23.6 tptp 44.51 44.0 6.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 26.8 p -45.65 154.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -101.79 -31.19 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.36 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 176.54 31.67 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.122 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.604 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -69.27 -47.39 28.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.991 . . . . 0.0 111.369 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -60.84 -21.97 72.27 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.175 1.092 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.413 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.9 mm-40 -84.03 -35.76 23.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 42.1 t -69.3 -31.55 70.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.67 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.586 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -51.83 -59.07 8.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 109.839 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.13 -45.44 31.66 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.292 1.154 . . . . 0.0 109.684 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -52.85 -41.21 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.9 m -69.66 -27.77 65.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.577 179.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 2.0 ttpm? -71.06 -22.02 62.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.787 . . . . 0.0 109.73 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.77 -26.03 18.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.146 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.52 -45.16 17.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.27 -32.62 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 110.339 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 96.25 36.36 5.2 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -121.82 -9.22 8.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.509 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.21 47.22 2.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.767 . . . . 0.0 110.4 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.94 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -151.62 -178.11 26.06 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 mttp -143.0 172.11 13.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -1.106 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.7 t -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.334 -0.854 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.7 tpp -135.94 127.3 28.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 110.501 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.05 23.65 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 6' ' ' LYS . . . 88.75 3.98 76.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 150.97 24.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.918 -1.342 . . . . 0.0 110.36 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -95.82 126.31 40.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -104.75 84.69 2.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.694 -179.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -85.17 148.79 25.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.101 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.86 108.37 28.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 109.994 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 O-C-N 123.469 1.247 . . . . 0.0 110.624 -179.791 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.378 0.609 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 20.6 p30 -87.26 67.91 9.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.37 4.5 42.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 56.49 57.62 4.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -65.56 166.73 10.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -107.31 -9.52 16.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.46 156.02 27.38 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.15 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.633 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -63.41 -42.58 75.06 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.964 . . . . 0.0 112.074 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.7 Cg_exo -60.12 -13.49 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 122.848 0.92 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.412 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -75.54 -22.04 57.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.036 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 10' ' ' SER . 1.3 m -71.8 -26.25 62.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.57 -0.706 . . . . 0.0 110.147 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -58.65 -57.78 24.08 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.15 -45.7 22.2 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.326 1.172 . . . . 0.0 109.97 179.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -62.09 -50.29 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 49.9 m -54.27 -36.99 64.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.021 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -60.88 -52.35 65.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -76.42 -4.55 42.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.042 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.75 -47.69 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 6.9 tt -116.92 -28.16 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 85.11 38.65 9.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -138.08 2.2 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.292 . . . . 0.0 110.706 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.55 48.24 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.42 108.82 4.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.06 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -178.11 -178.0 47.26 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.112 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -146.92 175.08 10.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.957 . . . . 0.0 109.448 179.664 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.83 128.87 41.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 110.267 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.1 tpp -143.38 154.08 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 110.111 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.56 20.88 6.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.069 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 77.55 29.7 54.91 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 41.6 mttt -141.73 153.76 44.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -1.189 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' C ' ' CG ' ' A' ' 34' ' ' LYS . 9.9 t -93.01 154.81 17.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.84 . . . . 0.0 110.827 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' CG ' ' C ' ' A' ' 33' ' ' CYS . 23.8 mtmm -148.68 99.67 3.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.035 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 58.1 m -81.81 173.85 11.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.199 -0.938 . . . . 0.0 110.386 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.5 m-85 -108.58 140.43 21.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.291 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.509 1.268 . . . . 0.0 110.587 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.55 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.9 pt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.212 0.529 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 44.5 p30 -98.05 75.59 2.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.945 . . . . 0.0 110.572 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 15.16 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.875 . . . . 0.0 109.872 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER 48.51 55.25 9.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 -179.895 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 22.0 p -61.12 144.19 54.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.29 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -26.64 13.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -137.31 152.7 21.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.11 -46.22 96.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.397 -1.061 . . . . 0.0 111.67 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.6 Cg_exo -61.58 -16.7 49.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.064 1.033 . . . . 0.0 111.429 -179.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -73.99 -32.56 63.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.938 -1.101 . . . . 0.0 109.699 179.464 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 1.9 t -68.2 -24.8 64.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -55.1 -59.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 179.765 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.04 -44.43 29.76 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.365 1.192 . . . . 0.0 109.878 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 11.5 mmtt -64.83 -39.11 93.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 110.247 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 55.9 m -66.0 -25.18 66.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 110.409 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -77.91 -41.36 36.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 110.509 -179.752 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.0 -24.53 47.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 110.668 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -88.35 -23.6 23.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 35' ' ' CYS . 8.1 mt -131.06 -29.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 110.48 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 112.37 -19.15 22.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.03 119.93 38.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -1.144 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 14' ' ' LEU . . . -68.63 79.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.004 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.24 127.91 12.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 157.9 -175.22 35.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -146.7 -170.33 3.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 31.2 t -132.73 111.86 11.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -122.36 125.59 46.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 -179.883 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 65.16 16.14 10.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 179.805 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.64 18.76 54.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 4.0 mmtp -112.8 144.98 41.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.333 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -93.88 114.53 26.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.133 -179.709 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -109.96 116.37 31.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.042 179.836 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 17.3 m -111.06 144.56 39.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 27.2 m-85 -93.32 149.95 38.22 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 O-C-N 123.754 1.397 . . . . 0.0 110.522 -179.725 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.0 pt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.295 0.569 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 5' ' ' ALA . 14.7 p30 -64.13 -7.52 9.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 110.894 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.39 113.62 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 110.436 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.25 79.99 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.922 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.0 p -75.09 172.33 12.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -132.41 -27.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.948 . . . . 0.0 110.876 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.04 141.79 16.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.9 -52.7 70.49 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.385 -1.068 . . . . 0.0 110.771 179.887 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' SER . 2.9 Cg_endo -62.32 -35.68 71.92 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.387 1.204 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt-10 -62.36 -26.14 68.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -67.93 -38.05 82.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.991 179.794 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.583 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 mp -44.77 -58.55 5.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.774 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -57.75 -55.46 2.36 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.426 1.224 . . . . 0.0 109.805 179.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 22.5 mmmt -52.68 -39.06 61.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.251 179.233 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' O ' HG21 ' A' ' 21' ' ' ILE . 38.0 t -67.97 -43.14 79.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 2.5 tttp -55.0 -25.05 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.699 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.85 -21.44 18.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.795 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.3 -43.35 12.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 HG12 ' HD3' ' A' ' 23' ' ' LYS . 8.8 tt -113.87 -33.34 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.099 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 89.64 40.8 5.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HD3' HG12 ' A' ' 21' ' ' ILE . 1.6 mptp? -139.16 4.73 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -1.163 . . . . 0.0 110.663 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 40.37 45.57 1.87 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.434 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.97 86.83 1.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.144 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -162.95 176.4 39.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 4.7 mtmp? -142.04 174.97 10.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 109.828 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 35.8 t -117.63 119.17 34.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.3 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.456 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -150.57 151.22 32.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.314 -179.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.96 18.14 3.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 110.466 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 81.33 20.21 65.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.28 169.37 17.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.246 -1.149 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 1.8 t -107.82 125.4 51.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 110.35 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 1.5 mtpt -94.44 101.42 13.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.919 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 142.01 33.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 110.369 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.35 168.71 12.18 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.89 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.614 1.323 . . . . 0.0 110.508 179.741 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.359 0.6 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.82 47.14 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 110.032 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.86 13.03 4.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER 50.76 67.72 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.016 -179.874 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 p -55.6 176.05 0.07 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.58 -40.9 6.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.049 -1.032 . . . . 0.0 110.784 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -166.46 -41.96 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.093 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.58 -55.23 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.11 -1.229 . . . . 0.0 110.863 -179.659 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.26 -12.44 16.35 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.413 1.217 . . . . 0.0 110.955 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.6 mp0 -96.74 -21.54 17.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -75.05 -49.02 21.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.511 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -42.42 -52.88 9.8 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 110.446 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -62.37 -57.06 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.348 1.183 . . . . 0.0 109.905 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 9.7 mmtp -50.99 -37.28 43.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.4 t -67.88 -37.48 81.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.639 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 7.4 tttm -61.39 -27.59 68.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.759 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 14.4 mt-10 -94.68 -24.99 16.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -47.6 42.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.379 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 17' ' ' CYS . 11.6 pt -115.61 -28.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -0.951 . . . . 0.0 110.413 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 109.92 16.19 10.98 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 37' ' ' PRO . 7.5 ttpt -139.94 119.74 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.242 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.74 67.92 0.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . . . -139.05 68.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.96 170.18 29.35 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 29.7 mtmt -142.91 171.69 13.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.3 t -110.4 132.86 53.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 109.618 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -150.09 133.52 16.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.1 m120 61.49 13.0 4.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 90.68 28.49 16.13 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.1 mtpp -139.88 167.49 21.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -1.163 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.37 118.45 36.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 110.053 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -111.11 103.58 12.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.536 -179.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 96.8 m -98.82 165.7 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -147.91 95.55 4.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.518 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.4 mm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -110.81 42.16 1.66 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.417 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.72 15.86 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt 45.17 59.12 3.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.622 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 16.1 p -45.21 134.18 6.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.471 -0.768 . . . . 0.0 110.735 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.4 -24.54 15.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.24 144.25 15.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.57 -50.69 85.79 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -1.104 . . . . 0.0 110.841 -179.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -62.91 -19.24 68.38 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.461 1.243 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.45 -32.06 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.775 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 4.0 t -66.36 -29.95 70.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -50.89 -59.56 7.27 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.556 179.375 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -56.64 -44.51 44.74 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.345 1.182 . . . . 0.0 109.486 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -58.31 -33.05 69.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 108.989 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.7 -39.45 80.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.579 -0.701 . . . . 0.0 109.724 179.472 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -69.05 -20.78 64.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 110.137 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -103.82 -10.52 18.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.7 -54.06 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.124 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.526 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 14.9 tt -105.12 -12.69 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.94 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.84 89.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ALA . 15.7 tptt -135.24 1.75 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 110.316 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.6 46.87 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 110.487 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.08 88.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.336 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -153.53 175.61 31.84 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 2.0 mtmp? -146.11 -168.45 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -1.118 . . . . 0.0 110.461 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 38.0 t -125.21 105.87 9.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 tpt -128.34 137.42 51.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.24 28.01 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.396 179.79 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . 69.73 37.44 76.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -139.3 150.97 46.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.328 -1.101 . . . . 0.0 110.015 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.539 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.4 104.69 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 110.173 -179.819 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 15.8 mtpt -89.75 159.06 17.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.518 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -155.83 154.31 31.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -104.42 152.02 39.24 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.587 1.309 . . . . 0.0 110.608 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 3' ' ' ILE . 5.7 mt . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -99.68 20.95 13.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.3 124.92 22.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 2.6 ptmt -68.6 77.03 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.438 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 6' ' ' LYS . 4.2 p -50.68 -178.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 109.969 179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -129.88 -37.66 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.375 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -146.92 -52.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.86 -54.85 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.185 -1.185 . . . . 0.0 111.222 -179.854 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.15 -37.1 96.96 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.279 1.147 . . . . 0.0 111.478 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 pm0 -58.76 -27.47 65.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.975 -1.078 . . . . 0.0 110.464 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -67.75 -37.24 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.548 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -49.46 -56.77 14.5 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 110.478 -180.0 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -58.73 -41.79 59.87 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.316 1.167 . . . . 0.0 109.686 179.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -49.3 77.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.792 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.468 ' O ' HG21 ' A' ' 21' ' ' ILE . 75.5 m -58.81 -35.57 73.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -62.33 -37.57 86.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.855 . . . . 0.0 110.038 179.766 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.73 -17.79 57.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 109.921 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.45 -43.39 5.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.526 HG21 ' N ' ' A' ' 22' ' ' GLY . 11.5 tt -111.59 -25.75 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.958 . . . . 0.0 110.169 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 69.81 37.58 75.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CB ' HG23 ' A' ' 21' ' ' ILE . 7.0 tttp -130.04 -2.64 4.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -1.207 . . . . 0.0 110.314 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' C ' ' CD1' ' A' ' 14' ' ' LEU . . . 48.82 57.46 6.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.34 119.33 6.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.025 -1.047 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . 149.69 172.2 18.96 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -141.73 -168.16 2.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -1.018 . . . . 0.0 110.005 179.794 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -102.08 150.56 23.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.746 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.426 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.53 73.38 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -179.605 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.5 m120 51.93 30.04 6.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 139.78 -31.37 2.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 29' ' ' MET . 0.3 OUTLIER -106.32 -175.81 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.902 -1.351 . . . . 0.0 110.35 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.8 t -120.76 155.25 34.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.009 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -136.38 88.94 2.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.648 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.486 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 19.4 m -80.17 139.65 36.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.903 . . . . 0.0 109.751 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.47 140.98 52.27 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.149 -0.97 . . . . 0.0 110.36 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.561 1.295 . . . . 0.0 110.503 179.653 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.473 HG13 ' HB3' ' A' ' 33' ' ' CYS . 2.7 pt . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.248 0.547 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' ALA . 15.7 p-10 -56.41 -43.65 79.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.802 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . 37.78 -141.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.606 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.3 50.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.473 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 25.4 p -57.73 146.42 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.4 0.619 . . . . 0.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -111.63 -11.36 14.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.368 -0.833 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -144.29 -71.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.562 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.59 -54.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 110.523 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -60.27 -20.66 63.46 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.326 1.172 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 33.9 mm-40 -74.84 -17.77 60.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -68.33 -26.43 65.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.345 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.578 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.6 mt -59.02 -58.42 19.66 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.95 -49.95 10.1 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.373 1.196 . . . . 0.0 110.175 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -43.42 74.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.853 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 1.7 m -75.82 -38.06 58.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.963 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -28.43 43.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -101.65 -19.02 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 110.329 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . . . -80.98 -50.66 9.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.237 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 21' ' ' ILE . 5.9 pt -106.06 -36.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 110.34 21.29 6.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.35 -139.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -1.2 . . . . 0.0 109.937 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.61 50.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.0 -1.062 . . . . 0.0 110.201 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.34 100.24 3.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 27' ' ' LYS . . . 173.67 -176.63 46.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 25.2 mtmm -143.99 -172.23 3.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -1.218 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -100.26 159.08 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -0.82 . . . . 0.0 109.941 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -146.08 98.74 3.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.033 . . . . 0.0 111.137 -179.711 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 51.78 29.8 6.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 101.07 19.98 15.31 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 mttp -131.28 164.5 25.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -1.205 . . . . 0.0 109.824 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.473 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.9 t -112.4 131.71 55.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.039 -1.038 . . . . 0.0 111.296 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HD2' ' HB2' ' A' ' 29' ' ' MET . 0.0 OUTLIER -113.3 93.03 4.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.687 -0.633 . . . . 0.0 109.426 179.279 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.0 m -115.86 164.62 14.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.975 -1.078 . . . . 0.0 110.696 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -102.36 155.83 36.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.321 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.311 -1.446 0 O-C-N 123.772 1.406 . . . . 0.0 110.46 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.123 0.487 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 11.4 m-85 -122.85 169.98 10.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 33' ' ' CYS . 1.6 pt -130.12 144.33 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' ALA . 10.5 p30 -67.67 -13.91 62.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 110.389 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.484 ' CB ' HG13 ' A' ' 3' ' ' ILE . . . -44.25 104.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.02 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.27 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 5' ' ' ALA . 26.3 p -75.57 153.58 37.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -128.8 -9.54 4.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.039 -1.038 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.98 131.0 4.72 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.154 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -49.4 -49.23 72.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 110.952 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.63 -21.02 70.19 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.303 1.159 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -75.63 -30.94 59.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 109.599 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -68.0 -22.0 65.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.579 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -64.14 -58.9 12.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.8 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.76 -32.19 96.53 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.362 1.191 . . . . 0.0 109.354 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -56.14 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.494 -0.754 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' HD12 ' A' ' 21' ' ' ILE . 94.5 m -50.33 -47.38 55.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -58.75 -34.47 71.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.245 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.8 tm-20 -82.36 -16.12 50.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 109.363 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 21' ' ' ILE . . . -88.1 -58.42 2.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.189 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -105.3 -28.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.274 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 -15.27 5.07 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.037 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 8.7 mmmt -118.81 144.6 46.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.235 . . . . 0.0 110.508 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 14' ' ' LEU . . . -90.09 64.22 6.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.39 103.99 7.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.83 178.38 45.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.34 -175.64 4.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -1.178 . . . . 0.0 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.2 t -126.55 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.421 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 13.1 mtp -150.15 160.82 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 110.308 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 51.05 24.78 2.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.314 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 69.16 41.57 79.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 26.4 mttm -156.98 161.65 39.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -1.135 . . . . 0.0 110.023 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -99.36 134.0 42.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.179 -0.95 . . . . 0.0 110.194 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HA ' ' CD2' ' A' ' 2' ' ' PHE . 8.6 mtpt -107.0 86.07 2.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.9 m -91.54 135.65 33.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.85 113.8 65.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.229 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.268 1.141 . . . . 0.0 110.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.529 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 10.5 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.375 0.607 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 1' ' ' VAL . 27.4 m-85 -150.59 152.98 34.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.019 -1.05 . . . . 0.0 110.66 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.04 164.36 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 109.701 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' ALA . 21.8 p30 -106.89 -10.58 15.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.33 116.07 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.833 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.65 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 0.0 110.378 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 27.3 p -60.35 151.67 27.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -110.64 -22.21 11.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.962 . . . . 0.0 110.595 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.37 153.51 24.49 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.07 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.609 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -65.18 -48.24 69.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.474 -1.015 . . . . 0.0 111.207 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.77 -20.92 72.44 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.34 1.179 . . . . 0.0 111.103 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 tt0 -75.18 -37.13 61.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 109.807 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -67.48 -23.32 65.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.854 . . . . 0.0 110.132 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.1 mm? -59.38 -59.06 15.06 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.993 . . . . 0.0 109.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.4 -47.95 15.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.277 1.146 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 1.7 mtpt -64.53 -53.5 46.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -0.801 . . . . 0.0 110.176 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 13' ' ' CYS . 38.4 t -55.16 -36.49 65.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -62.87 -42.93 99.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.38 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -74.39 -15.85 60.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -0.998 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 19' ' ' GLU . . . -93.64 -34.52 13.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.504 ' CG2' ' O ' ' A' ' 17' ' ' CYS . 9.3 tt -110.91 -15.17 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 110.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 99.22 -14.71 60.99 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' ALA . 4.3 tptt -138.84 125.8 21.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.129 -1.218 . . . . 0.0 110.378 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.53 77.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -131.79 67.23 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -159.6 -173.65 28.35 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -162.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.5 t -130.96 118.35 20.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.66 162.55 40.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 48.77 23.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 69.32 26.52 74.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 15.7 mtpt -136.34 175.2 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.987 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -112.81 116.98 30.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.015 . . . . 0.0 110.381 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -96.9 151.07 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 109.499 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 34' ' ' LYS . 97.1 m -149.88 154.49 38.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 110.654 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.53 129.79 21.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.367 1.193 . . . . 0.0 110.588 -179.82 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.304 0.573 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 5.9 m-30 -99.19 145.25 27.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.1 pt -122.62 137.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.7 p30 -76.31 1.95 14.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.307 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.0 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.237 -0.914 . . . . 0.0 110.095 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -47.57 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.32 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 5' ' ' ALA . 12.1 p -78.72 -173.43 3.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.171 -0.956 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB2' ' OE1' ' A' ' 12' ' ' GLU . 3.0 mmt180 -112.04 -27.1 8.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.2 -173.62 33.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.603 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -70.27 -46.94 20.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.521 -0.988 . . . . 0.0 111.866 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.72 -9.92 15.34 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.127 1.067 . . . . 0.0 111.493 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -87.06 -20.41 27.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.981 -1.074 . . . . 0.0 109.536 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -36.97 83.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.441 -0.787 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.587 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -47.56 -58.71 6.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.13 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.63 -42.25 55.95 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.352 1.185 . . . . 0.0 109.918 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 16' ' ' LYS . 6.2 mptt -65.21 -51.18 62.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.3 m -57.06 -45.84 82.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.182 -0.949 . . . . 0.0 109.893 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.5 ttpt -61.96 -33.0 73.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.8 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.02 -11.62 43.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.56 -49.44 8.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.069 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 pt -125.61 -33.96 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.75 27.09 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HD2' ' OXT' ' A' ' 37' ' ' PRO . 4.0 mmtm -126.97 -156.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.378 -1.072 . . . . 0.0 109.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.88 44.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 110.066 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.37 101.01 6.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 176.72 171.91 40.84 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -138.72 -176.44 4.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.564 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -132.24 134.12 44.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.051 -1.03 . . . . 0.0 110.411 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.477 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -144.06 146.39 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 29' ' ' MET . 78.6 m-20 57.61 14.06 2.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 89.29 32.27 10.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.6 OUTLIER -141.69 143.9 33.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -1.22 . . . . 0.0 109.767 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.531 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.9 t -94.36 147.78 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.852 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.1 OUTLIER -132.85 99.9 4.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.205 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 6.4 m -101.5 174.88 5.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.132 -0.98 . . . . 0.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 21.2 m-85 -141.98 161.49 50.89 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' OXT' ' HD2' ' A' ' 23' ' ' LYS . 3.0 Cg_endo . . . . . 0 C--N 1.31 -1.462 0 O-C-N 123.701 1.369 . . . . 0.0 110.497 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.412 ' HB ' HG23 ' A' ' 21' ' ' ILE . 27.7 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 1.6 m-85 -121.61 144.93 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.456 HG13 ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -145.23 164.77 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.095 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.465 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 50.2 p30 -118.91 68.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 110.389 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . . . -79.78 6.2 11.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 65.98 51.25 1.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.4 p -71.48 166.88 20.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.83 -8.44 5.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 110.478 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.67 170.2 31.79 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.147 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -66.12 -48.29 59.86 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.946 . . . . 0.0 111.465 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.4 -10.64 16.64 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.321 1.169 . . . . 0.0 111.157 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -84.3 -47.12 11.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.128 -0.982 . . . . 0.0 109.631 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 53.2 t -67.93 -23.84 65.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.787 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.84 -59.44 11.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 109.566 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -58.98 -43.51 42.42 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.364 1.192 . . . . 0.0 109.359 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -57.15 -39.8 75.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 109.779 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 52.2 m -69.31 -42.93 74.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 -35.99 49.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 109.723 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -12.26 32.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 17' ' ' CYS . . . -81.09 -64.06 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.477 HD13 HG23 ' A' ' 21' ' ' ILE . 13.4 pt -109.97 -33.09 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.26 1.93 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' HD12 ' A' ' 21' ' ' ILE . 28.1 mmtm -142.29 114.34 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.69 62.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.404 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.01 102.57 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 110.11 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.93 -176.77 43.51 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -145.83 -170.58 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.063 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.1 t -128.8 111.8 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.441 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -133.13 150.58 52.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.31 26.04 2.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.31 40.76 80.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 17.1 mtpp -141.68 159.3 42.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.136 . . . . 0.0 110.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HB3' HG13 ' A' ' 3' ' ' ILE . 48.6 t -101.97 115.47 30.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 0.0 110.506 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.2 OUTLIER -102.2 123.83 46.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.709 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -107.14 148.39 28.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.967 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 47.8 m-85 -133.11 149.3 72.35 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.523 -0.736 . . . . 0.0 109.808 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 O-C-N 123.661 1.348 . . . . 0.0 110.548 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.195 0.521 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.553 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 12.7 m-30 -107.24 158.42 17.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.167 -0.958 . . . . 0.0 110.422 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -139.4 154.5 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ALA . 9.5 p30 -72.69 0.87 9.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.887 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.97 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.26 -164.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -40.08 1.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.337 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -156.86 -53.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.568 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 170.32 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.194 . . . . 0.0 110.7 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -59.85 -13.07 20.8 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.26 1.137 . . . . 0.0 110.709 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 26.1 mt-10 -92.5 -19.99 21.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -38.31 71.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.385 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.565 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -50.04 -56.0 20.61 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.67 -38.12 74.16 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.291 1.153 . . . . 0.0 109.781 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -64.41 -53.77 43.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.461 ' O ' HG21 ' A' ' 21' ' ' ILE . 85.4 m -53.95 -38.87 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.451 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -56.56 -44.94 81.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.863 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -78.32 -8.88 58.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.98 -51.18 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.378 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 22' ' ' GLY . 16.1 tt -99.66 -26.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 122.53 -28.64 5.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.95 147.68 52.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.82 95.17 6.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.23 50.85 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 110.153 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -143.76 -178.88 19.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 39.0 mtmt -139.44 179.73 6.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.444 -1.033 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 t -107.98 118.36 36.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.775 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.463 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.34 152.96 39.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.465 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.432 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 14.6 m-20 50.45 23.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.79 79.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -132.83 166.05 23.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 t -101.61 121.12 41.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HG2' ' CE2' ' A' ' 2' ' ' PHE . 6.8 mtpm? -97.63 90.34 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.953 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 13.2 m -87.48 139.3 30.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 3.3 m-30 -88.45 150.36 46.42 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.162 -0.962 . . . . 0.0 110.397 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 O-C-N 123.686 1.361 . . . . 0.0 110.532 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.198 0.523 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.623 ' CE2' ' CG ' ' A' ' 34' ' ' LYS . 25.2 m-85 -121.99 148.86 44.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 110.43 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.516 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 15.7 pt -133.65 137.55 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 109.917 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.72 75.44 9.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 110.47 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.4 15.21 20.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.907 . . . . 0.0 109.992 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 48.81 59.3 4.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 110.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 12.1 p -56.56 147.82 21.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 3.9 mmt-85 -99.03 -30.06 12.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.11 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.15 149.46 20.86 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.568 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -51.76 -54.56 38.66 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.231 -1.158 . . . . 0.0 110.656 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.93 -40.16 64.81 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.384 1.202 . . . . 0.0 110.312 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.2 mm-40 -64.94 -24.69 67.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.458 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.31 -31.23 70.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.1 mp -51.95 -58.68 10.35 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.65 -48.62 14.32 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.398 1.21 . . . . 0.0 110.034 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -60.58 -41.07 93.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 t -55.66 -39.71 71.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -44.53 80.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.991 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 7.5 tp10 -67.03 -14.01 62.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.1 -65.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 110.283 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.37 -25.08 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.93 13.23 10.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -119.1 111.69 18.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.157 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.2 55.92 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.164 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.75 108.69 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -179.16 152.22 10.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.9 -162.09 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 110.145 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 27.9 t -143.34 131.88 22.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.111 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtt -148.23 137.11 21.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.493 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.86 17.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.503 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 94.95 -1.06 64.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 38.3 mmtt -105.66 159.77 15.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.0 t -107.53 134.62 50.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.698 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.623 ' CG ' ' CE2' ' A' ' 2' ' ' PHE . 0.5 OUTLIER -99.14 83.66 2.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.51 137.53 37.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.421 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -109.25 117.99 52.0 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.271 1.143 . . . . 0.0 110.534 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 1' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.268 0.556 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 9.1 m-30 -97.92 153.8 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 110.261 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.468 HG12 ' HB3' ' A' ' 33' ' ' CYS . 29.6 pt -105.72 144.05 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -82.7 71.02 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.843 . . . . 0.0 110.364 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -110.97 23.65 13.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 5' ' ' ALA . 3.3 pttm 33.18 62.63 0.37 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.59 0.709 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 28.2 p -57.6 168.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.717 -0.614 . . . . 0.0 110.422 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HB2' ' OE2' ' A' ' 12' ' ' GLU . 3.3 mmt-85 -122.77 -25.11 4.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -150.67 148.66 20.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.582 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -45.82 -50.95 32.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 111.137 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -62.06 -17.86 58.55 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.327 1.172 . . . . 0.0 110.934 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 3.1 tt0 -70.68 -26.21 63.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.126 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -75.17 -27.64 59.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.16 -54.54 49.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.81 -1.181 . . . . 0.0 109.595 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.6 Cg_endo -64.41 -49.36 3.52 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.344 1.181 . . . . 0.0 110.54 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -69.34 -52.45 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.0 111.062 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 13' ' ' CYS . 32.9 t -55.26 -48.17 74.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 110.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -58.96 -35.38 73.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.987 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.32 9.01 42.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.59 -17.69 7.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 17' ' ' CYS . 8.4 tt -130.02 -26.02 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.053 -1.03 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 110.82 3.12 28.54 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 133.49 28.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.0 110.239 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 18' ' ' LYS . . . -73.99 55.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.63 96.52 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.91 156.53 28.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -129.73 -176.17 3.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.381 -1.07 . . . . 0.0 110.003 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -132.89 116.25 16.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.972 -1.08 . . . . 0.0 110.828 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.438 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 43.6 tpp -150.36 152.0 33.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.84 . . . . 0.0 110.121 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' MET . 3.7 m-80 61.19 13.01 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.04 23.71 56.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 49.7 mttt -132.33 161.46 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -1.141 . . . . 0.0 109.925 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.468 ' HB3' HG12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -104.44 122.61 45.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.748 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -89.63 155.11 19.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.4 m -147.62 162.28 39.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 110.534 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.87 159.73 49.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.816 . . . . 0.0 109.89 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 O-C-N 123.729 1.384 . . . . 0.0 110.611 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.177 0.513 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 22.1 m-30 -121.1 144.39 48.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 110.549 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.11 163.78 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.633 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -113.71 59.31 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.98 . . . . 0.0 109.85 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.53 10.69 26.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 110.6 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 54.06 44.12 29.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.08 -1.012 . . . . 0.0 110.099 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 6' ' ' LYS . 16.6 p -44.14 170.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.466 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.41 -22.03 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -0.839 . . . . 0.0 110.253 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.65 166.46 26.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.568 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.17 -50.0 1.41 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.331 -1.099 . . . . 0.0 111.058 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.7 -25.41 68.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.355 1.187 . . . . 0.0 110.704 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.46 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -70.88 -34.87 72.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.035 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -25.82 67.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.599 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.42 -59.9 9.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.92 . . . . 0.0 109.928 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.22 -49.04 13.49 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.311 1.164 . . . . 0.0 109.53 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.97 -37.67 74.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.439 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 24.7 t -70.37 -36.82 74.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.935 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 2.5 tttp -56.59 -44.16 80.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.942 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -17.89 48.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 110.184 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . . . -77.03 -54.03 7.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 110.426 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.424 HD13 ' SG ' ' A' ' 17' ' ' CYS . 12.1 pt -112.41 -34.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -0.918 . . . . 0.0 110.387 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 116.87 26.35 3.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -123.53 -147.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -1.09 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.56 48.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.235 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.81 68.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.106 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -126.12 161.85 20.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 -165.0 1.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -1.165 . . . . 0.0 110.345 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 29' ' ' MET . 43.3 t -137.98 114.09 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.451 ' HA ' ' HE3' ' A' ' 29' ' ' MET . 1.2 mmt -146.92 145.51 29.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.038 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.35 33.43 23.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.129 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.55 35.2 88.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 31' ' ' GLY . 10.5 mttt -142.09 159.19 42.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.59 122.54 37.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.131 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 3.1 mtmt -99.38 94.09 6.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.827 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.5 m -84.5 147.17 27.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 110.652 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -136.7 91.47 15.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.309 -1.51 0 O-C-N 123.689 1.363 . . . . 0.0 110.606 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.189 0.518 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 8.8 m-30 -90.3 154.12 19.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 5' ' ' ALA . 25.3 pt -113.22 151.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.883 . . . . 0.0 110.042 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 5' ' ' ALA . 1.2 p-10 -75.17 -0.65 20.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -42.5 116.86 0.91 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.099 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.6 ttmm -64.35 69.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 4.2 p -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -76.43 -15.57 59.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . 152.64 -23.96 0.83 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.67 -55.83 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.27 . . . . 0.0 110.927 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.13 -14.25 18.64 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.283 1.149 . . . . 0.0 110.652 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.48 -29.56 13.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.765 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.4 t -74.34 -33.58 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -59.95 -57.68 25.0 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.7 -50.53 9.04 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 109.464 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -52.87 -34.38 54.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.101 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 5.0 t -68.22 -43.57 77.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -54.63 -32.59 59.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.666 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.49 -16.08 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.782 . . . . 0.0 109.961 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.18 -50.6 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.389 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.48 -9.29 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 82.69 32.17 27.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -144.63 103.99 3.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 110.064 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 65.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -134.44 88.75 2.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 177.52 -175.64 47.67 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 20.2 mttp -151.14 177.02 10.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.6 t -112.16 139.28 47.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.288 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 29' ' ' MET . 3.9 ppp? -150.86 131.56 14.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 t30 58.1 41.65 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.747 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.62 30.07 76.57 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -137.39 155.8 48.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -1.214 . . . . 0.0 109.784 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.8 t -110.86 129.94 55.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.492 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.3 mtpt -100.88 144.81 29.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.346 -0.846 . . . . 0.0 109.751 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m -149.38 143.2 25.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.364 -0.835 . . . . 0.0 110.55 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -89.52 123.87 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 O-C-N 123.313 1.165 . . . . 0.0 110.529 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.202 0.525 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 19.9 m-30 -93.24 -178.98 4.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.72 148.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 5' ' ' ALA . 2.8 p-10 -74.57 -10.11 59.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -43.95 110.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.3 tttp -59.85 94.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -71.04 152.38 43.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.687 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -8.1 8.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.031 . . . . 0.0 110.74 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -155.7 135.39 4.56 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.188 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.6 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -52.45 -50.2 81.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -1.083 . . . . 0.0 110.698 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.79 -16.29 48.01 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.427 1.225 . . . . 0.0 110.576 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.44 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 11.9 tt0 -82.48 -39.43 22.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 0.0 109.726 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.96 -20.31 65.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.833 . . . . 0.0 109.993 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.589 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.8 mp -63.64 -59.65 11.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -59.84 -32.67 95.73 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.369 1.194 . . . . 0.0 109.92 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -64.07 -54.95 26.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 110.351 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 85.9 m -56.8 -39.88 74.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.053 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.9 tttt -59.22 -46.23 89.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.23 -16.74 62.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.93 -43.58 10.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 4.1 pt -115.83 -34.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 131.03 -14.0 5.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -126.65 145.11 50.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.242 . . . . 0.0 110.466 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.49 60.61 4.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.82 84.35 2.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -165.84 179.56 40.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 177.03 8.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -1.131 . . . . 0.0 110.298 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 29' ' ' MET . 1.5 t -123.27 114.04 19.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.833 . . . . 0.0 109.637 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -144.26 157.71 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.92 24.53 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.369 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 68.87 39.31 85.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -145.81 167.99 21.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -1.157 . . . . 0.0 110.035 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.4 t -109.88 123.4 49.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.696 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 1.5 mtmm -107.49 91.88 3.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.364 -0.835 . . . . 0.0 110.202 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 18.4 m -91.48 141.22 28.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.11 -0.994 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.415 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 4.5 m-85 -113.32 138.13 22.31 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.514 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG1' ' HG2' ' A' ' 37' ' ' PRO . 2.5 p . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.221 0.534 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 9.0 m-85 -123.97 -178.82 4.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.507 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.473 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.1 pt -136.62 160.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.387 -0.821 . . . . 0.0 109.745 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 19.4 p-10 -86.33 30.2 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -75.08 101.91 4.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 0.0 109.959 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 7.1 ptpp? -39.56 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.757 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' ALA . 25.4 p -78.42 146.33 34.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.912 . . . . 0.0 110.1 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -20.58 13.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -167.14 154.85 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -46.39 -50.23 40.6 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.4 -1.059 . . . . 0.0 111.03 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.35 -20.43 68.22 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.346 1.182 . . . . 0.0 110.968 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 tp10 -78.59 -39.67 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.944 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.1 t -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.046 -1.034 . . . . 0.0 110.143 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.589 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.1 mp -49.32 -59.09 7.16 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.026 -1.046 . . . . 0.0 109.768 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.45 -40.57 65.68 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.418 1.22 . . . . 0.0 109.898 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 2.1 mmtp -57.8 -46.04 85.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.965 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.43 -45.61 83.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -23.76 62.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.041 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.26 -12.17 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -103.41 -65.65 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 35' ' ' CYS . 11.8 pt -86.47 -21.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.95 18.5 26.96 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.99 119.58 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 110.158 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 64.71 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.32 76.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.938 . . . . 0.0 110.207 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -166.28 168.31 39.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 19.2 mtmt -132.7 -175.31 3.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -1.082 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 7' ' ' CYS . 11.3 t -100.97 147.33 26.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 0.0 109.791 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.463 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.43 93.9 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.002 -1.061 . . . . 0.0 110.814 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.4 m120 61.56 9.54 2.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.45 -0.781 . . . . 0.0 111.097 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 122.66 10.38 5.94 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 6.3 mttt -121.23 154.73 35.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.258 . . . . 0.0 110.227 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.473 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -96.43 120.22 36.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 22.3 mtmt -97.49 78.14 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.932 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 53.8 m -80.71 156.12 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.363 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.56 75.45 68.97 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.852 . . . . 0.0 110.153 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HG2' ' CG1' ' A' ' 1' ' ' VAL . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 O-C-N 123.611 1.322 . . . . 0.0 110.553 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.278 0.561 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -95.96 139.28 32.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.196 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -148.32 145.9 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -87.16 67.53 9.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.476 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -93.94 28.72 2.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 36.4 48.8 0.62 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.0 110.95 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 27.4 p -53.44 138.55 33.15 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.518 -0.739 . . . . 0.0 109.966 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -9.72 13.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.63 147.16 15.92 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.09 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.606 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -61.22 -43.97 91.92 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 111.613 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.0 -21.85 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 122.875 0.934 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 tt0 -78.64 -34.03 46.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.6 -26.62 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -57.19 -57.71 22.98 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 109.898 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.58 -41.37 48.39 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.38 1.2 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -62.49 -50.97 69.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.5 m -54.76 -36.52 64.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 109.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -67.11 -51.43 54.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.709 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.13 -5.09 33.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.719 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -57.01 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.15 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 pt -116.91 -32.5 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.61 17.16 2.16 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.233 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -144.68 125.43 14.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.974 -1.309 . . . . 0.0 110.058 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.34 81.32 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.442 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -146.9 119.46 8.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 150.35 177.95 24.79 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -148.13 -170.02 3.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.158 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.5 132.51 55.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.228 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 30' ' ' ASN . 6.3 tpt -149.64 143.95 25.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' N ' ' HG3' ' A' ' 29' ' ' MET . 1.0 OUTLIER 50.2 30.42 4.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 70.68 24.97 76.47 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 mttt -127.48 155.46 43.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 110.298 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 t -105.42 123.1 47.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.1 mtpm? -109.49 105.8 15.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 36.0 m -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.493 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -125.59 158.82 63.45 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 109.994 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.389 0 O-C-N 123.707 1.372 . . . . 0.0 110.587 -179.751 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.9 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.236 0.541 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.62 ' CE2' ' CD ' ' A' ' 34' ' ' LYS . 8.7 m-30 -107.87 149.91 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.477 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.4 pt -128.72 136.15 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -88.84 65.54 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.647 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 6' ' ' LYS . . . -81.54 1.1 35.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 68.46 52.47 0.61 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 28.8 p -55.54 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.393 -0.817 . . . . 0.0 109.952 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -141.45 -33.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 110.663 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -159.97 -40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.556 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 168.11 -53.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.267 -1.137 . . . . 0.0 110.473 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.53 -11.1 18.53 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.281 1.148 . . . . 0.0 110.507 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 tp10 -91.86 -47.47 7.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.913 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -67.03 -16.02 64.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 mt -72.83 -58.37 2.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.46 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -59.49 -46.55 20.43 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.314 1.166 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -38.46 85.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 31.9 t -65.22 -44.96 86.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -54.97 -41.89 71.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.04 -16.87 59.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.96 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.57 -55.14 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 110.333 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.51 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 1.5 tt -86.58 -17.7 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.71 -33.8 5.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.05 133.19 35.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -1.196 . . . . 0.0 110.159 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB2' HD22 ' A' ' 14' ' ' LEU . . . -67.3 91.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.182 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.82 66.59 1.39 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.375 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -158.56 -168.23 20.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.26 171.58 13.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -1.187 . . . . 0.0 110.117 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -110.57 142.51 42.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.95 . . . . 0.0 109.883 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.473 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -150.32 117.0 5.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.68 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' MET . 25.8 m-20 57.26 35.04 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.971 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 80.5 24.04 59.44 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.349 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.52 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -126.18 152.68 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.181 -1.188 . . . . 0.0 109.835 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.4 t -107.74 119.21 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 110.234 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' CD ' ' CE2' ' A' ' 2' ' ' PHE . 11.4 mtmt -108.39 117.23 33.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HA ' ' CA ' ' A' ' 26' ' ' GLY . 97.3 m -120.56 141.57 50.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.542 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 m-85 -79.39 -53.16 1.08 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 110.939 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 36' ' ' TYR . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.327 0 O-C-N 123.25 1.131 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 35' ' ' CYS . 32.9 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.232 0.539 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.565 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 20.8 m-85 -119.79 162.85 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.431 HG13 ' HB3' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -136.0 149.78 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -90.81 46.78 1.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.57 8.1 8.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 34.5 mmtt 51.77 51.3 16.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 27.1 p -55.87 150.72 12.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.838 . . . . 0.0 110.234 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -111.49 -24.13 10.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 150.79 22.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.36 -47.93 95.19 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.074 . . . . 0.0 111.241 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -64.5 -39.44 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.301 1.159 . . . . 0.0 110.72 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -60.38 -26.48 66.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.145 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -29.62 68.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.578 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.5 mp -54.0 -58.94 11.26 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.73 -47.27 19.24 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.346 1.182 . . . . 0.0 110.017 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -60.85 -47.83 84.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 109.89 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.1 t -59.75 -37.21 78.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 109.974 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -58.21 -47.87 82.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.13 -25.67 60.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.42 60.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.68 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 pt -124.31 -31.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 0.0 110.58 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 113.43 18.62 7.01 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' CE ' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -145.12 125.29 13.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.147 . . . . 0.0 110.181 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.7 7.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.35 68.19 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.336 -0.852 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -156.54 152.04 23.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.3 mtmt -114.52 179.84 3.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -1.178 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 32.0 t -120.75 138.88 53.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.454 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -148.06 116.36 6.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.94 . . . . 0.0 110.489 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 66.33 7.23 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.623 179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 106.76 16.0 15.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 24.0 mmtt -123.24 142.66 50.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -1.194 . . . . 0.0 109.894 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.9 t -93.34 127.54 38.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.373 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HG2' ' CE2' ' A' ' 2' ' ' PHE . 24.2 mtpt -101.08 80.93 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' O ' ' N ' ' A' ' 1' ' ' VAL . 68.3 m -86.28 147.5 26.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.4 m-85 -79.26 -60.32 0.55 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 110.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 36' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.366 0 O-C-N 123.213 1.112 . . . . 0.0 110.52 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 44.4 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.247 0.546 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 12.1 m-30 -97.05 164.33 12.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 110.284 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.47 HD13 ' HB1' ' A' ' 5' ' ' ALA . 20.7 pt -130.34 144.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.869 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -79.43 16.1 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 111.244 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HB1' HD13 ' A' ' 3' ' ' ILE . . . -46.88 171.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.93 -1.106 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 2.7 tppt? -116.32 69.3 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.564 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LYS . 5.0 p -49.12 175.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 109.703 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.48 -10.02 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.116 -0.99 . . . . 0.0 110.777 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -161.42 -74.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.579 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 175.88 -58.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 110.545 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 3.0 Cg_endo -57.94 -15.63 22.98 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.293 1.154 . . . . 0.0 110.287 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 mt-10 -87.55 -15.55 37.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.08 -40.41 68.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.561 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 tp -50.09 -54.29 34.8 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -60.5 -55.86 1.29 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.396 1.208 . . . . 0.0 110.254 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -62.11 -31.62 72.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 13' ' ' CYS . 35.8 t -71.89 -46.11 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -58.11 -45.14 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.71 -21.41 60.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.424 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.96 -51.39 8.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 21' ' ' ILE . 2.5 tt -101.94 -24.19 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 104.2 -6.74 46.93 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.39 115.34 25.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.133 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 18' ' ' LYS . . . -70.8 67.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.68 103.51 3.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 170.66 178.67 41.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -147.78 -176.12 5.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -1.076 . . . . 0.0 110.124 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 6.6 t -107.91 128.62 54.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -145.95 126.9 14.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.47 -0.769 . . . . 0.0 109.788 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.2 m120 62.68 42.58 8.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 62.43 23.88 65.14 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 20.2 mttm -134.03 175.99 8.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -1.183 . . . . 0.0 109.922 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB3' HG12 ' A' ' 3' ' ' ILE . 1.9 t -118.47 129.25 55.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HD2' ' CE2' ' A' ' 2' ' ' PHE . 1.9 mmmm -99.92 92.47 5.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 110.148 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.87 142.81 27.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.394 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -96.47 133.92 24.1 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.451 1.237 . . . . 0.0 110.548 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.554 ' C ' ' CD1' ' A' ' 2' ' ' PHE . 8.0 p . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.21 0.529 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.633 ' CE2' ' CG ' ' A' ' 34' ' ' LYS . 13.6 m-85 -132.65 157.84 43.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.666 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.538 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 1.3 pt -125.78 137.8 56.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.227 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.87 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.362 0.601 . . . . 0.0 111.074 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -144.55 88.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.214 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 6.3 mmtp -36.01 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.373 0.606 . . . . 0.0 110.897 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 5' ' ' ALA . 23.8 p -78.71 139.57 38.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.349 -0.845 . . . . 0.0 110.352 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 -15.19 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.265 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -154.27 151.4 23.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.579 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -60.09 -50.98 83.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -1.149 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.16 -11.98 21.21 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.422 1.222 . . . . 0.0 110.841 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -80.51 -34.82 35.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 2.0 t -67.1 -27.19 67.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -53.72 -59.08 10.51 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 0.0 109.723 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.21 -41.97 54.73 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.362 1.19 . . . . 0.0 109.785 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -50.31 64.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 59.6 m -56.48 -45.93 80.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.112 -0.992 . . . . 0.0 109.822 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -39.78 69.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.712 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -78.97 -13.42 59.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.53 -15.69 25.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 pt -148.52 -37.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.352 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -9.13 10.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 126.55 52.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 110.263 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' O ' HD11 ' A' ' 14' ' ' LEU . . . -76.57 74.11 3.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.361 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 110.12 4.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 109.865 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 177.6 171.16 40.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -145.37 -168.73 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -1.118 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.77 133.04 55.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.27 141.62 23.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.0 110.968 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.14 22.3 0.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.33 -0.856 . . . . 0.0 110.621 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 82.2 13.84 78.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 7.6 mttt -117.69 160.17 21.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -1.174 . . . . 0.0 109.618 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.538 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -97.04 128.16 43.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.856 -1.152 . . . . 0.0 110.146 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' CG ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 mtpt -96.88 117.38 30.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.41 ' O ' HG11 ' A' ' 1' ' ' VAL . 85.8 m -123.34 134.98 53.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.978 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' OH ' ' CE ' ' A' ' 34' ' ' LYS . 23.6 m-85 -108.38 151.28 41.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 O-C-N 123.655 1.345 . . . . 0.0 110.359 179.911 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.195 0.521 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 10.5 m-30 -104.78 170.16 8.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.925 . . . . 0.0 110.247 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.0 pt -133.35 134.36 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.84 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.444 ' HA ' ' CE ' ' A' ' 32' ' ' LYS . 27.9 p-10 -79.34 48.09 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.399 -0.813 . . . . 0.0 110.47 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -95.09 90.77 6.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -0.952 . . . . 0.0 109.81 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -45.76 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.437 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 10.3 p -73.11 -167.68 0.42 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.135 -0.978 . . . . 0.0 110.367 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.31 -17.38 6.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.213 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.69 150.29 22.35 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -58.84 -51.0 84.96 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -1.093 . . . . 0.0 111.163 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.44 -24.73 78.84 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.39 1.205 . . . . 0.0 111.217 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.444 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 39.4 tp10 -58.88 -26.51 64.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -70.96 -23.05 62.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -58.05 -57.39 26.22 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.4 -45.0 19.94 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.424 1.223 . . . . 0.0 109.864 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -49.05 79.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 m -61.78 -42.55 99.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.726 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 12.2 ttpp -55.99 -30.1 61.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.04 -20.11 23.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.55 -57.88 2.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.521 ' CG1' ' N ' ' A' ' 22' ' ' GLY . 10.0 pt -100.9 -41.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.09 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 103.01 32.79 4.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 19.9 mmtt -129.69 -2.27 4.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -1.178 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.62 60.33 1.64 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.742 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 36' ' ' TYR . . . -150.22 82.37 1.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.0 -175.2 33.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 5.3 mttp -150.0 -176.92 5.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -1.068 . . . . 0.0 109.948 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.1 t -121.97 127.54 50.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 110.585 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.512 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -144.11 155.27 43.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 109.823 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.87 18.21 1.54 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.127 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' C ' ' CG ' ' A' ' 32' ' ' LYS . . . 78.06 43.3 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 3.9 mttt -153.07 160.33 42.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.132 -1.216 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -91.26 134.2 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 0.0 109.96 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.4 OUTLIER -120.89 99.68 6.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.547 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 57.1 m -87.74 156.4 19.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.101 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' ALA . 32.6 m-85 -140.33 141.24 25.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 0.0 110.23 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--N 1.313 -1.314 0 O-C-N 123.508 1.268 . . . . 0.0 110.451 179.853 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.164 0.507 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.568 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 16.2 m-30 -105.07 175.19 5.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.523 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.8 pt -141.74 150.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 6' ' ' LYS . 12.3 p-10 -62.6 -9.77 10.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.464 -0.773 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' CB ' HD12 ' A' ' 3' ' ' ILE . . . -41.2 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.86 . . . . 0.0 110.265 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' ASN . 10.5 mmtm -49.04 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 110.345 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . 16.9 p -76.07 149.36 37.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -122.38 -10.67 8.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.01 143.84 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -49.75 -50.26 68.37 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.338 -1.095 . . . . 0.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.14 -9.35 16.88 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.368 1.194 . . . . 0.0 110.776 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -87.8 -35.63 17.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 8.4 t -73.24 -39.92 65.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.584 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -44.56 -55.65 9.89 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.059 -1.026 . . . . 0.0 109.845 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -62.54 -47.76 8.77 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.367 1.193 . . . . 0.0 110.119 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -54.01 -44.14 70.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.873 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 60.6 m -62.65 -39.34 93.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.856 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 10.6 tttt -61.92 -26.96 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -32.49 21.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.475 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.63 -18.02 21.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.119 -0.988 . . . . 0.0 110.325 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.593 ' CD1' ' CB ' ' A' ' 35' ' ' CYS . 37.0 mt -128.92 -45.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 97.18 35.76 5.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -134.78 1.39 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -1.226 . . . . 0.0 110.338 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.16 46.28 1.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.463 -0.773 . . . . 0.0 110.442 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.84 106.85 7.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 110.237 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 173.49 178.99 43.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -146.58 -165.36 2.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.011 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 t -126.71 122.56 35.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 tpt -150.02 134.96 17.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 62.15 31.01 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.261 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.76 33.88 88.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 18.3 mttt -136.36 150.87 49.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.221 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.45 118.16 30.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 109.846 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.6 OUTLIER -101.22 103.73 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.454 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.593 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 9.8 m -111.76 166.74 10.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.89 157.4 42.0 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.423 0 O-C-N 123.69 1.363 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.502 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 49.8 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.353 0.597 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 3.2 m-30 -90.44 165.7 13.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 3' ' ' ILE . 17.9 pt -147.73 135.34 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.506 ' CB ' ' HD3' ' A' ' 32' ' ' LYS . 14.6 p-10 -101.34 60.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.283 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.71 4.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 47.65 79.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.51 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -70.42 -165.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 0.0 109.982 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -126.45 -18.0 4.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.01 . . . . 0.0 110.63 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -154.3 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 168.65 -55.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.095 -1.238 . . . . 0.0 111.309 -179.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.9 Cg_exo -56.15 -11.95 6.76 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.309 1.163 . . . . 0.0 111.69 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.85 -31.2 64.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 109.533 179.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.1 t -69.12 -28.65 66.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.506 -0.746 . . . . 0.0 110.633 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.562 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 tp -59.36 -56.5 35.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.581 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.26 -46.44 18.41 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.405 1.213 . . . . 0.0 110.291 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -62.58 -32.6 73.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 21' ' ' ILE . 20.0 m -64.24 -52.33 59.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 ttpt -57.94 -35.84 71.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 mm-40 -76.05 -18.17 59.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.95 -9.94 12.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' CYS . 5.8 tt -131.06 -28.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.504 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 116.65 -38.0 3.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -124.0 132.92 53.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.339 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.85 90.61 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' TYR . . . -141.42 89.55 2.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 27' ' ' LYS . . . 177.7 -175.42 47.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 15.1 mtmm -150.15 175.03 12.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -1.094 . . . . 0.0 109.584 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 18.4 t -109.44 130.71 55.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.927 -1.108 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.527 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 1.6 ttt -130.51 138.6 50.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 61.24 11.93 3.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 95.63 17.48 35.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HD3' ' CB ' ' A' ' 4' ' ' ASN . 2.1 mttt -131.24 143.29 50.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.917 -1.343 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.7 t -84.47 145.51 28.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 0.0 110.638 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 2.4 mtmp? -133.24 100.84 4.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.742 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.6 m -81.93 168.4 17.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.519 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 5.4 m-85 -122.08 159.6 51.07 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.004 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 0.0 110.554 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.289 0.566 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 14.3 m-30 -104.08 165.78 10.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.481 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -116.72 156.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -108.14 42.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.51 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -96.15 27.78 3.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.581 -0.699 . . . . 0.0 110.278 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 3.1 ptmm? 36.06 72.57 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.582 0.706 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.9 p -51.82 134.46 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.63 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -94.26 -15.58 24.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 0.0 109.845 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -160.1 156.98 28.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.43 -50.02 89.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.13 -11.44 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.425 1.224 . . . . 0.0 110.857 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 8.5 mm-40 -81.7 -33.72 31.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.3 t -67.03 -21.01 65.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -59.65 -59.36 14.1 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.068 -1.02 . . . . 0.0 109.314 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -57.94 -37.98 94.01 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.3 1.158 . . . . 0.0 109.697 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 18.5 mttp -69.81 -38.31 76.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' O ' HG12 ' A' ' 21' ' ' ILE . 62.6 m -75.65 -34.82 60.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.902 . . . . 0.0 109.703 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -67.78 -36.24 80.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.83 -18.29 27.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.188 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -75.04 -55.33 5.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.338 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 17' ' ' CYS . 18.1 pt -108.34 -35.03 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.14 11.02 3.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -135.52 135.92 40.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.281 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -85.73 76.64 9.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 93.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -164.79 178.45 39.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 3.6 mtmp? -142.71 -175.16 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -1.107 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 5.8 t -132.18 119.7 21.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 110.168 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.449 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.13 145.35 30.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.829 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.83 28.28 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.817 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.82 75.7 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -126.57 159.39 33.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -1.154 . . . . 0.0 110.344 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.5 119.78 40.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.974 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.3 mtmt -105.36 125.78 51.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.404 ' SG ' HD12 ' A' ' 3' ' ' ILE . 40.0 m -119.11 142.14 48.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -110.2 125.1 31.73 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 110.148 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.401 1.211 . . . . 0.0 110.516 179.983 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.464 HG22 ' HD3' ' A' ' 37' ' ' PRO . 33.7 m . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.594 0.712 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 2.6 m-85 -109.67 148.2 31.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 110.032 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 33' ' ' CYS . 1.7 pt -128.31 141.02 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.101 -0.999 . . . . 0.0 110.043 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.467 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 31.5 p-10 -101.0 68.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.86 11.16 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 4' ' ' ASN . 4.4 mttt 50.64 60.86 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 23.7 p -71.97 159.07 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 110.409 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.54 -17.13 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.01 151.78 22.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -52.9 -48.0 93.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.392 -1.063 . . . . 0.0 111.529 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.01 -25.9 78.09 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.201 1.106 . . . . 0.0 111.684 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.3 tp10 -52.33 -29.58 24.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.806 -1.184 . . . . 0.0 110.095 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 5.6 t -69.35 -35.59 76.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.499 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.589 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -44.62 -57.5 6.63 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.947 -1.096 . . . . 0.0 109.816 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -61.49 -48.4 9.51 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.392 1.206 . . . . 0.0 109.323 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.779 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 5.1 t -61.6 -48.73 79.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.429 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 4.5 ttmt -66.16 -19.81 65.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.885 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.54 -12.98 30.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.98 -69.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.365 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 23' ' ' LYS . 6.2 pt -84.78 -29.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 110.204 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 112.67 18.1 7.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -149.99 122.88 8.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -1.225 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 14' ' ' LEU . . . -81.48 82.33 7.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.84 92.17 2.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . 171.13 -159.36 31.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.5 mtmp? -147.73 -163.37 1.75 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -1.092 . . . . 0.0 109.859 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' CB ' ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -138.86 127.71 23.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.884 -1.135 . . . . 0.0 110.682 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 29.5 ttm -141.91 166.19 25.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 109.657 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 48.92 22.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.965 . . . . 0.0 109.892 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.401 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 73.6 34.97 56.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.2 mttp -148.19 147.05 28.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.485 ' HB3' HD12 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -83.4 139.44 32.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -115.55 149.57 37.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.845 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.05 147.83 37.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.566 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -123.13 104.05 35.62 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.024 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HD3' HG22 ' A' ' 1' ' ' VAL . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 O-C-N 123.457 1.241 . . . . 0.0 110.594 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.248 0.547 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 17.1 m-30 -116.59 163.44 16.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.509 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.537 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.9 pt -110.39 154.02 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 109.67 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 24.8 p-10 -100.24 55.31 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.817 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.79 15.15 17.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 4.7 mmtp 46.63 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.343 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 8' ' ' ARG . 19.6 p -69.7 -168.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 3.5 mmt85 -140.37 -34.89 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -138.45 -65.19 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.105 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER 169.9 -55.85 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.119 -1.224 . . . . 0.0 110.88 -179.691 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -57.92 -26.67 75.55 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.377 1.199 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt-10 -61.2 -23.12 65.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -69.64 -31.01 68.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.941 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.575 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -53.58 -58.43 12.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.072 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.66 -51.93 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.367 1.193 . . . . 0.0 109.976 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -60.27 -46.65 89.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.1 t -62.61 -44.43 96.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -58.54 -28.3 65.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -105.25 1.58 28.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.17 -62.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.488 HG21 ' N ' ' A' ' 22' ' ' GLY . 4.4 tt -90.34 -39.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 110.03 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.488 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 109.38 26.68 5.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.79 127.66 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.539 -0.977 . . . . 0.0 109.828 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.28 50.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 110.779 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -137.16 110.97 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.046 -1.034 . . . . 0.0 109.837 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 179.26 173.36 44.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -150.04 -172.39 4.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.136 . . . . 0.0 110.302 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t -122.54 122.12 38.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 3.6 tmm? -146.91 137.07 23.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 63.94 10.75 5.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 110.343 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.79 22.8 37.97 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -124.97 162.44 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -1.153 . . . . 0.0 110.269 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.537 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -108.64 106.81 17.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 108.726 179.736 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 3.9 mtpm? -89.4 152.96 21.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.018 . . . . 0.0 111.003 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 23.7 m -144.23 136.71 26.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.689 . . . . 0.0 109.751 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -97.22 154.03 38.24 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.942 . . . . 0.0 110.464 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.732 1.385 . . . . 0.0 110.639 179.862 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.239 0.543 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 20.1 m-30 -105.85 140.96 38.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.433 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.511 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.8 pt -135.98 138.77 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -0.844 . . . . 0.0 110.208 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 4' ' ' ASN . 16.0 p-10 -79.84 75.44 6.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 0.0 110.087 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -108.36 15.95 23.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' CA ' ' O ' ' A' ' 31' ' ' GLY . 23.6 tptp 44.51 44.0 6.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 26.8 p -45.65 154.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -101.79 -31.19 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.36 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 176.54 31.67 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.122 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.604 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -69.27 -47.39 28.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.991 . . . . 0.0 111.369 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -60.84 -21.97 72.27 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.175 1.092 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.9 mm-40 -84.03 -35.76 23.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 42.1 t -69.3 -31.55 70.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.67 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.586 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -51.83 -59.07 8.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 109.839 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.13 -45.44 31.66 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.292 1.154 . . . . 0.0 109.684 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -52.85 -41.21 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.9 m -69.66 -27.77 65.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.577 179.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 2.0 ttpm? -71.06 -22.02 62.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.787 . . . . 0.0 109.73 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.77 -26.03 18.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.146 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.52 -45.16 17.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.4 pt -123.27 -32.62 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 110.339 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 96.25 36.36 5.2 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -121.82 -9.22 8.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.509 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.21 47.22 2.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.767 . . . . 0.0 110.4 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.94 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -151.62 -178.11 26.06 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 mttp -143.0 172.11 13.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -1.106 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.7 t -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.334 -0.854 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 46.7 tpp -135.94 127.3 28.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 110.501 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.05 23.65 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 6' ' ' LYS . . . 88.75 3.98 76.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 150.97 24.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.918 -1.342 . . . . 0.0 110.36 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -95.82 126.31 40.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -104.75 84.69 2.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.694 -179.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -85.17 148.79 25.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.101 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.86 108.37 28.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 109.994 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 O-C-N 123.469 1.247 . . . . 0.0 110.624 -179.791 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 8.3 m-30 -90.35 -179.23 5.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.154 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 2' ' ' PHE . 1.6 pt -158.82 137.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 20.6 p30 -87.26 67.91 9.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.37 4.5 42.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 56.49 57.62 4.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -65.56 166.73 10.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -107.31 -9.52 16.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.46 156.02 27.38 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.15 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.633 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -63.41 -42.58 75.06 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.964 . . . . 0.0 112.074 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.7 Cg_exo -60.12 -13.49 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 122.848 0.92 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.412 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -75.54 -22.04 57.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.036 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 10' ' ' SER . 1.3 m -71.8 -26.25 62.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.57 -0.706 . . . . 0.0 110.147 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -58.65 -57.78 24.08 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.15 -45.7 22.2 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.326 1.172 . . . . 0.0 109.97 179.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -62.09 -50.29 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 49.9 m -54.27 -36.99 64.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.021 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -60.88 -52.35 65.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -76.42 -4.55 42.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.042 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.75 -47.69 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 36' ' ' TYR . 6.9 tt -116.92 -28.16 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 85.11 38.65 9.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -138.08 2.2 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.292 . . . . 0.0 110.706 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.55 48.24 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.42 108.82 4.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.06 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -178.11 -178.0 47.26 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.112 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -146.92 175.08 10.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.957 . . . . 0.0 109.448 179.664 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.83 128.87 41.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 110.267 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.1 tpp -143.38 154.08 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 110.111 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.56 20.88 6.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.069 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 77.55 29.7 54.91 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 41.6 mttt -141.73 153.76 44.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -1.189 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' C ' ' CG ' ' A' ' 34' ' ' LYS . 9.9 t -93.01 154.81 17.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.84 . . . . 0.0 110.827 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 23.8 mtmm -148.68 99.67 3.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.035 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 58.1 m -81.81 173.85 11.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.199 -0.938 . . . . 0.0 110.386 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.5 m-85 -108.58 140.43 21.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.291 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.509 1.268 . . . . 0.0 110.587 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 3.0 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.316 0.579 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 12.7 m-85 -140.76 163.57 32.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 110.089 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.55 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.9 pt -124.33 145.44 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 44.5 p30 -98.05 75.59 2.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.945 . . . . 0.0 110.572 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 15.16 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.875 . . . . 0.0 109.872 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER 48.51 55.25 9.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 -179.895 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 22.0 p -61.12 144.19 54.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.29 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -26.64 13.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -137.31 152.7 21.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.11 -46.22 96.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.397 -1.061 . . . . 0.0 111.67 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.6 Cg_exo -61.58 -16.7 49.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.064 1.033 . . . . 0.0 111.429 -179.144 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -73.99 -32.56 63.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.938 -1.101 . . . . 0.0 109.699 179.464 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 1.9 t -68.2 -24.8 64.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -55.1 -59.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 179.765 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.04 -44.43 29.76 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.365 1.192 . . . . 0.0 109.878 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 11.5 mmtt -64.83 -39.11 93.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 110.247 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 55.9 m -66.0 -25.18 66.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 110.409 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -77.91 -41.36 36.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 110.509 -179.752 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.0 -24.53 47.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 110.668 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 16' ' ' LYS . . . -88.35 -23.6 23.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 35' ' ' CYS . 8.1 mt -131.06 -29.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 110.48 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 112.37 -19.15 22.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.03 119.93 38.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -1.144 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' HB1' HD22 ' A' ' 14' ' ' LEU . . . -68.63 79.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.004 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.24 127.91 12.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 157.9 -175.22 35.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -146.7 -170.33 3.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 31.2 t -132.73 111.86 11.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -122.36 125.59 46.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 -179.883 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 65.16 16.14 10.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 179.805 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.64 18.76 54.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 4.0 mmtp -112.8 144.98 41.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.333 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -93.88 114.53 26.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.133 -179.709 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.7 OUTLIER -109.96 116.37 31.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.042 179.836 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 17.3 m -111.06 144.56 39.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 27.2 m-85 -93.32 149.95 38.22 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 O-C-N 123.754 1.397 . . . . 0.0 110.522 -179.725 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.108 0.48 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 9.3 m-85 -123.02 155.89 35.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.342 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.0 pt -112.01 138.53 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 109.985 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 5' ' ' ALA . 14.7 p30 -64.13 -7.52 9.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 110.894 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.39 113.62 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 110.436 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.25 79.99 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.922 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.0 p -75.09 172.33 12.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -132.41 -27.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.948 . . . . 0.0 110.876 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.04 141.79 16.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.9 -52.7 70.49 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.385 -1.068 . . . . 0.0 110.771 179.887 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' SER . 2.9 Cg_endo -62.32 -35.68 71.92 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.387 1.204 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt-10 -62.36 -26.14 68.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -67.93 -38.05 82.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.991 179.794 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.583 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.2 mp -44.77 -58.55 5.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.774 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -57.75 -55.46 2.36 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.426 1.224 . . . . 0.0 109.805 179.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 22.5 mmmt -52.68 -39.06 61.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.251 179.233 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' O ' HG21 ' A' ' 21' ' ' ILE . 38.0 t -67.97 -43.14 79.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 2.5 tttp -55.0 -25.05 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.699 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.85 -21.44 18.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.795 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.3 -43.35 12.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 HG12 ' HD3' ' A' ' 23' ' ' LYS . 8.8 tt -113.87 -33.34 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.099 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 89.64 40.8 5.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HD3' HG12 ' A' ' 21' ' ' ILE . 1.6 mptp? -139.16 4.73 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -1.163 . . . . 0.0 110.663 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 40.37 45.57 1.87 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.434 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.97 86.83 1.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.144 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -162.95 176.4 39.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 4.7 mtmp? -142.04 174.97 10.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 109.828 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 35.8 t -117.63 119.17 34.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.3 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.456 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -150.57 151.22 32.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.314 -179.992 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.96 18.14 3.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 110.466 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 81.33 20.21 65.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.28 169.37 17.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.246 -1.149 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 1.8 t -107.82 125.4 51.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 110.35 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.535 ' HA ' ' CD2' ' A' ' 2' ' ' PHE . 1.5 mtpt -94.44 101.42 13.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.919 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 142.01 33.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 110.369 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.35 168.71 12.18 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.89 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.614 1.323 . . . . 0.0 110.508 179.741 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 50.5 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.281 0.563 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 34' ' ' LYS . 7.6 m-30 -108.15 146.64 32.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt -117.1 164.15 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.971 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.82 47.14 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 110.032 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.86 13.03 4.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER 50.76 67.72 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.016 -179.874 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 p -55.6 176.05 0.07 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.58 -40.9 6.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.049 -1.032 . . . . 0.0 110.784 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -166.46 -41.96 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.093 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.58 -55.23 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.11 -1.229 . . . . 0.0 110.863 -179.659 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.26 -12.44 16.35 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.413 1.217 . . . . 0.0 110.955 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.6 mp0 -96.74 -21.54 17.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -75.05 -49.02 21.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.511 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -42.42 -52.88 9.8 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 110.446 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -62.37 -57.06 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.348 1.183 . . . . 0.0 109.905 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 9.7 mmtp -50.99 -37.28 43.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.4 t -67.88 -37.48 81.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.639 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 7.4 tttm -61.39 -27.59 68.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.759 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 14.4 mt-10 -94.68 -24.99 16.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -47.6 42.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.379 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 17' ' ' CYS . 11.6 pt -115.61 -28.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -0.951 . . . . 0.0 110.413 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 109.92 16.19 10.98 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 37' ' ' PRO . 7.5 ttpt -139.94 119.74 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.242 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.74 67.92 0.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . . . -139.05 68.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.96 170.18 29.35 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 29.7 mtmt -142.91 171.69 13.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.3 t -110.4 132.86 53.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 109.618 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -150.09 133.52 16.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.1 m120 61.49 13.0 4.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 90.68 28.49 16.13 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.1 mtpp -139.88 167.49 21.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -1.163 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.37 118.45 36.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 110.053 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HB3' ' CE1' ' A' ' 2' ' ' PHE . 14.1 mtpt -111.11 103.58 12.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.536 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 96.8 m -98.82 165.7 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -147.91 95.55 4.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.518 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 1' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.362 0.601 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 2.8 m-30 -102.39 169.82 8.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.539 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.4 mm -98.97 164.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.262 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -110.81 42.16 1.66 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.417 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.72 15.86 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt 45.17 59.12 3.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.622 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 16.1 p -45.21 134.18 6.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.471 -0.768 . . . . 0.0 110.735 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.4 -24.54 15.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.24 144.25 15.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.57 -50.69 85.79 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -1.104 . . . . 0.0 110.841 -179.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -62.91 -19.24 68.38 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.461 1.243 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.45 -32.06 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.775 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 4.0 t -66.36 -29.95 70.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -50.89 -59.56 7.27 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.556 179.375 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -56.64 -44.51 44.74 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.345 1.182 . . . . 0.0 109.486 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -58.31 -33.05 69.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 108.989 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.7 -39.45 80.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.579 -0.701 . . . . 0.0 109.724 179.472 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -69.05 -20.78 64.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 110.137 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -103.82 -10.52 18.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.7 -54.06 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.124 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.526 ' CG2' ' SG ' ' A' ' 17' ' ' CYS . 14.9 tt -105.12 -12.69 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.94 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.84 89.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ALA . 15.7 tptt -135.24 1.75 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 110.316 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.6 46.87 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 110.487 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.08 88.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.336 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -153.53 175.61 31.84 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 2.0 mtmp? -146.11 -168.45 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -1.118 . . . . 0.0 110.461 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 38.0 t -125.21 105.87 9.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 tpt -128.34 137.42 51.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.24 28.01 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.396 179.79 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . 69.73 37.44 76.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -139.3 150.97 46.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.328 -1.101 . . . . 0.0 110.015 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.539 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.4 104.69 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 110.173 -179.819 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 15.8 mtpt -89.75 159.06 17.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.518 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -155.83 154.31 31.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -104.42 152.02 39.24 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.587 1.309 . . . . 0.0 110.608 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.277 0.56 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.637 ' CE2' ' CD ' ' A' ' 34' ' ' LYS . 3.9 m-85 -90.46 160.52 15.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 3' ' ' ILE . 5.7 mt -145.84 168.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -99.68 20.95 13.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.3 124.92 22.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 2.6 ptmt -68.6 77.03 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.438 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 6' ' ' LYS . 4.2 p -50.68 -178.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 109.969 179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -129.88 -37.66 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.375 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -146.92 -52.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.86 -54.85 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.185 -1.185 . . . . 0.0 111.222 -179.854 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.15 -37.1 96.96 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.279 1.147 . . . . 0.0 111.478 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 pm0 -58.76 -27.47 65.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.975 -1.078 . . . . 0.0 110.464 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -67.75 -37.24 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.548 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -49.46 -56.77 14.5 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 110.478 -180.0 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -58.73 -41.79 59.87 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.316 1.167 . . . . 0.0 109.686 179.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -49.3 77.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.792 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.468 ' O ' HG21 ' A' ' 21' ' ' ILE . 75.5 m -58.81 -35.57 73.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -62.33 -37.57 86.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.855 . . . . 0.0 110.038 179.766 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.73 -17.79 57.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 109.921 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.45 -43.39 5.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.526 HG21 ' N ' ' A' ' 22' ' ' GLY . 11.5 tt -111.59 -25.75 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.958 . . . . 0.0 110.169 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' N ' HG21 ' A' ' 21' ' ' ILE . . . 69.81 37.58 75.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CB ' HG23 ' A' ' 21' ' ' ILE . 7.0 tttp -130.04 -2.64 4.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -1.207 . . . . 0.0 110.314 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' C ' ' CD1' ' A' ' 14' ' ' LEU . . . 48.82 57.46 6.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.34 119.33 6.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.025 -1.047 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . 149.69 172.2 18.96 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -141.73 -168.16 2.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -1.018 . . . . 0.0 110.005 179.794 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -102.08 150.56 23.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.746 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.426 ' HB3' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.53 73.38 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -179.605 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.5 m120 51.93 30.04 6.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 139.78 -31.37 2.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 29' ' ' MET . 0.3 OUTLIER -106.32 -175.81 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.902 -1.351 . . . . 0.0 110.35 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.8 t -120.76 155.25 34.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.009 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' CD ' ' CE2' ' A' ' 2' ' ' PHE . 6.0 mtmt -136.38 88.94 2.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.648 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.486 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 19.4 m -80.17 139.65 36.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.903 . . . . 0.0 109.751 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.47 140.98 52.27 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.149 -0.97 . . . . 0.0 110.36 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.561 1.295 . . . . 0.0 110.503 179.653 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.505 HG23 ' CG ' ' A' ' 37' ' ' PRO . 57.9 t . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 2.7 m-85 -140.41 144.21 36.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 0.0 109.881 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.473 HG13 ' HB3' ' A' ' 33' ' ' CYS . 2.7 pt -138.89 139.65 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.936 . . . . 0.0 110.569 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' ALA . 15.7 p-10 -56.41 -43.65 79.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.802 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . 37.78 -141.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.606 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.3 50.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.473 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 25.4 p -57.73 146.42 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.4 0.619 . . . . 0.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -111.63 -11.36 14.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.368 -0.833 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -144.29 -71.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.562 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.59 -54.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 110.523 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -60.27 -20.66 63.46 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.326 1.172 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 33.9 mm-40 -74.84 -17.77 60.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -68.33 -26.43 65.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.345 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.578 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 1.6 mt -59.02 -58.42 19.66 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.95 -49.95 10.1 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.373 1.196 . . . . 0.0 110.175 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -43.42 74.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.853 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 1.7 m -75.82 -38.06 58.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.963 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -28.43 43.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -101.65 -19.02 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 110.329 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' CYS . . . -80.98 -50.66 9.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.237 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 21' ' ' ILE . 5.9 pt -106.06 -36.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 110.34 21.29 6.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.35 -139.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -1.2 . . . . 0.0 109.937 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.61 50.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.0 -1.062 . . . . 0.0 110.201 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.34 100.24 3.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 27' ' ' LYS . . . 173.67 -176.63 46.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 25.2 mtmm -143.99 -172.23 3.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -1.218 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -100.26 159.08 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -0.82 . . . . 0.0 109.941 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -146.08 98.74 3.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.033 . . . . 0.0 111.137 -179.711 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 51.78 29.8 6.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 101.07 19.98 15.31 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 mttp -131.28 164.5 25.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -1.205 . . . . 0.0 109.824 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.473 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.9 t -112.4 131.71 55.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.039 -1.038 . . . . 0.0 111.296 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -113.3 93.03 4.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.687 -0.633 . . . . 0.0 109.426 179.279 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 1' ' ' VAL . 83.0 m -115.86 164.62 14.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.975 -1.078 . . . . 0.0 110.696 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -102.36 155.83 36.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.321 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' CG ' HG23 ' A' ' 1' ' ' VAL . 2.8 Cg_endo . . . . . 0 C--N 1.311 -1.446 0 O-C-N 123.772 1.406 . . . . 0.0 110.46 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 5' ' ' ALA . 1.6 pt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.181 0.515 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' ALA . 10.5 p30 -67.67 -13.91 62.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 110.389 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 3' ' ' ILE . . . -44.25 104.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.02 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.27 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 5' ' ' ALA . 26.3 p -75.57 153.58 37.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -128.8 -9.54 4.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.039 -1.038 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.98 131.0 4.72 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.154 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.604 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -49.4 -49.23 72.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 110.952 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.63 -21.02 70.19 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.303 1.159 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -75.63 -30.94 59.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 109.599 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -68.0 -22.0 65.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -64.14 -58.9 12.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.8 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.76 -32.19 96.53 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.362 1.191 . . . . 0.0 109.354 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -56.14 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.494 -0.754 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -50.33 -47.38 55.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -58.75 -34.47 71.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.245 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.8 tm-20 -82.36 -16.12 50.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 109.363 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 21' ' ' ILE . . . -88.1 -58.42 2.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.189 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -105.3 -28.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.274 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 -15.27 5.07 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.037 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 8.7 mmmt -118.81 144.6 46.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.235 . . . . 0.0 110.508 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 14' ' ' LEU . . . -90.09 64.22 6.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.39 103.99 7.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.83 178.38 45.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.34 -175.64 4.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -1.178 . . . . 0.0 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.2 t -126.55 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.428 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 13.1 mtp -150.15 160.82 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 110.308 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 51.05 24.78 2.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.314 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 69.16 41.57 79.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 26.4 mttm -156.98 161.65 39.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -1.135 . . . . 0.0 110.023 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -99.36 134.0 42.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.179 -0.95 . . . . 0.0 110.194 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HD2' ' HB2' ' A' ' 29' ' ' MET . 8.6 mtpt -107.0 86.07 2.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.9 m -91.54 135.65 33.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.85 113.8 65.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.229 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.268 1.141 . . . . 0.0 110.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.308 0.575 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' ALA . 21.8 p30 -106.89 -10.58 15.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.33 116.07 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.833 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.65 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 0.0 110.378 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 27.3 p -60.35 151.67 27.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -110.64 -22.21 11.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.962 . . . . 0.0 110.595 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.37 153.51 24.49 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.07 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -65.18 -48.24 69.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.474 -1.015 . . . . 0.0 111.207 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.77 -20.92 72.44 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.34 1.179 . . . . 0.0 111.103 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 tt0 -75.18 -37.13 61.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 109.807 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -67.48 -23.32 65.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.854 . . . . 0.0 110.132 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.1 mm? -59.38 -59.06 15.06 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.993 . . . . 0.0 109.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.4 -47.95 15.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.277 1.146 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 1.7 mtpt -64.53 -53.5 46.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -0.801 . . . . 0.0 110.176 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 1.025 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.4 t -55.16 -36.49 65.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 tttm -62.87 -42.93 99.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.38 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -74.39 -15.85 60.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -0.998 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 19' ' ' GLU . . . -93.64 -34.52 13.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.025 HG22 ' O ' ' A' ' 17' ' ' CYS . 9.3 tt -110.91 -15.17 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 110.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 99.22 -14.71 60.99 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.824 ' H ' HG23 ' A' ' 21' ' ' ILE . 4.3 tptt -138.84 125.8 21.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.129 -1.218 . . . . 0.0 110.378 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -65.53 77.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -131.79 67.23 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -159.6 -173.65 28.35 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -162.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.5 t -130.96 118.35 20.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.445 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -150.66 162.55 40.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 48.77 23.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 69.32 26.52 74.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 15.7 mtpt -136.34 175.2 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.987 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -112.81 116.98 30.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.015 . . . . 0.0 110.381 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -96.9 151.07 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 109.499 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 34' ' ' LYS . 97.1 m -149.88 154.49 38.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 110.654 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.53 129.79 21.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.367 1.193 . . . . 0.0 110.588 -179.82 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.1 pt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.36 0.6 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.7 p30 -76.31 1.95 14.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.307 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.0 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.237 -0.914 . . . . 0.0 110.095 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -47.57 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.32 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 5' ' ' ALA . 12.1 p -78.72 -173.43 3.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.171 -0.956 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' OE1' ' A' ' 12' ' ' GLU . 3.0 mmt180 -112.04 -27.1 8.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.2 -173.62 33.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -70.27 -46.94 20.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.521 -0.988 . . . . 0.0 111.866 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.72 -9.92 15.34 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.127 1.067 . . . . 0.0 111.493 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -87.06 -20.41 27.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.981 -1.074 . . . . 0.0 109.536 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -36.97 83.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.441 -0.787 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.683 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -47.56 -58.71 6.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.13 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.63 -42.25 55.95 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.352 1.185 . . . . 0.0 109.918 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 6.2 mptt -65.21 -51.18 62.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.3 m -57.06 -45.84 82.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.182 -0.949 . . . . 0.0 109.893 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.5 ttpt -61.96 -33.0 73.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.8 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.02 -11.62 43.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.56 -49.44 8.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.069 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 pt -125.61 -33.96 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.75 27.09 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' HD2' ' OXT' ' A' ' 37' ' ' PRO . 4.0 mmtm -126.97 -156.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.378 -1.072 . . . . 0.0 109.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -160.88 44.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 110.066 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.37 101.01 6.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 176.72 171.91 40.84 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -138.72 -176.44 4.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.564 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -132.24 134.12 44.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.051 -1.03 . . . . 0.0 110.411 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -144.06 146.39 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 29' ' ' MET . 78.6 m-20 57.61 14.06 2.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 89.29 32.27 10.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.6 OUTLIER -141.69 143.9 33.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -1.22 . . . . 0.0 109.767 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.9 t -94.36 147.78 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.852 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -132.85 99.9 4.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.205 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 6.4 m -101.5 174.88 5.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.132 -0.98 . . . . 0.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 21.2 m-85 -141.98 161.49 50.89 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' OXT' ' HD2' ' A' ' 23' ' ' LYS . 3.0 Cg_endo . . . . . 0 C--N 1.31 -1.462 0 O-C-N 123.701 1.369 . . . . 0.0 110.497 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.495 HG13 ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.573 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 50.2 p30 -118.91 68.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 110.389 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . . . -79.78 6.2 11.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 65.98 51.25 1.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.4 p -71.48 166.88 20.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.83 -8.44 5.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 110.478 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.67 170.2 31.79 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.147 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -66.12 -48.29 59.86 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.946 . . . . 0.0 111.465 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.4 -10.64 16.64 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.321 1.169 . . . . 0.0 111.157 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -84.3 -47.12 11.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.128 -0.982 . . . . 0.0 109.631 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 53.2 t -67.93 -23.84 65.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.787 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.84 -59.44 11.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 109.566 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -58.98 -43.51 42.42 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.364 1.192 . . . . 0.0 109.359 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 13.8 mmtp -57.15 -39.8 75.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 109.779 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 52.2 m -69.31 -42.93 74.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 -35.99 49.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 109.723 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -12.26 32.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -81.09 -64.06 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 23' ' ' LYS . 13.4 pt -109.97 -33.09 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.26 1.93 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' HD11 ' A' ' 21' ' ' ILE . 28.1 mmtm -142.29 114.34 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.69 62.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.404 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -143.01 102.57 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 110.11 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.93 -176.77 43.51 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.83 -170.58 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.063 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 43.1 t -128.8 111.8 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.441 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -133.13 150.58 52.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.31 26.04 2.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.31 40.76 80.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 17.1 mtpp -141.68 159.3 42.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.136 . . . . 0.0 110.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG13 ' A' ' 3' ' ' ILE . 48.6 t -101.97 115.47 30.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 0.0 110.506 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -102.2 123.83 46.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.709 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -107.14 148.39 28.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.967 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 47.8 m-85 -133.11 149.3 72.35 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.523 -0.736 . . . . 0.0 109.808 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 O-C-N 123.661 1.348 . . . . 0.0 110.548 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.387 0.613 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ALA . 9.5 p30 -72.69 0.87 9.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.887 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.97 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.26 -164.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -40.08 1.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.337 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -156.86 -53.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.583 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 170.32 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.194 . . . . 0.0 110.7 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -59.85 -13.07 20.8 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.26 1.137 . . . . 0.0 110.709 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 26.1 mt-10 -92.5 -19.99 21.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -38.31 71.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.385 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -50.04 -56.0 20.61 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.67 -38.12 74.16 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.291 1.153 . . . . 0.0 109.781 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -64.41 -53.77 43.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.701 ' O ' HG22 ' A' ' 21' ' ' ILE . 85.4 m -53.95 -38.87 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.451 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -56.56 -44.94 81.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.863 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -78.32 -8.88 58.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.98 -51.18 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.378 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 23' ' ' LYS . 16.1 tt -99.66 -26.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 18' ' ' LYS . . . 122.53 -28.64 5.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.781 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -130.95 147.68 52.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.145 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.82 95.17 6.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.23 50.85 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 110.153 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -143.76 -178.88 19.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 39.0 mtmt -139.44 179.73 6.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.444 -1.033 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 t -107.98 118.36 36.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.775 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.487 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.34 152.96 39.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.465 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 14.6 m-20 50.45 23.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.79 79.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -132.83 166.05 23.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 t -101.61 121.12 41.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 29' ' ' MET . 6.8 mtpm? -97.63 90.34 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.953 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 13.2 m -87.48 139.3 30.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 3.3 m-30 -88.45 150.36 46.42 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.162 -0.962 . . . . 0.0 110.397 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 O-C-N 123.686 1.361 . . . . 0.0 110.532 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 15.7 pt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.27 0.557 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.72 75.44 9.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 110.47 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.4 15.21 20.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.907 . . . . 0.0 109.992 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 48.81 59.3 4.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 110.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 12.1 p -56.56 147.82 21.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 3.9 mmt-85 -99.03 -30.06 12.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.11 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.15 149.46 20.86 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -51.76 -54.56 38.66 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.231 -1.158 . . . . 0.0 110.656 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.93 -40.16 64.81 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.384 1.202 . . . . 0.0 110.312 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.2 mm-40 -64.94 -24.69 67.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.31 -31.23 70.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -51.95 -58.68 10.35 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.65 -48.62 14.32 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.398 1.21 . . . . 0.0 110.034 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -60.58 -41.07 93.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 t -55.66 -39.71 71.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -44.53 80.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.991 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.03 -14.01 62.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.1 -65.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 110.283 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.37 -25.08 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.93 13.23 10.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -119.1 111.69 18.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.157 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.2 55.92 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.164 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.75 108.69 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -179.16 152.22 10.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.9 -162.09 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 110.145 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 27.9 t -143.34 131.88 22.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.111 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtt -148.23 137.11 21.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.493 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.86 17.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.503 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 94.95 -1.06 64.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 38.3 mmtt -105.66 159.77 15.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.0 t -107.53 134.62 50.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.698 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -99.14 83.66 2.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.51 137.53 37.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.421 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -109.25 117.99 52.0 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.271 1.143 . . . . 0.0 110.534 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 33' ' ' CYS . 29.6 pt . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.331 0.586 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -82.7 71.02 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.843 . . . . 0.0 110.364 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -110.97 23.65 13.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 5' ' ' ALA . 3.3 pttm 33.18 62.63 0.37 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.59 0.709 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 28.2 p -57.6 168.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.717 -0.614 . . . . 0.0 110.422 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB2' ' OE2' ' A' ' 12' ' ' GLU . 3.3 mmt-85 -122.77 -25.11 4.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -150.67 148.66 20.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -45.82 -50.95 32.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 111.137 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -62.06 -17.86 58.55 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.327 1.172 . . . . 0.0 110.934 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 3.1 tt0 -70.68 -26.21 63.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.126 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -75.17 -27.64 59.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.16 -54.54 49.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.81 -1.181 . . . . 0.0 109.595 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.6 Cg_endo -64.41 -49.36 3.52 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.344 1.181 . . . . 0.0 110.54 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -69.34 -52.45 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.0 111.062 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.955 ' O ' HG22 ' A' ' 21' ' ' ILE . 32.9 t -55.26 -48.17 74.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 110.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -58.96 -35.38 73.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.987 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.32 9.01 42.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.59 -17.69 7.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.955 HG22 ' O ' ' A' ' 17' ' ' CYS . 8.4 tt -130.02 -26.02 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.053 -1.03 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.82 3.12 28.54 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.678 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -141.25 133.49 28.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.0 110.239 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -73.99 55.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -134.63 96.52 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.91 156.53 28.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -129.73 -176.17 3.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.381 -1.07 . . . . 0.0 110.003 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -132.89 116.25 16.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.972 -1.08 . . . . 0.0 110.828 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 43.6 tpp -150.36 152.0 33.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.84 . . . . 0.0 110.121 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 29' ' ' MET . 3.7 m-80 61.19 13.01 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.04 23.71 56.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 49.7 mttt -132.33 161.46 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -1.141 . . . . 0.0 109.925 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' HG12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -104.44 122.61 45.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.748 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -89.63 155.11 19.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HB3' HD12 ' A' ' 21' ' ' ILE . 11.4 m -147.62 162.28 39.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 110.534 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.87 159.73 49.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.816 . . . . 0.0 109.89 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 O-C-N 123.729 1.384 . . . . 0.0 110.611 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.171 0.51 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.71 59.31 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.98 . . . . 0.0 109.85 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.53 10.69 26.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 110.6 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 54.06 44.12 29.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.08 -1.012 . . . . 0.0 110.099 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 6' ' ' LYS . 16.6 p -44.14 170.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.466 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.41 -22.03 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -0.839 . . . . 0.0 110.253 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.65 166.46 26.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.17 -50.0 1.41 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.331 -1.099 . . . . 0.0 111.058 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.7 -25.41 68.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.355 1.187 . . . . 0.0 110.704 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -70.88 -34.87 72.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.035 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -65.43 -25.82 67.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.599 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.42 -59.9 9.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.92 . . . . 0.0 109.928 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.22 -49.04 13.49 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.311 1.164 . . . . 0.0 109.53 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.97 -37.67 74.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 24.7 t -70.37 -36.82 74.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.935 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 2.5 tttp -56.59 -44.16 80.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.942 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -17.89 48.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 110.184 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -54.03 7.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 110.426 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 22' ' ' GLY . 12.1 pt -112.41 -34.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -0.918 . . . . 0.0 110.387 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 116.87 26.35 3.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -123.53 -147.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -1.09 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.56 48.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.235 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.81 68.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.106 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -126.12 161.85 20.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 -165.0 1.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -1.165 . . . . 0.0 110.345 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' MET . 43.3 t -137.98 114.09 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 1.2 mmt -146.92 145.51 29.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.038 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.35 33.43 23.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.129 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.55 35.2 88.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' C ' ' A' ' 31' ' ' GLY . 10.5 mttt -142.09 159.19 42.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.59 122.54 37.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.131 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.479 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 3.1 mtmt -99.38 94.09 6.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.827 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.5 m -84.5 147.17 27.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 110.652 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -136.7 91.47 15.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.309 -1.51 0 O-C-N 123.689 1.363 . . . . 0.0 110.606 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.255 0.55 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 5' ' ' ALA . 1.2 p-10 -75.17 -0.65 20.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -42.5 116.86 0.91 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.099 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.6 ttmm -64.35 69.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 4.2 p -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -76.43 -15.57 59.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . 152.64 -23.96 0.83 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.67 -55.83 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.27 . . . . 0.0 110.927 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.13 -14.25 18.64 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.283 1.149 . . . . 0.0 110.652 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' OE1' ' HG3' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -97.48 -29.56 13.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.765 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.4 t -74.34 -33.58 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -59.95 -57.68 25.0 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.7 -50.53 9.04 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 109.464 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG3' ' OE1' ' A' ' 12' ' ' GLU . 2.2 mttm -52.87 -34.38 54.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.101 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 5.0 t -68.22 -43.57 77.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -54.63 -32.59 59.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.666 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.49 -16.08 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.782 . . . . 0.0 109.961 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.18 -50.6 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.389 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.48 -9.29 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 82.69 32.17 27.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -144.63 103.99 3.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 110.064 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 65.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -134.44 88.75 2.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 177.52 -175.64 47.67 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 20.2 mttp -151.14 177.02 10.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.6 t -112.16 139.28 47.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.288 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 29' ' ' MET . 3.9 ppp? -150.86 131.56 14.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 t30 58.1 41.65 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.747 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.62 30.07 76.57 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -137.39 155.8 48.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -1.214 . . . . 0.0 109.784 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.8 t -110.86 129.94 55.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.3 mtpt -100.88 144.81 29.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.346 -0.846 . . . . 0.0 109.751 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m -149.38 143.2 25.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.364 -0.835 . . . . 0.0 110.55 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -89.52 123.87 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 O-C-N 123.313 1.165 . . . . 0.0 110.529 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.34 0.59 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 5' ' ' ALA . 2.8 p-10 -74.57 -10.11 59.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -43.95 110.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.3 tttp -59.85 94.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -71.04 152.38 43.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.687 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -8.1 8.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.031 . . . . 0.0 110.74 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -155.7 135.39 4.56 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.188 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -52.45 -50.2 81.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -1.083 . . . . 0.0 110.698 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.79 -16.29 48.01 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.427 1.225 . . . . 0.0 110.576 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 11.9 tt0 -82.48 -39.43 22.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 0.0 109.726 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -66.96 -20.31 65.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.833 . . . . 0.0 109.993 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.608 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.8 mp -63.64 -59.65 11.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -59.84 -32.67 95.73 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.369 1.194 . . . . 0.0 109.92 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 1.7 mmtp -64.07 -54.95 26.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 110.351 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 85.9 m -56.8 -39.88 74.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.053 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 5.9 tttt -59.22 -46.23 89.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.23 -16.74 62.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.93 -43.58 10.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 4.1 pt -115.83 -34.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 131.03 -14.0 5.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -126.65 145.11 50.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.242 . . . . 0.0 110.466 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.49 60.61 4.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.82 84.35 2.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -165.84 179.56 40.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 177.03 8.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -1.131 . . . . 0.0 110.298 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 29' ' ' MET . 1.5 t -123.27 114.04 19.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.833 . . . . 0.0 109.637 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -144.26 157.71 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.92 24.53 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.369 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 68.87 39.31 85.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -145.81 167.99 21.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -1.157 . . . . 0.0 110.035 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.4 t -109.88 123.4 49.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.696 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -107.49 91.88 3.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.364 -0.835 . . . . 0.0 110.202 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 18.4 m -91.48 141.22 28.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.11 -0.994 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.415 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 4.5 m-85 -113.32 138.13 22.31 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.514 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.495 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.1 pt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.083 0.468 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 19.4 p-10 -86.33 30.2 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -75.08 101.91 4.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 0.0 109.959 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 7.1 ptpp? -39.56 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.757 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' ALA . 25.4 p -78.42 146.33 34.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.912 . . . . 0.0 110.1 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -20.58 13.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -167.14 154.85 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -46.39 -50.23 40.6 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.4 -1.059 . . . . 0.0 111.03 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.35 -20.43 68.22 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.346 1.182 . . . . 0.0 110.968 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 tp10 -78.59 -39.67 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.944 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 30.1 t -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.046 -1.034 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -49.32 -59.09 7.16 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.026 -1.046 . . . . 0.0 109.768 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.45 -40.57 65.68 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.418 1.22 . . . . 0.0 109.898 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 2.1 mmtp -57.8 -46.04 85.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.965 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' ILE . 66.1 m -65.43 -45.61 83.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -23.76 62.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.041 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.26 -12.17 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.41 -65.65 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.846 HD13 ' HB3' ' A' ' 35' ' ' CYS . 11.8 pt -86.47 -21.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.95 18.5 26.96 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -145.99 119.58 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 110.158 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 64.71 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.32 76.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.938 . . . . 0.0 110.207 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -166.28 168.31 39.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 19.2 mtmt -132.7 -175.31 3.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -1.082 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 7' ' ' CYS . 11.3 t -100.97 147.33 26.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 0.0 109.791 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.43 93.9 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.002 -1.061 . . . . 0.0 110.814 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.4 m120 61.56 9.54 2.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.45 -0.781 . . . . 0.0 111.097 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 122.66 10.38 5.94 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 6.3 mttt -121.23 154.73 35.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.258 . . . . 0.0 110.227 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -96.43 120.22 36.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 22.3 mtmt -97.49 78.14 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.932 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.846 ' HB3' HD13 ' A' ' 21' ' ' ILE . 53.8 m -80.71 156.12 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.363 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.56 75.45 68.97 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.852 . . . . 0.0 110.153 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 O-C-N 123.611 1.322 . . . . 0.0 110.553 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.188 0.518 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -87.16 67.53 9.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.476 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -93.94 28.72 2.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 36.4 48.8 0.62 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.0 110.95 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 27.4 p -53.44 138.55 33.15 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.518 -0.739 . . . . 0.0 109.966 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -9.72 13.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.63 147.16 15.92 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.09 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -61.22 -43.97 91.92 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 111.613 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.0 -21.85 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 122.875 0.934 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 tt0 -78.64 -34.03 46.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.6 -26.62 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.621 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -57.19 -57.71 22.98 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 109.898 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.58 -41.37 48.39 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.38 1.2 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -62.49 -50.97 69.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.5 m -54.76 -36.52 64.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 109.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -67.11 -51.43 54.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.709 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.13 -5.09 33.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.719 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -57.01 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.15 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 pt -116.91 -32.5 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.61 17.16 2.16 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.233 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -144.68 125.43 14.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.974 -1.309 . . . . 0.0 110.058 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -72.34 81.32 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.442 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -146.9 119.46 8.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 150.35 177.95 24.79 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -148.13 -170.02 3.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.158 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.5 132.51 55.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.228 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 tpt -149.64 143.95 25.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 50.2 30.42 4.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 70.68 24.97 76.47 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 mttt -127.48 155.46 43.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 110.298 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 t -105.42 123.1 47.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.1 mtpm? -109.49 105.8 15.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 36.0 m -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.493 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -125.59 158.82 63.45 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 109.994 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.389 0 O-C-N 123.707 1.372 . . . . 0.0 110.587 -179.751 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.4 pt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.195 0.521 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -88.84 65.54 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.647 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.536 ' HB1' ' HE3' ' A' ' 16' ' ' LYS . . . -81.54 1.1 35.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 68.46 52.47 0.61 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 28.8 p -55.54 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.393 -0.817 . . . . 0.0 109.952 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -141.45 -33.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 110.663 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -159.97 -40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 168.11 -53.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.267 -1.137 . . . . 0.0 110.473 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.53 -11.1 18.53 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.281 1.148 . . . . 0.0 110.507 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 tp10 -91.86 -47.47 7.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.913 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -67.03 -16.02 64.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 mt -72.83 -58.37 2.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.46 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -59.49 -46.55 20.43 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.314 1.166 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -60.8 -38.46 85.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 31.9 t -65.22 -44.96 86.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 27.7 ttpp -54.97 -41.89 71.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.04 -16.87 59.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.96 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.57 -55.14 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 110.333 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 37' ' ' PRO . 1.5 tt -86.58 -17.7 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.71 -33.8 5.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -137.05 133.19 35.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -1.196 . . . . 0.0 110.159 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . . . -67.3 91.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.182 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HB3' ' HG2' ' A' ' 37' ' ' PRO . . . -139.82 66.59 1.39 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.375 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -158.56 -168.23 20.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -141.26 171.58 13.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -1.187 . . . . 0.0 110.117 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -110.57 142.51 42.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.95 . . . . 0.0 109.883 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -150.32 117.0 5.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.68 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 25.8 m-20 57.26 35.04 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.971 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 80.5 24.04 59.44 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.349 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -126.18 152.68 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.181 -1.188 . . . . 0.0 109.835 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.4 t -107.74 119.21 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 110.234 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 11.4 mtmt -108.39 117.23 33.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 26' ' ' GLY . 97.3 m -120.56 141.57 50.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 m-85 -79.39 -53.16 1.08 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 110.939 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.926 ' O ' HD11 ' A' ' 21' ' ' ILE . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.327 0 O-C-N 123.25 1.131 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.442 HG13 ' HB3' ' A' ' 33' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.189 0.518 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -90.81 46.78 1.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.57 8.1 8.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 34.5 mmtt 51.77 51.3 16.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 27.1 p -55.87 150.72 12.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.838 . . . . 0.0 110.234 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -111.49 -24.13 10.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 150.79 22.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.36 -47.93 95.19 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.074 . . . . 0.0 111.241 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -64.5 -39.44 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.301 1.159 . . . . 0.0 110.72 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -60.38 -26.48 66.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.145 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -29.62 68.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.5 mp -54.0 -58.94 11.26 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.73 -47.27 19.24 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.346 1.182 . . . . 0.0 110.017 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -60.85 -47.83 84.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 109.89 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 21' ' ' ILE . 19.1 t -59.75 -37.21 78.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -58.21 -47.87 82.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.13 -25.67 60.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.42 60.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.68 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.593 HD11 ' SG ' ' A' ' 17' ' ' CYS . 7.3 pt -124.31 -31.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 0.0 110.58 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 113.43 18.62 7.01 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' CE ' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -145.12 125.29 13.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.147 . . . . 0.0 110.181 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.7 7.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.35 68.19 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.336 -0.852 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -156.54 152.04 23.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.3 mtmt -114.52 179.84 3.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -1.178 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 32.0 t -120.75 138.88 53.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.454 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -148.06 116.36 6.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.94 . . . . 0.0 110.489 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 66.33 7.23 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.623 179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 106.76 16.0 15.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 24.0 mmtt -123.24 142.66 50.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -1.194 . . . . 0.0 109.894 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.9 t -93.34 127.54 38.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.373 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 24.2 mtpt -101.08 80.93 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -86.28 147.5 26.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.044 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.4 m-85 -79.26 -60.32 0.55 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 110.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 36' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.366 0 O-C-N 123.213 1.112 . . . . 0.0 110.52 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 33' ' ' CYS . 20.7 pt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.225 0.536 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 3.6 p-10 -79.43 16.1 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 111.244 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' ASN . . . -46.88 171.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.93 -1.106 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 2.7 tppt? -116.32 69.3 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.564 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LYS . 5.0 p -49.12 175.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 109.703 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.48 -10.02 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.116 -0.99 . . . . 0.0 110.777 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -161.42 -74.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.595 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 175.88 -58.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 110.545 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.0 Cg_endo -57.94 -15.63 22.98 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.293 1.154 . . . . 0.0 110.287 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 mt-10 -87.55 -15.55 37.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.08 -40.41 68.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.58 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 tp -50.09 -54.29 34.8 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -60.5 -55.86 1.29 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.396 1.208 . . . . 0.0 110.254 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -62.11 -31.62 72.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.81 ' O ' HG22 ' A' ' 21' ' ' ILE . 35.8 t -71.89 -46.11 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -58.11 -45.14 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.71 -21.41 60.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.424 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.96 -51.39 8.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 23' ' ' LYS . 2.5 tt -101.94 -24.19 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 104.2 -6.74 46.93 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.908 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -117.39 115.34 25.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.133 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -70.8 67.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.68 103.51 3.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 170.66 178.67 41.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.6 mttp -147.78 -176.12 5.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -1.076 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.6 t -107.91 128.62 54.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -145.95 126.9 14.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.47 -0.769 . . . . 0.0 109.788 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.2 m120 62.68 42.58 8.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 62.43 23.88 65.14 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 20.2 mttm -134.03 175.99 8.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -1.183 . . . . 0.0 109.922 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.5 ' HB3' HG12 ' A' ' 3' ' ' ILE . 1.9 t -118.47 129.25 55.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 1.9 mmmm -99.92 92.47 5.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 110.148 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.87 142.81 27.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.394 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -96.47 133.92 24.1 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.451 1.237 . . . . 0.0 110.548 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 33' ' ' CYS . 1.3 pt . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 1.6 p-10 -63.87 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.362 0.601 . . . . 0.0 111.074 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -144.55 88.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.214 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 6.3 mmtp -36.01 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.373 0.606 . . . . 0.0 110.897 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 5' ' ' ALA . 23.8 p -78.71 139.57 38.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.349 -0.845 . . . . 0.0 110.352 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 -15.19 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.265 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -154.27 151.4 23.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -60.09 -50.98 83.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -1.149 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.16 -11.98 21.21 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.422 1.222 . . . . 0.0 110.841 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -80.51 -34.82 35.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 2.0 t -67.1 -27.19 67.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -53.72 -59.08 10.51 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 0.0 109.723 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.21 -41.97 54.73 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.362 1.19 . . . . 0.0 109.785 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -50.31 64.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 59.6 m -56.48 -45.93 80.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.112 -0.992 . . . . 0.0 109.822 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -39.78 69.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.712 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -78.97 -13.42 59.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.53 -15.69 25.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 17' ' ' CYS . 2.0 pt -148.52 -37.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.352 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -9.13 10.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 126.55 52.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 110.263 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -76.57 74.11 3.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.361 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 110.12 4.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 109.865 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 177.6 171.16 40.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.37 -168.73 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -1.118 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.77 133.04 55.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.27 141.62 23.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.0 110.968 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.14 22.3 0.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.33 -0.856 . . . . 0.0 110.621 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 82.2 13.84 78.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 7.6 mttt -117.69 160.17 21.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -1.174 . . . . 0.0 109.618 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.578 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -97.04 128.16 43.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.856 -1.152 . . . . 0.0 110.146 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 36.7 mtpt -96.88 117.38 30.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -123.34 134.98 53.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' OH ' ' CE ' ' A' ' 34' ' ' LYS . 23.6 m-85 -108.38 151.28 41.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 O-C-N 123.655 1.345 . . . . 0.0 110.359 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 ' CB ' ' A' ' 33' ' ' CYS . 36.0 pt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.237 0.541 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.423 ' HA ' ' CE ' ' A' ' 32' ' ' LYS . 27.9 p-10 -79.34 48.09 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.399 -0.813 . . . . 0.0 110.47 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -95.09 90.77 6.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -0.952 . . . . 0.0 109.81 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -45.76 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.437 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 10.3 p -73.11 -167.68 0.42 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.135 -0.978 . . . . 0.0 110.367 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.31 -17.38 6.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.213 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.69 150.29 22.35 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.609 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -58.84 -51.0 84.96 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -1.093 . . . . 0.0 111.163 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.44 -24.73 78.84 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.39 1.205 . . . . 0.0 111.217 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 39.4 tp10 -58.88 -26.51 64.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -70.96 -23.05 62.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.613 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -58.05 -57.39 26.22 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.4 -45.0 19.94 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.424 1.223 . . . . 0.0 109.864 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -49.05 79.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 m -61.78 -42.55 99.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.726 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 12.2 ttpp -55.99 -30.1 61.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.04 -20.11 23.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.55 -57.88 2.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 35' ' ' CYS . 10.0 pt -100.9 -41.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.09 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 103.01 32.79 4.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 19.9 mmtt -129.69 -2.27 4.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -1.178 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.62 60.33 1.64 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.742 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 36' ' ' TYR . . . -150.22 82.37 1.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.0 -175.2 33.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 5.3 mttp -150.0 -176.92 5.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -1.068 . . . . 0.0 109.948 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.1 t -121.97 127.54 50.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 110.585 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.531 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -144.11 155.27 43.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 109.823 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.87 18.21 1.54 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.127 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 78.06 43.3 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 3.9 mttt -153.07 160.33 42.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.132 -1.216 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.636 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -91.26 134.2 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 0.0 109.96 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.531 ' CD ' ' HB2' ' A' ' 29' ' ' MET . 0.4 OUTLIER -120.89 99.68 6.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.547 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HB3' HD13 ' A' ' 21' ' ' ILE . 57.1 m -87.74 156.4 19.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.101 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 32.6 m-85 -140.33 141.24 25.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 0.0 110.23 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.7 Cg_endo . . . . . 0 C--N 1.313 -1.314 0 O-C-N 123.508 1.268 . . . . 0.0 110.451 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 5' ' ' ALA . 3.8 pt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.348 0.594 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 6' ' ' LYS . 12.3 p-10 -62.6 -9.77 10.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.464 -0.773 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . -41.2 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.86 . . . . 0.0 110.265 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' ASN . 10.5 mmtm -49.04 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 110.345 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . 16.9 p -76.07 149.36 37.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -122.38 -10.67 8.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.01 143.84 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -49.75 -50.26 68.37 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.338 -1.095 . . . . 0.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.14 -9.35 16.88 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.368 1.194 . . . . 0.0 110.776 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -87.8 -35.63 17.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 8.4 t -73.24 -39.92 65.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -44.56 -55.65 9.89 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.059 -1.026 . . . . 0.0 109.845 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -62.54 -47.76 8.77 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.367 1.193 . . . . 0.0 110.119 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 20.0 mttt -54.01 -44.14 70.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 60.6 m -62.65 -39.34 93.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.856 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.631 ' CD ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 tttt -61.92 -26.96 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -32.49 21.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.475 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.63 -18.02 21.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.119 -0.988 . . . . 0.0 110.325 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.593 ' CD1' ' CB ' ' A' ' 35' ' ' CYS . 37.0 mt -128.92 -45.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 97.18 35.76 5.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -134.78 1.39 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -1.226 . . . . 0.0 110.338 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . . . 39.16 46.28 1.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.463 -0.773 . . . . 0.0 110.442 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.84 106.85 7.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 110.237 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 173.49 178.99 43.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -146.58 -165.36 2.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.011 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 t -126.71 122.56 35.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 tpt -150.02 134.96 17.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER 62.15 31.01 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.261 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.76 33.88 88.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 18.3 mttt -136.36 150.87 49.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.221 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.547 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.45 118.16 30.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 109.846 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -101.22 103.73 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.454 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.593 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 9.8 m -111.76 166.74 10.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.89 157.4 42.0 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.423 0 O-C-N 123.69 1.363 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.503 HG13 ' HB3' ' A' ' 33' ' ' CYS . 17.9 pt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.434 0.635 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 32' ' ' LYS . 14.6 p-10 -101.34 60.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.283 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.71 4.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 47.65 79.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.51 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -70.42 -165.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 0.0 109.982 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -126.45 -18.0 4.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.01 . . . . 0.0 110.63 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -154.3 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.622 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 168.65 -55.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.095 -1.238 . . . . 0.0 111.309 -179.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.9 Cg_exo -56.15 -11.95 6.76 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.309 1.163 . . . . 0.0 111.69 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.85 -31.2 64.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 109.533 179.237 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.1 t -69.12 -28.65 66.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.506 -0.746 . . . . 0.0 110.633 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 tp -59.36 -56.5 35.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.581 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.26 -46.44 18.41 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.405 1.213 . . . . 0.0 110.291 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -62.58 -32.6 73.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.857 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.0 m -64.24 -52.33 59.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 ttpt -57.94 -35.84 71.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 mm-40 -76.05 -18.17 59.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.95 -9.94 12.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.857 HG22 ' O ' ' A' ' 17' ' ' CYS . 5.8 tt -131.06 -28.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.65 -38.0 3.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.73 ' H ' HG23 ' A' ' 21' ' ' ILE . 3.5 mtpt -124.0 132.92 53.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.339 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.85 90.61 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' TYR . . . -141.42 89.55 2.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 27' ' ' LYS . . . 177.7 -175.42 47.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 15.1 mtmm -150.15 175.03 12.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -1.094 . . . . 0.0 109.584 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 18.4 t -109.44 130.71 55.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.927 -1.108 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.55 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 1.6 ttt -130.51 138.6 50.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 61.24 11.93 3.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 95.63 17.48 35.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 2.1 mttt -131.24 143.29 50.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.917 -1.343 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.7 t -84.47 145.51 28.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 0.0 110.638 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HE2' ' CB ' ' A' ' 29' ' ' MET . 2.4 mtmp? -133.24 100.84 4.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.742 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.6 m -81.93 168.4 17.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.519 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 5.4 m-85 -122.08 159.6 51.07 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.004 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 0.0 110.554 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.293 0.568 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -108.14 42.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -96.15 27.78 3.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.581 -0.699 . . . . 0.0 110.278 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 3.1 ptmm? 36.06 72.57 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.582 0.706 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.9 p -51.82 134.46 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.63 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -94.26 -15.58 24.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 0.0 109.845 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -160.1 156.98 28.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.605 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.43 -50.02 89.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.13 -11.44 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.425 1.224 . . . . 0.0 110.857 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.5 mm-40 -81.7 -33.72 31.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.3 t -67.03 -21.01 65.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -59.65 -59.36 14.1 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.068 -1.02 . . . . 0.0 109.314 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -57.94 -37.98 94.01 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.3 1.158 . . . . 0.0 109.697 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 18.5 mttp -69.81 -38.31 76.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' HG12 ' A' ' 21' ' ' ILE . 62.6 m -75.65 -34.82 60.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.902 . . . . 0.0 109.703 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -67.78 -36.24 80.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.83 -18.29 27.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.188 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -75.04 -55.33 5.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.338 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 17' ' ' CYS . 18.1 pt -108.34 -35.03 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.14 11.02 3.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -135.52 135.92 40.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.281 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -85.73 76.64 9.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 93.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -164.79 178.45 39.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 3.6 mtmp? -142.71 -175.16 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -1.107 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 5.8 t -132.18 119.7 21.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 110.168 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.13 145.35 30.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.829 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.83 28.28 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.817 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.82 75.7 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -126.57 159.39 33.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -1.154 . . . . 0.0 110.344 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.5 119.78 40.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.974 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.3 mtmt -105.36 125.78 51.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.41 ' SG ' HD11 ' A' ' 3' ' ' ILE . 40.0 m -119.11 142.14 48.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -110.2 125.1 31.73 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 110.148 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.401 1.211 . . . . 0.0 110.516 179.983 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.7 pt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.317 0.58 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.493 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 31.5 p-10 -101.0 68.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.86 11.16 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 4' ' ' ASN . 4.4 mttt 50.64 60.86 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 23.7 p -71.97 159.07 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 110.409 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.54 -17.13 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.01 151.78 22.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -52.9 -48.0 93.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.392 -1.063 . . . . 0.0 111.529 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.01 -25.9 78.09 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.201 1.106 . . . . 0.0 111.684 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.3 tp10 -52.33 -29.58 24.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.806 -1.184 . . . . 0.0 110.095 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 5.6 t -69.35 -35.59 76.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.499 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.741 HD12 ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -44.62 -57.5 6.63 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.947 -1.096 . . . . 0.0 109.816 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -61.49 -48.4 9.51 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.392 1.206 . . . . 0.0 109.323 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.779 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 5.1 t -61.6 -48.73 79.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 4.5 ttmt -66.16 -19.81 65.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.885 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.54 -12.98 30.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.98 -69.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.365 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 22' ' ' GLY . 6.2 pt -84.78 -29.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 110.204 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 112.67 18.1 7.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -149.99 122.88 8.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -1.225 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -81.48 82.33 7.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.84 92.17 2.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . 171.13 -159.36 31.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.5 mtmp? -147.73 -163.37 1.75 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -1.092 . . . . 0.0 109.859 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -138.86 127.71 23.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.884 -1.135 . . . . 0.0 110.682 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 29.5 ttm -141.91 166.19 25.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 109.657 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 48.92 22.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.965 . . . . 0.0 109.892 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 73.6 34.97 56.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.2 mttp -148.19 147.05 28.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -83.4 139.44 32.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -115.55 149.57 37.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.845 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.05 147.83 37.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.566 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -123.13 104.05 35.62 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.024 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 O-C-N 123.457 1.241 . . . . 0.0 110.594 -179.715 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.561 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.9 pt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.148 0.499 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 24.8 p-10 -100.24 55.31 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.817 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.79 15.15 17.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 4.7 mmtp 46.63 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.343 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 8' ' ' ARG . 19.6 p -69.7 -168.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 3.5 mmt85 -140.37 -34.89 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -138.45 -65.19 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.105 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER 169.9 -55.85 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.119 -1.224 . . . . 0.0 110.88 -179.691 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -57.92 -26.67 75.55 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.377 1.199 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt-10 -61.2 -23.12 65.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -69.64 -31.01 68.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.941 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.6 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -53.58 -58.43 12.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.072 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.66 -51.93 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.367 1.193 . . . . 0.0 109.976 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -60.27 -46.65 89.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.1 t -62.61 -44.43 96.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -58.54 -28.3 65.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -105.25 1.58 28.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.17 -62.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 22' ' ' GLY . 4.4 tt -90.34 -39.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 110.03 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 21' ' ' ILE . . . 109.38 26.68 5.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -147.79 127.66 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.539 -0.977 . . . . 0.0 109.828 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -76.28 50.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 110.779 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -137.16 110.97 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.046 -1.034 . . . . 0.0 109.837 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 179.26 173.36 44.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -150.04 -172.39 4.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.136 . . . . 0.0 110.302 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.1 t -122.54 122.12 38.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 3.6 tmm? -146.91 137.07 23.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 63.94 10.75 5.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 110.343 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.79 22.8 37.97 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 27.8 mttt -124.97 162.44 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -1.153 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -108.64 106.81 17.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 108.726 179.736 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.9 mtpm? -89.4 152.96 21.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.018 . . . . 0.0 111.003 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 23.7 m -144.23 136.71 26.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.689 . . . . 0.0 109.751 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -97.22 154.03 38.24 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.942 . . . . 0.0 110.464 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.732 1.385 . . . . 0.0 110.639 179.862 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.8 pt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.181 0.515 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 16.0 p-10 -79.84 75.44 6.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 0.0 110.087 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -108.36 15.95 23.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 23.6 tptp 44.51 44.0 6.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 26.8 p -45.65 154.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -101.79 -31.19 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.36 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 176.54 31.67 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.122 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.637 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -69.27 -47.39 28.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.991 . . . . 0.0 111.369 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -60.84 -21.97 72.27 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.175 1.092 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.9 mm-40 -84.03 -35.76 23.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 42.1 t -69.3 -31.55 70.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.67 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -51.83 -59.07 8.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 109.839 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.13 -45.44 31.66 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.292 1.154 . . . . 0.0 109.684 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -52.85 -41.21 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.9 m -69.66 -27.77 65.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.577 179.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 2.0 ttpm? -71.06 -22.02 62.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.787 . . . . 0.0 109.73 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.77 -26.03 18.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.146 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.52 -45.16 17.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 23' ' ' LYS . 5.4 pt -123.27 -32.62 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 96.25 36.36 5.2 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -121.82 -9.22 8.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.509 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 41.21 47.22 2.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.767 . . . . 0.0 110.4 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.94 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -151.62 -178.11 26.06 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 mttp -143.0 172.11 13.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -1.106 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.7 t -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.334 -0.854 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.414 ' HB3' ' CD ' ' A' ' 34' ' ' LYS . 46.7 tpp -135.94 127.3 28.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 110.501 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.05 23.65 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.75 3.98 76.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 150.97 24.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.918 -1.342 . . . . 0.0 110.36 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -95.82 126.31 40.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -104.75 84.69 2.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.694 -179.621 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -85.17 148.79 25.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.101 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.86 108.37 28.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 109.994 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 O-C-N 123.469 1.247 . . . . 0.0 110.624 -179.791 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.378 0.609 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.552 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -87.26 67.91 9.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.37 4.5 42.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 56.49 57.62 4.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -65.56 166.73 10.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -107.31 -9.52 16.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.46 156.02 27.38 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.15 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -63.41 -42.58 75.06 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.964 . . . . 0.0 112.074 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.7 Cg_exo -60.12 -13.49 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 122.848 0.92 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -75.54 -22.04 57.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.036 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' SER . 1.3 m -71.8 -26.25 62.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.57 -0.706 . . . . 0.0 110.147 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -58.65 -57.78 24.08 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.15 -45.7 22.2 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.326 1.172 . . . . 0.0 109.97 179.156 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -62.09 -50.29 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.838 ' O ' HG22 ' A' ' 21' ' ' ILE . 49.9 m -54.27 -36.99 64.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.021 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -60.88 -52.35 65.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -76.42 -4.55 42.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.042 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.75 -47.69 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 17' ' ' CYS . 6.9 tt -116.92 -28.16 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.11 38.65 9.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -138.08 2.2 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.292 . . . . 0.0 110.706 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.55 48.24 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.42 108.82 4.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.06 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -178.11 -178.0 47.26 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.112 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -146.92 175.08 10.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.957 . . . . 0.0 109.448 179.664 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.83 128.87 41.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 110.267 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.1 tpp -143.38 154.08 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 110.111 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.56 20.88 6.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.069 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 77.55 29.7 54.91 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.6 mttt -141.73 153.76 44.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -1.189 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' C ' ' CG ' ' A' ' 34' ' ' LYS . 9.9 t -93.01 154.81 17.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.84 . . . . 0.0 110.827 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' CG ' ' C ' ' A' ' 33' ' ' CYS . 23.8 mtmm -148.68 99.67 3.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.035 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 58.1 m -81.81 173.85 11.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.199 -0.938 . . . . 0.0 110.386 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.5 m-85 -108.58 140.43 21.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.291 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.509 1.268 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.9 pt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.212 0.529 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 44.5 p30 -98.05 75.59 2.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.945 . . . . 0.0 110.572 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 15.16 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.875 . . . . 0.0 109.872 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER 48.51 55.25 9.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 -179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 22.0 p -61.12 144.19 54.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.29 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -26.64 13.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -137.31 152.7 21.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.11 -46.22 96.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.397 -1.061 . . . . 0.0 111.67 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.6 Cg_exo -61.58 -16.7 49.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.064 1.033 . . . . 0.0 111.429 -179.144 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -73.99 -32.56 63.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.938 -1.101 . . . . 0.0 109.699 179.464 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 1.9 t -68.2 -24.8 64.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.624 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -55.1 -59.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 179.765 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.04 -44.43 29.76 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.365 1.192 . . . . 0.0 109.878 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -64.83 -39.11 93.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 110.247 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 55.9 m -66.0 -25.18 66.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 110.409 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -77.91 -41.36 36.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 110.509 -179.752 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.0 -24.53 47.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 110.668 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.35 -23.6 23.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 35' ' ' CYS . 8.1 mt -131.06 -29.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 110.48 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 112.37 -19.15 22.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.03 119.93 38.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -1.144 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -68.63 79.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.004 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -149.24 127.91 12.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 157.9 -175.22 35.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -146.7 -170.33 3.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 31.2 t -132.73 111.86 11.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -122.36 125.59 46.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 -179.883 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 65.16 16.14 10.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 179.805 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.64 18.76 54.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 4.0 mmtp -112.8 144.98 41.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.333 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -93.88 114.53 26.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.133 -179.709 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -109.96 116.37 31.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.042 179.836 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 17.3 m -111.06 144.56 39.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 27.2 m-85 -93.32 149.95 38.22 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 O-C-N 123.754 1.397 . . . . 0.0 110.522 -179.725 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.0 pt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.295 0.569 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 5' ' ' ALA . 14.7 p30 -64.13 -7.52 9.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 110.894 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.39 113.62 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 110.436 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.25 79.99 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.922 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.0 p -75.09 172.33 12.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -132.41 -27.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.948 . . . . 0.0 110.876 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.04 141.79 16.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.9 -52.7 70.49 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.385 -1.068 . . . . 0.0 110.771 179.887 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 2.9 Cg_endo -62.32 -35.68 71.92 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.387 1.204 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt-10 -62.36 -26.14 68.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -67.93 -38.05 82.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.991 179.794 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -44.77 -58.55 5.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.774 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -57.75 -55.46 2.36 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.426 1.224 . . . . 0.0 109.805 179.037 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 22.5 mmmt -52.68 -39.06 61.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.251 179.233 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.0 t -67.97 -43.14 79.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 tttp -55.0 -25.05 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.699 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.85 -21.44 18.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.795 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.3 -43.35 12.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.457 HG12 ' HD3' ' A' ' 23' ' ' LYS . 8.8 tt -113.87 -33.34 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.099 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 89.64 40.8 5.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HD3' HG12 ' A' ' 21' ' ' ILE . 1.6 mptp? -139.16 4.73 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -1.163 . . . . 0.0 110.663 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . 40.37 45.57 1.87 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.434 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.97 86.83 1.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.144 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -162.95 176.4 39.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 4.7 mtmp? -142.04 174.97 10.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 109.828 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 35.8 t -117.63 119.17 34.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.3 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.475 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -150.57 151.22 32.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.314 -179.992 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.96 18.14 3.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 110.466 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 81.33 20.21 65.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.28 169.37 17.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.246 -1.149 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 1.8 t -107.82 125.4 51.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 110.35 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 1.5 mtpt -94.44 101.42 13.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.919 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 142.01 33.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 110.369 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.35 168.71 12.18 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.89 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.614 1.323 . . . . 0.0 110.508 179.741 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.359 0.6 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.82 47.14 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 110.032 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.86 13.03 4.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER 50.76 67.72 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.016 -179.874 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 p -55.6 176.05 0.07 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.58 -40.9 6.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.049 -1.032 . . . . 0.0 110.784 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -166.46 -41.96 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.093 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.58 -55.23 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.11 -1.229 . . . . 0.0 110.863 -179.659 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.26 -12.44 16.35 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.413 1.217 . . . . 0.0 110.955 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.6 mp0 -96.74 -21.54 17.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -75.05 -49.02 21.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.511 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -42.42 -52.88 9.8 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 110.446 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -62.37 -57.06 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.348 1.183 . . . . 0.0 109.905 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 9.7 mmtp -50.99 -37.28 43.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.475 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.4 t -67.88 -37.48 81.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.639 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 7.4 tttm -61.39 -27.59 68.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.759 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 14.4 mt-10 -94.68 -24.99 16.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -47.6 42.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.379 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 17' ' ' CYS . 11.6 pt -115.61 -28.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -0.951 . . . . 0.0 110.413 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 109.92 16.19 10.98 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 37' ' ' PRO . 7.5 ttpt -139.94 119.74 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.242 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -70.74 67.92 0.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.05 68.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.96 170.18 29.35 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 29.7 mtmt -142.91 171.69 13.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.3 t -110.4 132.86 53.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 109.618 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -150.09 133.52 16.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.1 m120 61.49 13.0 4.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 90.68 28.49 16.13 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.1 mtpp -139.88 167.49 21.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -1.163 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.37 118.45 36.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 110.053 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 29' ' ' MET . 14.1 mtpt -111.11 103.58 12.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.536 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 96.8 m -98.82 165.7 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -147.91 95.55 4.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.518 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.552 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.4 mm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -110.81 42.16 1.66 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.417 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.72 15.86 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt 45.17 59.12 3.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.622 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 16.1 p -45.21 134.18 6.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.471 -0.768 . . . . 0.0 110.735 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.4 -24.54 15.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.24 144.25 15.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.57 -50.69 85.79 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -1.104 . . . . 0.0 110.841 -179.89 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -62.91 -19.24 68.38 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.461 1.243 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.45 -32.06 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.775 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 4.0 t -66.36 -29.95 70.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -50.89 -59.56 7.27 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.556 179.375 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -56.64 -44.51 44.74 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.345 1.182 . . . . 0.0 109.486 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 8.0 mmtt -58.31 -33.05 69.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 108.989 178.892 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.7 -39.45 80.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.579 -0.701 . . . . 0.0 109.724 179.472 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -69.05 -20.78 64.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 110.137 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -103.82 -10.52 18.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.7 -54.06 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.124 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.595 HG21 ' SG ' ' A' ' 17' ' ' CYS . 14.9 tt -105.12 -12.69 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.94 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.84 89.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ALA . 15.7 tptt -135.24 1.75 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 110.316 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.6 46.87 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 110.487 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.08 88.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.336 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -153.53 175.61 31.84 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 2.0 mtmp? -146.11 -168.45 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -1.118 . . . . 0.0 110.461 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 38.0 t -125.21 105.87 9.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 tpt -128.34 137.42 51.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.24 28.01 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.396 179.79 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . 69.73 37.44 76.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -139.3 150.97 46.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.328 -1.101 . . . . 0.0 110.015 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.4 104.69 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 110.173 -179.819 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 15.8 mtpt -89.75 159.06 17.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.518 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -155.83 154.31 31.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -104.42 152.02 39.24 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.587 1.309 . . . . 0.0 110.608 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE . 5.7 mt . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -99.68 20.95 13.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.3 124.92 22.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 2.6 ptmt -68.6 77.03 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.438 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 6' ' ' LYS . 4.2 p -50.68 -178.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 109.969 179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -129.88 -37.66 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.375 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -146.92 -52.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.86 -54.85 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.185 -1.185 . . . . 0.0 111.222 -179.854 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.15 -37.1 96.96 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.279 1.147 . . . . 0.0 111.478 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 pm0 -58.76 -27.47 65.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.975 -1.078 . . . . 0.0 110.464 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -67.75 -37.24 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.548 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -49.46 -56.77 14.5 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 110.478 -180.0 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -58.73 -41.79 59.87 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.316 1.167 . . . . 0.0 109.686 179.418 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -49.3 77.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.792 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 21' ' ' ILE . 75.5 m -58.81 -35.57 73.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -62.33 -37.57 86.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.855 . . . . 0.0 110.038 179.766 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.73 -17.79 57.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 109.921 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.45 -43.39 5.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 17' ' ' CYS . 11.5 tt -111.59 -25.75 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.958 . . . . 0.0 110.169 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 69.81 37.58 75.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.75 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HG23 ' A' ' 21' ' ' ILE . 7.0 tttp -130.04 -2.64 4.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -1.207 . . . . 0.0 110.314 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 48.82 57.46 6.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.34 119.33 6.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.025 -1.047 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . 149.69 172.2 18.96 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -141.73 -168.16 2.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -1.018 . . . . 0.0 110.005 179.794 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -102.08 150.56 23.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.746 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.53 73.38 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -179.605 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.5 m120 51.93 30.04 6.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 139.78 -31.37 2.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -106.32 -175.81 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.902 -1.351 . . . . 0.0 110.35 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.8 t -120.76 155.25 34.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.009 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -136.38 88.94 2.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.648 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 19.4 m -80.17 139.65 36.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.903 . . . . 0.0 109.751 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.47 140.98 52.27 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.149 -0.97 . . . . 0.0 110.36 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.561 1.295 . . . . 0.0 110.503 179.653 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 33' ' ' CYS . 2.7 pt . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.248 0.547 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' ALA . 15.7 p-10 -56.41 -43.65 79.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.802 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . 37.78 -141.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.606 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.3 50.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.473 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 25.4 p -57.73 146.42 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.4 0.619 . . . . 0.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -111.63 -11.36 14.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.368 -0.833 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -144.29 -71.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.59 -54.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 110.523 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -60.27 -20.66 63.46 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.326 1.172 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 33.9 mm-40 -74.84 -17.77 60.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -68.33 -26.43 65.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.345 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.6 mt -59.02 -58.42 19.66 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.95 -49.95 10.1 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.373 1.196 . . . . 0.0 110.175 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -43.42 74.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.853 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 1.7 m -75.82 -38.06 58.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.963 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -28.43 43.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -101.65 -19.02 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 110.329 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.98 -50.66 9.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.237 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 23' ' ' LYS . 5.9 pt -106.06 -36.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 110.34 21.29 6.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -127.35 -139.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -1.2 . . . . 0.0 109.937 179.688 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 14' ' ' LEU . . . 179.61 50.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.0 -1.062 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.34 100.24 3.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 27' ' ' LYS . . . 173.67 -176.63 46.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 25.2 mtmm -143.99 -172.23 3.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -1.218 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -100.26 159.08 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -0.82 . . . . 0.0 109.941 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.494 ' HG3' ' HE3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -146.08 98.74 3.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.033 . . . . 0.0 111.137 -179.711 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 51.78 29.8 6.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 101.07 19.98 15.31 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 mttp -131.28 164.5 25.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -1.205 . . . . 0.0 109.824 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.9 t -112.4 131.71 55.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.039 -1.038 . . . . 0.0 111.296 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HE3' ' HG3' ' A' ' 29' ' ' MET . 0.0 OUTLIER -113.3 93.03 4.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.687 -0.633 . . . . 0.0 109.426 179.279 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.0 m -115.86 164.62 14.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.975 -1.078 . . . . 0.0 110.696 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -102.36 155.83 36.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.321 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.311 -1.446 0 O-C-N 123.772 1.406 . . . . 0.0 110.46 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 2' ' ' PHE . 9.0 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.123 0.487 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 11.4 m-85 -122.85 169.98 10.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 5' ' ' ALA . 1.6 pt -130.12 144.33 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' ALA . 10.5 p30 -67.67 -13.91 62.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 110.389 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 3' ' ' ILE . . . -44.25 104.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.02 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.27 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 5' ' ' ALA . 26.3 p -75.57 153.58 37.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -128.8 -9.54 4.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.039 -1.038 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.98 131.0 4.72 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.154 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.604 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -49.4 -49.23 72.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 110.952 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.63 -21.02 70.19 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.303 1.159 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -75.63 -30.94 59.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 109.599 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -68.0 -22.0 65.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -64.14 -58.9 12.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.8 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.76 -32.19 96.53 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.362 1.191 . . . . 0.0 109.354 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -56.14 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.494 -0.754 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -50.33 -47.38 55.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -58.75 -34.47 71.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.245 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.8 tm-20 -82.36 -16.12 50.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 109.363 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 21' ' ' ILE . . . -88.1 -58.42 2.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.189 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -105.3 -28.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.274 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 -15.27 5.07 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.037 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 8.7 mmmt -118.81 144.6 46.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.235 . . . . 0.0 110.508 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 14' ' ' LEU . . . -90.09 64.22 6.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.39 103.99 7.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.83 178.38 45.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.34 -175.64 4.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -1.178 . . . . 0.0 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.2 t -126.55 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.428 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 13.1 mtp -150.15 160.82 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 110.308 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 51.05 24.78 2.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.314 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 69.16 41.57 79.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 26.4 mttm -156.98 161.65 39.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -1.135 . . . . 0.0 110.023 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -99.36 134.0 42.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.179 -0.95 . . . . 0.0 110.194 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HA ' ' CD2' ' A' ' 2' ' ' PHE . 8.6 mtpt -107.0 86.07 2.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.9 m -91.54 135.65 33.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.85 113.8 65.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.229 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.268 1.141 . . . . 0.0 110.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.839 HG21 HD12 ' A' ' 21' ' ' ILE . 10.5 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.375 0.607 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 1' ' ' VAL . 27.4 m-85 -150.59 152.98 34.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.019 -1.05 . . . . 0.0 110.66 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.04 164.36 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 109.701 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' ALA . 21.8 p30 -106.89 -10.58 15.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.33 116.07 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.833 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.65 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 0.0 110.378 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 27.3 p -60.35 151.67 27.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -110.64 -22.21 11.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.962 . . . . 0.0 110.595 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.37 153.51 24.49 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.07 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -65.18 -48.24 69.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.474 -1.015 . . . . 0.0 111.207 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.77 -20.92 72.44 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.34 1.179 . . . . 0.0 111.103 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 tt0 -75.18 -37.13 61.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 109.807 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -67.48 -23.32 65.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.854 . . . . 0.0 110.132 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.1 mm? -59.38 -59.06 15.06 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.993 . . . . 0.0 109.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.4 -47.95 15.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.277 1.146 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 1.7 mtpt -64.53 -53.5 46.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -0.801 . . . . 0.0 110.176 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 1.025 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.4 t -55.16 -36.49 65.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 tttm -62.87 -42.93 99.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.38 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -74.39 -15.85 60.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -0.998 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 19' ' ' GLU . . . -93.64 -34.52 13.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.025 HG22 ' O ' ' A' ' 17' ' ' CYS . 9.3 tt -110.91 -15.17 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 110.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 99.22 -14.71 60.99 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.824 ' H ' HG23 ' A' ' 21' ' ' ILE . 4.3 tptt -138.84 125.8 21.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.129 -1.218 . . . . 0.0 110.378 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -65.53 77.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -131.79 67.23 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -159.6 -173.65 28.35 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -162.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.5 t -130.96 118.35 20.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.445 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -150.66 162.55 40.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 48.77 23.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 69.32 26.52 74.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 15.7 mtpt -136.34 175.2 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.987 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -112.81 116.98 30.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.015 . . . . 0.0 110.381 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -96.9 151.07 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 109.499 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 34' ' ' LYS . 97.1 m -149.88 154.49 38.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 110.654 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.53 129.79 21.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.367 1.193 . . . . 0.0 110.588 -179.82 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.304 0.573 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 5.9 m-30 -99.19 145.25 27.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.1 pt -122.62 137.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.7 p30 -76.31 1.95 14.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.307 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.0 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.237 -0.914 . . . . 0.0 110.095 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -47.57 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.32 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 5' ' ' ALA . 12.1 p -78.72 -173.43 3.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.171 -0.956 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' OE1' ' A' ' 12' ' ' GLU . 3.0 mmt180 -112.04 -27.1 8.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.2 -173.62 33.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -70.27 -46.94 20.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.521 -0.988 . . . . 0.0 111.866 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.72 -9.92 15.34 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.127 1.067 . . . . 0.0 111.493 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -87.06 -20.41 27.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.981 -1.074 . . . . 0.0 109.536 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -36.97 83.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.441 -0.787 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.683 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -47.56 -58.71 6.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.13 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.63 -42.25 55.95 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.352 1.185 . . . . 0.0 109.918 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 6.2 mptt -65.21 -51.18 62.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.3 m -57.06 -45.84 82.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.182 -0.949 . . . . 0.0 109.893 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.5 ttpt -61.96 -33.0 73.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.8 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.02 -11.62 43.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.56 -49.44 8.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.069 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 pt -125.61 -33.96 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.75 27.09 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' HD2' ' OXT' ' A' ' 37' ' ' PRO . 4.0 mmtm -126.97 -156.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.378 -1.072 . . . . 0.0 109.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -160.88 44.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 110.066 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.37 101.01 6.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 176.72 171.91 40.84 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -138.72 -176.44 4.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.564 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -132.24 134.12 44.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.051 -1.03 . . . . 0.0 110.411 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -144.06 146.39 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 29' ' ' MET . 78.6 m-20 57.61 14.06 2.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 89.29 32.27 10.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.6 OUTLIER -141.69 143.9 33.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -1.22 . . . . 0.0 109.767 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.9 t -94.36 147.78 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.852 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.1 OUTLIER -132.85 99.9 4.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.205 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 6.4 m -101.5 174.88 5.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.132 -0.98 . . . . 0.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 21.2 m-85 -141.98 161.49 50.89 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' OXT' ' HD2' ' A' ' 23' ' ' LYS . 3.0 Cg_endo . . . . . 0 C--N 1.31 -1.462 0 O-C-N 123.701 1.369 . . . . 0.0 110.497 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 21' ' ' ILE . 27.7 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 1.6 m-85 -121.61 144.93 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.495 HG13 ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -145.23 164.77 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.095 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 50.2 p30 -118.91 68.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 110.389 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . . . -79.78 6.2 11.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 65.98 51.25 1.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.4 p -71.48 166.88 20.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.83 -8.44 5.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 110.478 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.67 170.2 31.79 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.147 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -66.12 -48.29 59.86 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.946 . . . . 0.0 111.465 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.4 -10.64 16.64 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.321 1.169 . . . . 0.0 111.157 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -84.3 -47.12 11.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.128 -0.982 . . . . 0.0 109.631 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 53.2 t -67.93 -23.84 65.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.787 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.84 -59.44 11.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 109.566 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -58.98 -43.51 42.42 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.364 1.192 . . . . 0.0 109.359 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 13.8 mmtp -57.15 -39.8 75.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 109.779 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 52.2 m -69.31 -42.93 74.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 -35.99 49.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 109.723 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -12.26 32.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -81.09 -64.06 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 23' ' ' LYS . 13.4 pt -109.97 -33.09 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.26 1.93 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' HD11 ' A' ' 21' ' ' ILE . 28.1 mmtm -142.29 114.34 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.69 62.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.404 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -143.01 102.57 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 110.11 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.93 -176.77 43.51 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.83 -170.58 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.063 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 43.1 t -128.8 111.8 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.441 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -133.13 150.58 52.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.31 26.04 2.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.31 40.76 80.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 17.1 mtpp -141.68 159.3 42.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.136 . . . . 0.0 110.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG13 ' A' ' 3' ' ' ILE . 48.6 t -101.97 115.47 30.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 0.0 110.506 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -102.2 123.83 46.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.709 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -107.14 148.39 28.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.967 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 47.8 m-85 -133.11 149.3 72.35 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.523 -0.736 . . . . 0.0 109.808 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 O-C-N 123.661 1.348 . . . . 0.0 110.548 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 1' ' ' VAL . 41.7 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.195 0.521 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.552 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 12.7 m-30 -107.24 158.42 17.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.167 -0.958 . . . . 0.0 110.422 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -139.4 154.5 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ALA . 9.5 p30 -72.69 0.87 9.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.887 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.97 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.26 -164.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -40.08 1.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.337 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -156.86 -53.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.583 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 170.32 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.194 . . . . 0.0 110.7 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -59.85 -13.07 20.8 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.26 1.137 . . . . 0.0 110.709 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 26.1 mt-10 -92.5 -19.99 21.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -38.31 71.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.385 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -50.04 -56.0 20.61 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.67 -38.12 74.16 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.291 1.153 . . . . 0.0 109.781 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -64.41 -53.77 43.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.701 ' O ' HG22 ' A' ' 21' ' ' ILE . 85.4 m -53.95 -38.87 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.451 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -56.56 -44.94 81.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.863 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -78.32 -8.88 58.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.98 -51.18 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.378 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 23' ' ' LYS . 16.1 tt -99.66 -26.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 18' ' ' LYS . . . 122.53 -28.64 5.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.781 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -130.95 147.68 52.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.145 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.82 95.17 6.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.23 50.85 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 110.153 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -143.76 -178.88 19.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 39.0 mtmt -139.44 179.73 6.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.444 -1.033 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 t -107.98 118.36 36.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.775 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.487 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.34 152.96 39.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.465 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 14.6 m-20 50.45 23.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.79 79.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -132.83 166.05 23.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 t -101.61 121.12 41.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HG2' ' CE2' ' A' ' 2' ' ' PHE . 6.8 mtpm? -97.63 90.34 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.953 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 13.2 m -87.48 139.3 30.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 3.3 m-30 -88.45 150.36 46.42 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.162 -0.962 . . . . 0.0 110.397 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 O-C-N 123.686 1.361 . . . . 0.0 110.532 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.407 HG22 ' H3 ' ' A' ' 1' ' ' VAL . 11.9 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.198 0.523 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.623 ' CE2' ' CG ' ' A' ' 34' ' ' LYS . 25.2 m-85 -121.99 148.86 44.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 110.43 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 15.7 pt -133.65 137.55 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 109.917 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.72 75.44 9.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 110.47 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.4 15.21 20.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.907 . . . . 0.0 109.992 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 48.81 59.3 4.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 110.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 12.1 p -56.56 147.82 21.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 3.9 mmt-85 -99.03 -30.06 12.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.11 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.15 149.46 20.86 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -51.76 -54.56 38.66 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.231 -1.158 . . . . 0.0 110.656 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.93 -40.16 64.81 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.384 1.202 . . . . 0.0 110.312 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.2 mm-40 -64.94 -24.69 67.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.31 -31.23 70.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -51.95 -58.68 10.35 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.65 -48.62 14.32 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.398 1.21 . . . . 0.0 110.034 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -60.58 -41.07 93.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 t -55.66 -39.71 71.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -44.53 80.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.991 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.03 -14.01 62.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.1 -65.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 110.283 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.37 -25.08 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.93 13.23 10.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -119.1 111.69 18.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.157 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.2 55.92 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.164 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.75 108.69 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -179.16 152.22 10.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.9 -162.09 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 110.145 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 27.9 t -143.34 131.88 22.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.111 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtt -148.23 137.11 21.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.493 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.86 17.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.503 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 94.95 -1.06 64.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 38.3 mmtt -105.66 159.77 15.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.0 t -107.53 134.62 50.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.698 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.623 ' CG ' ' CE2' ' A' ' 2' ' ' PHE . 0.5 OUTLIER -99.14 83.66 2.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.51 137.53 37.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.421 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -109.25 117.99 52.0 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.271 1.143 . . . . 0.0 110.534 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 1' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.268 0.556 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 9.1 m-30 -97.92 153.8 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 110.261 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 33' ' ' CYS . 29.6 pt -105.72 144.05 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -82.7 71.02 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.843 . . . . 0.0 110.364 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -110.97 23.65 13.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 5' ' ' ALA . 3.3 pttm 33.18 62.63 0.37 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.59 0.709 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 28.2 p -57.6 168.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.717 -0.614 . . . . 0.0 110.422 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB2' ' OE2' ' A' ' 12' ' ' GLU . 3.3 mmt-85 -122.77 -25.11 4.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -150.67 148.66 20.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -45.82 -50.95 32.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 111.137 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -62.06 -17.86 58.55 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.327 1.172 . . . . 0.0 110.934 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 3.1 tt0 -70.68 -26.21 63.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.126 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -75.17 -27.64 59.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.16 -54.54 49.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.81 -1.181 . . . . 0.0 109.595 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.6 Cg_endo -64.41 -49.36 3.52 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.344 1.181 . . . . 0.0 110.54 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -69.34 -52.45 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.0 111.062 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.955 ' O ' HG22 ' A' ' 21' ' ' ILE . 32.9 t -55.26 -48.17 74.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 110.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -58.96 -35.38 73.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.987 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.32 9.01 42.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.59 -17.69 7.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.955 HG22 ' O ' ' A' ' 17' ' ' CYS . 8.4 tt -130.02 -26.02 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.053 -1.03 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.82 3.12 28.54 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.678 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -141.25 133.49 28.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.0 110.239 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -73.99 55.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -134.63 96.52 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.91 156.53 28.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -129.73 -176.17 3.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.381 -1.07 . . . . 0.0 110.003 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -132.89 116.25 16.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.972 -1.08 . . . . 0.0 110.828 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 43.6 tpp -150.36 152.0 33.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.84 . . . . 0.0 110.121 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 29' ' ' MET . 3.7 m-80 61.19 13.01 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.04 23.71 56.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 49.7 mttt -132.33 161.46 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -1.141 . . . . 0.0 109.925 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' HG12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -104.44 122.61 45.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.748 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -89.63 155.11 19.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HB3' HD12 ' A' ' 21' ' ' ILE . 11.4 m -147.62 162.28 39.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 110.534 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.87 159.73 49.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.816 . . . . 0.0 109.89 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 O-C-N 123.729 1.384 . . . . 0.0 110.611 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.177 0.513 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 22.1 m-30 -121.1 144.39 48.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 110.549 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.11 163.78 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.633 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -113.71 59.31 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.98 . . . . 0.0 109.85 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.53 10.69 26.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 110.6 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 54.06 44.12 29.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.08 -1.012 . . . . 0.0 110.099 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 6' ' ' LYS . 16.6 p -44.14 170.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.466 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.41 -22.03 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -0.839 . . . . 0.0 110.253 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.65 166.46 26.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.17 -50.0 1.41 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.331 -1.099 . . . . 0.0 111.058 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.7 -25.41 68.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.355 1.187 . . . . 0.0 110.704 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -70.88 -34.87 72.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.035 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -65.43 -25.82 67.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.599 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.42 -59.9 9.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.92 . . . . 0.0 109.928 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.22 -49.04 13.49 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.311 1.164 . . . . 0.0 109.53 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.97 -37.67 74.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 24.7 t -70.37 -36.82 74.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.935 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 2.5 tttp -56.59 -44.16 80.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.942 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -17.89 48.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 110.184 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -54.03 7.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 110.426 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 22' ' ' GLY . 12.1 pt -112.41 -34.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -0.918 . . . . 0.0 110.387 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 116.87 26.35 3.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -123.53 -147.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -1.09 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.56 48.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.235 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.81 68.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.106 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -126.12 161.85 20.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 -165.0 1.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -1.165 . . . . 0.0 110.345 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' MET . 43.3 t -137.98 114.09 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 1.2 mmt -146.92 145.51 29.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.038 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 57.35 33.43 23.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.129 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.55 35.2 88.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' C ' ' A' ' 31' ' ' GLY . 10.5 mttt -142.09 159.19 42.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.59 122.54 37.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.131 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 3.1 mtmt -99.38 94.09 6.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.827 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.5 m -84.5 147.17 27.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 110.652 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -136.7 91.47 15.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.309 -1.51 0 O-C-N 123.689 1.363 . . . . 0.0 110.606 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 1' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.189 0.518 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 8.8 m-30 -90.3 154.12 19.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.3 pt -113.22 151.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.883 . . . . 0.0 110.042 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 5' ' ' ALA . 1.2 p-10 -75.17 -0.65 20.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -42.5 116.86 0.91 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.099 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.6 ttmm -64.35 69.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 4.2 p -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -76.43 -15.57 59.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . 152.64 -23.96 0.83 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.67 -55.83 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.27 . . . . 0.0 110.927 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.13 -14.25 18.64 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.283 1.149 . . . . 0.0 110.652 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' OE1' ' HG3' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -97.48 -29.56 13.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.765 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.4 t -74.34 -33.58 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -59.95 -57.68 25.0 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.7 -50.53 9.04 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 109.464 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG3' ' OE1' ' A' ' 12' ' ' GLU . 2.2 mttm -52.87 -34.38 54.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.101 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 5.0 t -68.22 -43.57 77.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -54.63 -32.59 59.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.666 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.49 -16.08 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.782 . . . . 0.0 109.961 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.18 -50.6 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.389 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.48 -9.29 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 82.69 32.17 27.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -144.63 103.99 3.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 110.064 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 65.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -134.44 88.75 2.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 177.52 -175.64 47.67 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 20.2 mttp -151.14 177.02 10.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.6 t -112.16 139.28 47.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.288 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 29' ' ' MET . 3.9 ppp? -150.86 131.56 14.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 t30 58.1 41.65 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.747 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.62 30.07 76.57 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -137.39 155.8 48.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -1.214 . . . . 0.0 109.784 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.8 t -110.86 129.94 55.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.3 mtpt -100.88 144.81 29.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.346 -0.846 . . . . 0.0 109.751 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m -149.38 143.2 25.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.364 -0.835 . . . . 0.0 110.55 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -89.52 123.87 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 O-C-N 123.313 1.165 . . . . 0.0 110.529 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 1' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.202 0.525 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 19.9 m-30 -93.24 -178.98 4.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.72 148.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 5' ' ' ALA . 2.8 p-10 -74.57 -10.11 59.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -43.95 110.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.3 tttp -59.85 94.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -71.04 152.38 43.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.687 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -8.1 8.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.031 . . . . 0.0 110.74 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -155.7 135.39 4.56 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.188 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -52.45 -50.2 81.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -1.083 . . . . 0.0 110.698 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.79 -16.29 48.01 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.427 1.225 . . . . 0.0 110.576 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 11.9 tt0 -82.48 -39.43 22.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 0.0 109.726 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -66.96 -20.31 65.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.833 . . . . 0.0 109.993 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.608 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.8 mp -63.64 -59.65 11.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -59.84 -32.67 95.73 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.369 1.194 . . . . 0.0 109.92 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 1.7 mmtp -64.07 -54.95 26.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 110.351 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 85.9 m -56.8 -39.88 74.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.053 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 5.9 tttt -59.22 -46.23 89.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.23 -16.74 62.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.93 -43.58 10.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 4.1 pt -115.83 -34.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 131.03 -14.0 5.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -126.65 145.11 50.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.242 . . . . 0.0 110.466 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.49 60.61 4.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.82 84.35 2.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -165.84 179.56 40.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 177.03 8.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -1.131 . . . . 0.0 110.298 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 29' ' ' MET . 1.5 t -123.27 114.04 19.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.833 . . . . 0.0 109.637 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -144.26 157.71 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.92 24.53 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.369 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 68.87 39.31 85.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -145.81 167.99 21.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -1.157 . . . . 0.0 110.035 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.4 t -109.88 123.4 49.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.696 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 1.5 mtmm -107.49 91.88 3.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.364 -0.835 . . . . 0.0 110.202 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 18.4 m -91.48 141.22 28.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.11 -0.994 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.415 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 4.5 m-85 -113.32 138.13 22.31 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.514 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.538 HG11 ' HG2' ' A' ' 37' ' ' PRO . 2.5 p . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.221 0.534 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 9.0 m-85 -123.97 -178.82 4.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.507 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.495 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.1 pt -136.62 160.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.387 -0.821 . . . . 0.0 109.745 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 19.4 p-10 -86.33 30.2 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -75.08 101.91 4.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 0.0 109.959 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 7.1 ptpp? -39.56 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.757 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' ALA . 25.4 p -78.42 146.33 34.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.912 . . . . 0.0 110.1 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -20.58 13.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -167.14 154.85 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -46.39 -50.23 40.6 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.4 -1.059 . . . . 0.0 111.03 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.35 -20.43 68.22 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.346 1.182 . . . . 0.0 110.968 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 tp10 -78.59 -39.67 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.944 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 30.1 t -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.046 -1.034 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -49.32 -59.09 7.16 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.026 -1.046 . . . . 0.0 109.768 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.45 -40.57 65.68 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.418 1.22 . . . . 0.0 109.898 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 2.1 mmtp -57.8 -46.04 85.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.965 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' ILE . 66.1 m -65.43 -45.61 83.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -23.76 62.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.041 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.26 -12.17 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.41 -65.65 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.846 HD13 ' HB3' ' A' ' 35' ' ' CYS . 11.8 pt -86.47 -21.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.95 18.5 26.96 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -145.99 119.58 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 110.158 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 64.71 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.32 76.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.938 . . . . 0.0 110.207 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -166.28 168.31 39.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 19.2 mtmt -132.7 -175.31 3.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -1.082 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 7' ' ' CYS . 11.3 t -100.97 147.33 26.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 0.0 109.791 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.43 93.9 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.002 -1.061 . . . . 0.0 110.814 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.4 m120 61.56 9.54 2.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.45 -0.781 . . . . 0.0 111.097 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 122.66 10.38 5.94 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 6.3 mttt -121.23 154.73 35.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.258 . . . . 0.0 110.227 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -96.43 120.22 36.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 22.3 mtmt -97.49 78.14 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.932 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.846 ' HB3' HD13 ' A' ' 21' ' ' ILE . 53.8 m -80.71 156.12 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.363 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.56 75.45 68.97 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.852 . . . . 0.0 110.153 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' HG2' HG11 ' A' ' 1' ' ' VAL . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 O-C-N 123.611 1.322 . . . . 0.0 110.553 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.278 0.561 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.41 ' C ' HG23 ' A' ' 3' ' ' ILE . 4.1 m-30 -95.96 139.28 32.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.196 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.41 HG23 ' C ' ' A' ' 2' ' ' PHE . 12.1 pt -148.32 145.9 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -87.16 67.53 9.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.476 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -93.94 28.72 2.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 36.4 48.8 0.62 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.0 110.95 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 27.4 p -53.44 138.55 33.15 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.518 -0.739 . . . . 0.0 109.966 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -9.72 13.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.63 147.16 15.92 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.09 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -61.22 -43.97 91.92 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 111.613 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.0 -21.85 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 122.875 0.934 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 tt0 -78.64 -34.03 46.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.6 -26.62 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.621 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -57.19 -57.71 22.98 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 109.898 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.58 -41.37 48.39 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.38 1.2 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -62.49 -50.97 69.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.5 m -54.76 -36.52 64.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 109.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -67.11 -51.43 54.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.709 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.13 -5.09 33.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.719 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -57.01 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.15 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 pt -116.91 -32.5 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.61 17.16 2.16 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.233 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -144.68 125.43 14.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.974 -1.309 . . . . 0.0 110.058 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -72.34 81.32 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.442 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -146.9 119.46 8.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 150.35 177.95 24.79 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -148.13 -170.02 3.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.158 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.5 132.51 55.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.228 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 tpt -149.64 143.95 25.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 50.2 30.42 4.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 70.68 24.97 76.47 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 mttt -127.48 155.46 43.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 110.298 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 t -105.42 123.1 47.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.1 mtpm? -109.49 105.8 15.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 36.0 m -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.493 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -125.59 158.82 63.45 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 109.994 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.389 0 O-C-N 123.707 1.372 . . . . 0.0 110.587 -179.751 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 1' ' ' VAL . 77.9 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.236 0.541 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.62 ' CE2' ' CD ' ' A' ' 34' ' ' LYS . 8.7 m-30 -107.87 149.91 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.4 pt -128.72 136.15 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -88.84 65.54 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.647 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.536 ' HB1' ' HE3' ' A' ' 16' ' ' LYS . . . -81.54 1.1 35.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 68.46 52.47 0.61 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 28.8 p -55.54 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.393 -0.817 . . . . 0.0 109.952 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -141.45 -33.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 110.663 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -159.97 -40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 168.11 -53.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.267 -1.137 . . . . 0.0 110.473 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.53 -11.1 18.53 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.281 1.148 . . . . 0.0 110.507 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 tp10 -91.86 -47.47 7.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.913 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -67.03 -16.02 64.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 mt -72.83 -58.37 2.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.46 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -59.49 -46.55 20.43 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.314 1.166 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -60.8 -38.46 85.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 31.9 t -65.22 -44.96 86.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 27.7 ttpp -54.97 -41.89 71.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.04 -16.87 59.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.96 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.57 -55.14 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 110.333 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 37' ' ' PRO . 1.5 tt -86.58 -17.7 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.71 -33.8 5.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -137.05 133.19 35.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -1.196 . . . . 0.0 110.159 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . . . -67.3 91.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.182 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HB3' ' HG2' ' A' ' 37' ' ' PRO . . . -139.82 66.59 1.39 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.375 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -158.56 -168.23 20.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -141.26 171.58 13.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -1.187 . . . . 0.0 110.117 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -110.57 142.51 42.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.95 . . . . 0.0 109.883 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -150.32 117.0 5.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.68 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 25.8 m-20 57.26 35.04 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.971 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 80.5 24.04 59.44 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.349 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -126.18 152.68 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.181 -1.188 . . . . 0.0 109.835 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.4 t -107.74 119.21 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 110.234 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' CD ' ' CE2' ' A' ' 2' ' ' PHE . 11.4 mtmt -108.39 117.23 33.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 26' ' ' GLY . 97.3 m -120.56 141.57 50.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 m-85 -79.39 -53.16 1.08 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 110.939 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.926 ' O ' HD11 ' A' ' 21' ' ' ILE . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.327 0 O-C-N 123.25 1.131 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.232 0.539 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 20.8 m-85 -119.79 162.85 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.442 HG13 ' HB3' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -136.0 149.78 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -90.81 46.78 1.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.57 8.1 8.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 34.5 mmtt 51.77 51.3 16.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 27.1 p -55.87 150.72 12.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.838 . . . . 0.0 110.234 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -111.49 -24.13 10.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 150.79 22.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.36 -47.93 95.19 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.074 . . . . 0.0 111.241 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -64.5 -39.44 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.301 1.159 . . . . 0.0 110.72 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -60.38 -26.48 66.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.145 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -29.62 68.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.5 mp -54.0 -58.94 11.26 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.73 -47.27 19.24 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.346 1.182 . . . . 0.0 110.017 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -60.85 -47.83 84.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 109.89 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 21' ' ' ILE . 19.1 t -59.75 -37.21 78.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -58.21 -47.87 82.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.13 -25.67 60.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.42 60.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.68 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.593 HD11 ' SG ' ' A' ' 17' ' ' CYS . 7.3 pt -124.31 -31.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 0.0 110.58 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 113.43 18.62 7.01 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' CE ' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -145.12 125.29 13.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.147 . . . . 0.0 110.181 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.7 7.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.35 68.19 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.336 -0.852 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -156.54 152.04 23.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.3 mtmt -114.52 179.84 3.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -1.178 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 32.0 t -120.75 138.88 53.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.454 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -148.06 116.36 6.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.94 . . . . 0.0 110.489 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 66.33 7.23 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.623 179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 106.76 16.0 15.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 24.0 mmtt -123.24 142.66 50.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -1.194 . . . . 0.0 109.894 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.9 t -93.34 127.54 38.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.373 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG2' ' CD2' ' A' ' 2' ' ' PHE . 24.2 mtpt -101.08 80.93 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -86.28 147.5 26.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.044 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.4 m-85 -79.26 -60.32 0.55 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 110.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 36' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.366 0 O-C-N 123.213 1.112 . . . . 0.0 110.52 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 1' ' ' VAL . 44.4 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.247 0.546 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.562 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 12.1 m-30 -97.05 164.33 12.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 110.284 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 33' ' ' CYS . 20.7 pt -130.34 144.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.869 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 3.6 p-10 -79.43 16.1 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 111.244 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' ASN . . . -46.88 171.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.93 -1.106 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 2.7 tppt? -116.32 69.3 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.564 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LYS . 5.0 p -49.12 175.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 109.703 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.48 -10.02 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.116 -0.99 . . . . 0.0 110.777 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -161.42 -74.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.595 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 175.88 -58.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 110.545 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.0 Cg_endo -57.94 -15.63 22.98 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.293 1.154 . . . . 0.0 110.287 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 mt-10 -87.55 -15.55 37.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.08 -40.41 68.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.58 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 tp -50.09 -54.29 34.8 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -60.5 -55.86 1.29 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.396 1.208 . . . . 0.0 110.254 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -62.11 -31.62 72.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.81 ' O ' HG22 ' A' ' 21' ' ' ILE . 35.8 t -71.89 -46.11 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -58.11 -45.14 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.71 -21.41 60.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.424 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.96 -51.39 8.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 23' ' ' LYS . 2.5 tt -101.94 -24.19 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 104.2 -6.74 46.93 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.908 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -117.39 115.34 25.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.133 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -70.8 67.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.68 103.51 3.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 170.66 178.67 41.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.6 mttp -147.78 -176.12 5.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -1.076 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.6 t -107.91 128.62 54.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -145.95 126.9 14.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.47 -0.769 . . . . 0.0 109.788 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.2 m120 62.68 42.58 8.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 62.43 23.88 65.14 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 20.2 mttm -134.03 175.99 8.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -1.183 . . . . 0.0 109.922 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.5 ' HB3' HG12 ' A' ' 3' ' ' ILE . 1.9 t -118.47 129.25 55.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HD2' ' CE2' ' A' ' 2' ' ' PHE . 1.9 mmmm -99.92 92.47 5.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 110.148 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.87 142.81 27.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.394 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -96.47 133.92 24.1 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.451 1.237 . . . . 0.0 110.548 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.554 ' C ' ' CD1' ' A' ' 2' ' ' PHE . 8.0 p . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.21 0.529 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.633 ' CE2' ' CG ' ' A' ' 34' ' ' LYS . 13.6 m-85 -132.65 157.84 43.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.666 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 33' ' ' CYS . 1.3 pt -125.78 137.8 56.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.227 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 4' ' ' ASN . 1.6 p-10 -63.87 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.362 0.601 . . . . 0.0 111.074 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -144.55 88.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.214 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 6.3 mmtp -36.01 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.373 0.606 . . . . 0.0 110.897 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 5' ' ' ALA . 23.8 p -78.71 139.57 38.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.349 -0.845 . . . . 0.0 110.352 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 -15.19 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.265 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -154.27 151.4 23.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -60.09 -50.98 83.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -1.149 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.16 -11.98 21.21 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.422 1.222 . . . . 0.0 110.841 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -80.51 -34.82 35.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 2.0 t -67.1 -27.19 67.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -53.72 -59.08 10.51 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 0.0 109.723 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.21 -41.97 54.73 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.362 1.19 . . . . 0.0 109.785 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -50.31 64.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 59.6 m -56.48 -45.93 80.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.112 -0.992 . . . . 0.0 109.822 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -39.78 69.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.712 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -78.97 -13.42 59.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.53 -15.69 25.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 17' ' ' CYS . 2.0 pt -148.52 -37.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.352 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -9.13 10.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 126.55 52.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 110.263 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -76.57 74.11 3.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.361 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 110.12 4.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 109.865 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 177.6 171.16 40.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.37 -168.73 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -1.118 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.77 133.04 55.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.27 141.62 23.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.0 110.968 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.14 22.3 0.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.33 -0.856 . . . . 0.0 110.621 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 82.2 13.84 78.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 7.6 mttt -117.69 160.17 21.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -1.174 . . . . 0.0 109.618 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.578 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -97.04 128.16 43.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.856 -1.152 . . . . 0.0 110.146 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' CG ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 mtpt -96.88 117.38 30.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 1' ' ' VAL . 85.8 m -123.34 134.98 53.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.978 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' OH ' ' CE ' ' A' ' 34' ' ' LYS . 23.6 m-85 -108.38 151.28 41.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 O-C-N 123.655 1.345 . . . . 0.0 110.359 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.195 0.521 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 10.5 m-30 -104.78 170.16 8.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.925 . . . . 0.0 110.247 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 ' CB ' ' A' ' 33' ' ' CYS . 36.0 pt -133.35 134.36 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.84 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.423 ' HA ' ' CE ' ' A' ' 32' ' ' LYS . 27.9 p-10 -79.34 48.09 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.399 -0.813 . . . . 0.0 110.47 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -95.09 90.77 6.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -0.952 . . . . 0.0 109.81 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -45.76 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.437 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 10.3 p -73.11 -167.68 0.42 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.135 -0.978 . . . . 0.0 110.367 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.31 -17.38 6.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.213 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.69 150.29 22.35 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.609 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -58.84 -51.0 84.96 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -1.093 . . . . 0.0 111.163 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.44 -24.73 78.84 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.39 1.205 . . . . 0.0 111.217 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 39.4 tp10 -58.88 -26.51 64.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -70.96 -23.05 62.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.613 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -58.05 -57.39 26.22 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.4 -45.0 19.94 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.424 1.223 . . . . 0.0 109.864 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -49.05 79.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 m -61.78 -42.55 99.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.726 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 12.2 ttpp -55.99 -30.1 61.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.04 -20.11 23.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.55 -57.88 2.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 35' ' ' CYS . 10.0 pt -100.9 -41.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.09 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 103.01 32.79 4.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 19.9 mmtt -129.69 -2.27 4.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -1.178 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.62 60.33 1.64 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.742 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 36' ' ' TYR . . . -150.22 82.37 1.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.0 -175.2 33.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 5.3 mttp -150.0 -176.92 5.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -1.068 . . . . 0.0 109.948 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.1 t -121.97 127.54 50.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 110.585 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.531 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -144.11 155.27 43.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 109.823 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.87 18.21 1.54 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.127 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 78.06 43.3 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 3.9 mttt -153.07 160.33 42.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.132 -1.216 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.636 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -91.26 134.2 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 0.0 109.96 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.4 OUTLIER -120.89 99.68 6.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.547 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HB3' HD13 ' A' ' 21' ' ' ILE . 57.1 m -87.74 156.4 19.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.101 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 32.6 m-85 -140.33 141.24 25.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 0.0 110.23 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.7 Cg_endo . . . . . 0 C--N 1.313 -1.314 0 O-C-N 123.508 1.268 . . . . 0.0 110.451 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 1' ' ' VAL . 40.1 t . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.164 0.507 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 16.2 m-30 -105.07 175.19 5.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 5' ' ' ALA . 3.8 pt -141.74 150.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 6' ' ' LYS . 12.3 p-10 -62.6 -9.77 10.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.464 -0.773 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . -41.2 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.86 . . . . 0.0 110.265 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' ASN . 10.5 mmtm -49.04 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 110.345 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . 16.9 p -76.07 149.36 37.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -122.38 -10.67 8.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.01 143.84 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -49.75 -50.26 68.37 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.338 -1.095 . . . . 0.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.14 -9.35 16.88 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.368 1.194 . . . . 0.0 110.776 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -87.8 -35.63 17.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 8.4 t -73.24 -39.92 65.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -44.56 -55.65 9.89 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.059 -1.026 . . . . 0.0 109.845 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -62.54 -47.76 8.77 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.367 1.193 . . . . 0.0 110.119 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 20.0 mttt -54.01 -44.14 70.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 60.6 m -62.65 -39.34 93.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.856 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.631 ' CD ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 tttt -61.92 -26.96 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -32.49 21.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.475 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.63 -18.02 21.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.119 -0.988 . . . . 0.0 110.325 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.593 ' CD1' ' CB ' ' A' ' 35' ' ' CYS . 37.0 mt -128.92 -45.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 97.18 35.76 5.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -134.78 1.39 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -1.226 . . . . 0.0 110.338 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . . . 39.16 46.28 1.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.463 -0.773 . . . . 0.0 110.442 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.84 106.85 7.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 110.237 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 173.49 178.99 43.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -146.58 -165.36 2.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.011 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 t -126.71 122.56 35.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 tpt -150.02 134.96 17.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER 62.15 31.01 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.261 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.76 33.88 88.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 18.3 mttt -136.36 150.87 49.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.221 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.547 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.45 118.16 30.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 109.846 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.6 OUTLIER -101.22 103.73 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.454 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.593 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 9.8 m -111.76 166.74 10.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.89 157.4 42.0 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.423 0 O-C-N 123.69 1.363 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 1' ' ' VAL . 49.8 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.353 0.597 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 3.2 m-30 -90.44 165.7 13.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.503 HG13 ' HB3' ' A' ' 33' ' ' CYS . 17.9 pt -147.73 135.34 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 32' ' ' LYS . 14.6 p-10 -101.34 60.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.283 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.71 4.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 47.65 79.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.51 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -70.42 -165.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 0.0 109.982 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -126.45 -18.0 4.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.01 . . . . 0.0 110.63 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -154.3 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.622 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 168.65 -55.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.095 -1.238 . . . . 0.0 111.309 -179.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.9 Cg_exo -56.15 -11.95 6.76 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.309 1.163 . . . . 0.0 111.69 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.85 -31.2 64.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 109.533 179.237 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.1 t -69.12 -28.65 66.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.506 -0.746 . . . . 0.0 110.633 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 tp -59.36 -56.5 35.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.581 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.26 -46.44 18.41 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.405 1.213 . . . . 0.0 110.291 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -62.58 -32.6 73.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.857 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.0 m -64.24 -52.33 59.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 ttpt -57.94 -35.84 71.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 mm-40 -76.05 -18.17 59.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.95 -9.94 12.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.857 HG22 ' O ' ' A' ' 17' ' ' CYS . 5.8 tt -131.06 -28.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.65 -38.0 3.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.73 ' H ' HG23 ' A' ' 21' ' ' ILE . 3.5 mtpt -124.0 132.92 53.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.339 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.85 90.61 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' TYR . . . -141.42 89.55 2.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 27' ' ' LYS . . . 177.7 -175.42 47.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 15.1 mtmm -150.15 175.03 12.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -1.094 . . . . 0.0 109.584 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 18.4 t -109.44 130.71 55.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.927 -1.108 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.55 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 1.6 ttt -130.51 138.6 50.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 61.24 11.93 3.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 95.63 17.48 35.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 2.1 mttt -131.24 143.29 50.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.917 -1.343 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.7 t -84.47 145.51 28.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 0.0 110.638 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HE2' ' CB ' ' A' ' 29' ' ' MET . 2.4 mtmp? -133.24 100.84 4.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.742 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.6 m -81.93 168.4 17.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.519 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 5.4 m-85 -122.08 159.6 51.07 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.004 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 0.0 110.554 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.413 HG22 ' H3 ' ' A' ' 1' ' ' VAL . 18.8 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.289 0.566 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 14.3 m-30 -104.08 165.78 10.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -116.72 156.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -108.14 42.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -96.15 27.78 3.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.581 -0.699 . . . . 0.0 110.278 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 3.1 ptmm? 36.06 72.57 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.582 0.706 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.9 p -51.82 134.46 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.63 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -94.26 -15.58 24.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 0.0 109.845 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -160.1 156.98 28.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.605 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.43 -50.02 89.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.13 -11.44 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.425 1.224 . . . . 0.0 110.857 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.5 mm-40 -81.7 -33.72 31.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.3 t -67.03 -21.01 65.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -59.65 -59.36 14.1 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.068 -1.02 . . . . 0.0 109.314 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -57.94 -37.98 94.01 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.3 1.158 . . . . 0.0 109.697 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 18.5 mttp -69.81 -38.31 76.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' HG12 ' A' ' 21' ' ' ILE . 62.6 m -75.65 -34.82 60.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.902 . . . . 0.0 109.703 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -67.78 -36.24 80.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.83 -18.29 27.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.188 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -75.04 -55.33 5.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.338 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 17' ' ' CYS . 18.1 pt -108.34 -35.03 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.14 11.02 3.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -135.52 135.92 40.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.281 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -85.73 76.64 9.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 93.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -164.79 178.45 39.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 3.6 mtmp? -142.71 -175.16 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -1.107 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 5.8 t -132.18 119.7 21.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 110.168 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.13 145.35 30.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.829 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.83 28.28 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.817 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.82 75.7 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -126.57 159.39 33.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -1.154 . . . . 0.0 110.344 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.5 119.78 40.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.974 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.3 mtmt -105.36 125.78 51.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.41 ' SG ' HD11 ' A' ' 3' ' ' ILE . 40.0 m -119.11 142.14 48.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -110.2 125.1 31.73 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 110.148 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.401 1.211 . . . . 0.0 110.516 179.983 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 37' ' ' PRO . 33.7 m . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.594 0.712 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 2.6 m-85 -109.67 148.2 31.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 110.032 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.7 pt -128.31 141.02 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.101 -0.999 . . . . 0.0 110.043 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.493 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 31.5 p-10 -101.0 68.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.86 11.16 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 4' ' ' ASN . 4.4 mttt 50.64 60.86 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 23.7 p -71.97 159.07 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 110.409 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.54 -17.13 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.01 151.78 22.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -52.9 -48.0 93.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.392 -1.063 . . . . 0.0 111.529 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.01 -25.9 78.09 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.201 1.106 . . . . 0.0 111.684 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.3 tp10 -52.33 -29.58 24.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.806 -1.184 . . . . 0.0 110.095 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 5.6 t -69.35 -35.59 76.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.499 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.741 HD12 ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -44.62 -57.5 6.63 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.947 -1.096 . . . . 0.0 109.816 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -61.49 -48.4 9.51 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.392 1.206 . . . . 0.0 109.323 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.779 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 5.1 t -61.6 -48.73 79.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 4.5 ttmt -66.16 -19.81 65.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.885 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.54 -12.98 30.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.98 -69.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.365 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 22' ' ' GLY . 6.2 pt -84.78 -29.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 110.204 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 112.67 18.1 7.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -149.99 122.88 8.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -1.225 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -81.48 82.33 7.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.84 92.17 2.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . 171.13 -159.36 31.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.5 mtmp? -147.73 -163.37 1.75 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -1.092 . . . . 0.0 109.859 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -138.86 127.71 23.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.884 -1.135 . . . . 0.0 110.682 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 29.5 ttm -141.91 166.19 25.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 109.657 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 48.92 22.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.965 . . . . 0.0 109.892 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 73.6 34.97 56.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.2 mttp -148.19 147.05 28.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -83.4 139.44 32.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -115.55 149.57 37.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.845 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.05 147.83 37.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.566 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -123.13 104.05 35.62 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.024 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HD3' HG21 ' A' ' 1' ' ' VAL . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 O-C-N 123.457 1.241 . . . . 0.0 110.594 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.248 0.547 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 17.1 m-30 -116.59 163.44 16.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.509 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.561 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.9 pt -110.39 154.02 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 109.67 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 24.8 p-10 -100.24 55.31 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.817 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.79 15.15 17.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 4.7 mmtp 46.63 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.343 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 8' ' ' ARG . 19.6 p -69.7 -168.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 3.5 mmt85 -140.37 -34.89 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -138.45 -65.19 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.105 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER 169.9 -55.85 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.119 -1.224 . . . . 0.0 110.88 -179.691 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -57.92 -26.67 75.55 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.377 1.199 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt-10 -61.2 -23.12 65.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -69.64 -31.01 68.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.941 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.6 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -53.58 -58.43 12.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.072 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.66 -51.93 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.367 1.193 . . . . 0.0 109.976 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -60.27 -46.65 89.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.1 t -62.61 -44.43 96.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -58.54 -28.3 65.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -105.25 1.58 28.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.17 -62.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 22' ' ' GLY . 4.4 tt -90.34 -39.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 110.03 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 21' ' ' ILE . . . 109.38 26.68 5.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -147.79 127.66 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.539 -0.977 . . . . 0.0 109.828 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -76.28 50.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 110.779 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -137.16 110.97 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.046 -1.034 . . . . 0.0 109.837 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 179.26 173.36 44.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -150.04 -172.39 4.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.136 . . . . 0.0 110.302 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.1 t -122.54 122.12 38.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 3.6 tmm? -146.91 137.07 23.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 63.94 10.75 5.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 110.343 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.79 22.8 37.97 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 27.8 mttt -124.97 162.44 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -1.153 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -108.64 106.81 17.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 108.726 179.736 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 3.9 mtpm? -89.4 152.96 21.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.018 . . . . 0.0 111.003 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 23.7 m -144.23 136.71 26.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.689 . . . . 0.0 109.751 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -97.22 154.03 38.24 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.942 . . . . 0.0 110.464 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.732 1.385 . . . . 0.0 110.639 179.862 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.239 0.543 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 20.1 m-30 -105.85 140.96 38.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.433 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.8 pt -135.98 138.77 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -0.844 . . . . 0.0 110.208 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 16.0 p-10 -79.84 75.44 6.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 0.0 110.087 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -108.36 15.95 23.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 23.6 tptp 44.51 44.0 6.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 26.8 p -45.65 154.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -101.79 -31.19 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.36 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 176.54 31.67 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.122 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.637 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -69.27 -47.39 28.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.991 . . . . 0.0 111.369 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -60.84 -21.97 72.27 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.175 1.092 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.9 mm-40 -84.03 -35.76 23.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 42.1 t -69.3 -31.55 70.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.67 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -51.83 -59.07 8.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 109.839 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.13 -45.44 31.66 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.292 1.154 . . . . 0.0 109.684 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -52.85 -41.21 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.9 m -69.66 -27.77 65.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.577 179.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 2.0 ttpm? -71.06 -22.02 62.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.787 . . . . 0.0 109.73 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.77 -26.03 18.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.146 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.52 -45.16 17.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 23' ' ' LYS . 5.4 pt -123.27 -32.62 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 96.25 36.36 5.2 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -121.82 -9.22 8.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.509 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 41.21 47.22 2.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.767 . . . . 0.0 110.4 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.94 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -151.62 -178.11 26.06 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 mttp -143.0 172.11 13.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -1.106 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.7 t -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.334 -0.854 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.414 ' HB3' ' CD ' ' A' ' 34' ' ' LYS . 46.7 tpp -135.94 127.3 28.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 110.501 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.05 23.65 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.75 3.98 76.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 150.97 24.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.918 -1.342 . . . . 0.0 110.36 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -95.82 126.31 40.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -104.75 84.69 2.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.694 -179.621 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -85.17 148.79 25.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.101 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.86 108.37 28.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 109.994 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 O-C-N 123.469 1.247 . . . . 0.0 110.624 -179.791 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 1' ' ' VAL . 57.6 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 3' ' ' ILE . 8.3 m-30 -90.35 -179.23 5.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.154 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 2' ' ' PHE . 1.6 pt -158.82 137.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.552 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -87.26 67.91 9.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.37 4.5 42.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 56.49 57.62 4.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -65.56 166.73 10.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -107.31 -9.52 16.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.46 156.02 27.38 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.15 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -63.41 -42.58 75.06 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.964 . . . . 0.0 112.074 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.7 Cg_exo -60.12 -13.49 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 122.848 0.92 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -75.54 -22.04 57.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.036 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' SER . 1.3 m -71.8 -26.25 62.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.57 -0.706 . . . . 0.0 110.147 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -58.65 -57.78 24.08 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.15 -45.7 22.2 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.326 1.172 . . . . 0.0 109.97 179.156 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -62.09 -50.29 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.838 ' O ' HG22 ' A' ' 21' ' ' ILE . 49.9 m -54.27 -36.99 64.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.021 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -60.88 -52.35 65.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -76.42 -4.55 42.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.042 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.75 -47.69 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 17' ' ' CYS . 6.9 tt -116.92 -28.16 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.11 38.65 9.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -138.08 2.2 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.292 . . . . 0.0 110.706 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.55 48.24 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.42 108.82 4.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.06 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -178.11 -178.0 47.26 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.112 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -146.92 175.08 10.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.957 . . . . 0.0 109.448 179.664 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.83 128.87 41.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 110.267 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.1 tpp -143.38 154.08 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 110.111 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.56 20.88 6.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.069 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 77.55 29.7 54.91 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.6 mttt -141.73 153.76 44.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -1.189 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' C ' ' CG ' ' A' ' 34' ' ' LYS . 9.9 t -93.01 154.81 17.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.84 . . . . 0.0 110.827 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 23.8 mtmm -148.68 99.67 3.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.035 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 58.1 m -81.81 173.85 11.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.199 -0.938 . . . . 0.0 110.386 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.5 m-85 -108.58 140.43 21.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.291 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.509 1.268 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 1' ' ' VAL . 3.0 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.316 0.579 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 12.7 m-85 -140.76 163.57 32.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 110.089 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.9 pt -124.33 145.44 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 44.5 p30 -98.05 75.59 2.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.945 . . . . 0.0 110.572 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 15.16 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.875 . . . . 0.0 109.872 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER 48.51 55.25 9.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 -179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 22.0 p -61.12 144.19 54.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.29 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -26.64 13.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -137.31 152.7 21.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.11 -46.22 96.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.397 -1.061 . . . . 0.0 111.67 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.6 Cg_exo -61.58 -16.7 49.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.064 1.033 . . . . 0.0 111.429 -179.144 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -73.99 -32.56 63.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.938 -1.101 . . . . 0.0 109.699 179.464 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 1.9 t -68.2 -24.8 64.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.624 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -55.1 -59.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 179.765 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.04 -44.43 29.76 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.365 1.192 . . . . 0.0 109.878 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -64.83 -39.11 93.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 110.247 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 55.9 m -66.0 -25.18 66.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 110.409 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -77.91 -41.36 36.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 110.509 -179.752 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.0 -24.53 47.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 110.668 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.35 -23.6 23.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 35' ' ' CYS . 8.1 mt -131.06 -29.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 110.48 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 112.37 -19.15 22.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.03 119.93 38.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -1.144 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -68.63 79.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.004 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -149.24 127.91 12.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 157.9 -175.22 35.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -146.7 -170.33 3.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 31.2 t -132.73 111.86 11.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -122.36 125.59 46.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 -179.883 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 65.16 16.14 10.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 179.805 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.64 18.76 54.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 4.0 mmtp -112.8 144.98 41.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.333 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -93.88 114.53 26.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.133 -179.709 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.7 OUTLIER -109.96 116.37 31.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.042 179.836 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 17.3 m -111.06 144.56 39.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 27.2 m-85 -93.32 149.95 38.22 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 O-C-N 123.754 1.397 . . . . 0.0 110.522 -179.725 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.108 0.48 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 9.3 m-85 -123.02 155.89 35.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.342 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.0 pt -112.01 138.53 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 109.985 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 5' ' ' ALA . 14.7 p30 -64.13 -7.52 9.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 110.894 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.39 113.62 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 110.436 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.25 79.99 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.922 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.0 p -75.09 172.33 12.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -132.41 -27.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.948 . . . . 0.0 110.876 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.04 141.79 16.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.9 -52.7 70.49 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.385 -1.068 . . . . 0.0 110.771 179.887 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 2.9 Cg_endo -62.32 -35.68 71.92 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.387 1.204 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt-10 -62.36 -26.14 68.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -67.93 -38.05 82.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.991 179.794 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -44.77 -58.55 5.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.774 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -57.75 -55.46 2.36 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.426 1.224 . . . . 0.0 109.805 179.037 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 22.5 mmmt -52.68 -39.06 61.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.251 179.233 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.0 t -67.97 -43.14 79.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 tttp -55.0 -25.05 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.699 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.85 -21.44 18.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.795 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.3 -43.35 12.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.457 HG12 ' HD3' ' A' ' 23' ' ' LYS . 8.8 tt -113.87 -33.34 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.099 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 89.64 40.8 5.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HD3' HG12 ' A' ' 21' ' ' ILE . 1.6 mptp? -139.16 4.73 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -1.163 . . . . 0.0 110.663 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . 40.37 45.57 1.87 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.434 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.97 86.83 1.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.144 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -162.95 176.4 39.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 4.7 mtmp? -142.04 174.97 10.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 109.828 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 35.8 t -117.63 119.17 34.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.3 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.475 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -150.57 151.22 32.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.314 -179.992 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.96 18.14 3.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 110.466 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 81.33 20.21 65.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.28 169.37 17.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.246 -1.149 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 1.8 t -107.82 125.4 51.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 110.35 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HA ' ' CD2' ' A' ' 2' ' ' PHE . 1.5 mtpt -94.44 101.42 13.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.919 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 142.01 33.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 110.369 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.35 168.71 12.18 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.89 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.614 1.323 . . . . 0.0 110.508 179.741 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.78 ' O ' HG12 ' A' ' 1' ' ' VAL . 50.5 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.281 0.563 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.566 ' CZ ' ' HE2' ' A' ' 34' ' ' LYS . 7.6 m-30 -108.15 146.64 32.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt -117.1 164.15 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.971 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.82 47.14 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 110.032 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.86 13.03 4.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER 50.76 67.72 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.016 -179.874 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 p -55.6 176.05 0.07 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.58 -40.9 6.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.049 -1.032 . . . . 0.0 110.784 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -166.46 -41.96 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.093 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.58 -55.23 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.11 -1.229 . . . . 0.0 110.863 -179.659 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.26 -12.44 16.35 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.413 1.217 . . . . 0.0 110.955 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.6 mp0 -96.74 -21.54 17.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -75.05 -49.02 21.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.511 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -42.42 -52.88 9.8 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 110.446 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -62.37 -57.06 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.348 1.183 . . . . 0.0 109.905 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 9.7 mmtp -50.99 -37.28 43.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.475 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.4 t -67.88 -37.48 81.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.639 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 7.4 tttm -61.39 -27.59 68.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.759 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 14.4 mt-10 -94.68 -24.99 16.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -47.6 42.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.379 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 17' ' ' CYS . 11.6 pt -115.61 -28.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -0.951 . . . . 0.0 110.413 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 109.92 16.19 10.98 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 37' ' ' PRO . 7.5 ttpt -139.94 119.74 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.242 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -70.74 67.92 0.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.05 68.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.96 170.18 29.35 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 29.7 mtmt -142.91 171.69 13.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.3 t -110.4 132.86 53.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 109.618 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -150.09 133.52 16.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.1 m120 61.49 13.0 4.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 90.68 28.49 16.13 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.1 mtpp -139.88 167.49 21.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -1.163 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.37 118.45 36.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 110.053 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HE2' ' CZ ' ' A' ' 2' ' ' PHE . 14.1 mtpt -111.11 103.58 12.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.536 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 96.8 m -98.82 165.7 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.458 ' HH ' ' HZ ' ' A' ' 2' ' ' PHE . 15.7 m-85 -147.91 95.55 4.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.1 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.518 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 1' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.362 0.601 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 2.8 m-30 -102.39 169.82 8.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.552 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.4 mm -98.97 164.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.262 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -110.81 42.16 1.66 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.417 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.72 15.86 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt 45.17 59.12 3.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.622 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 16.1 p -45.21 134.18 6.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.471 -0.768 . . . . 0.0 110.735 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.4 -24.54 15.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.24 144.25 15.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.57 -50.69 85.79 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -1.104 . . . . 0.0 110.841 -179.89 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -62.91 -19.24 68.38 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.461 1.243 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.45 -32.06 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.775 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 4.0 t -66.36 -29.95 70.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -50.89 -59.56 7.27 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.556 179.375 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -56.64 -44.51 44.74 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.345 1.182 . . . . 0.0 109.486 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 8.0 mmtt -58.31 -33.05 69.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 108.989 178.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.7 -39.45 80.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.579 -0.701 . . . . 0.0 109.724 179.472 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -69.05 -20.78 64.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 110.137 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -103.82 -10.52 18.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.7 -54.06 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.124 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.595 HG21 ' SG ' ' A' ' 17' ' ' CYS . 14.9 tt -105.12 -12.69 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.94 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.84 89.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ALA . 15.7 tptt -135.24 1.75 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 110.316 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.6 46.87 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 110.487 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.08 88.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.336 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -153.53 175.61 31.84 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 2.0 mtmp? -146.11 -168.45 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -1.118 . . . . 0.0 110.461 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 38.0 t -125.21 105.87 9.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 tpt -128.34 137.42 51.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.24 28.01 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.396 179.79 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . 69.73 37.44 76.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -139.3 150.97 46.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.328 -1.101 . . . . 0.0 110.015 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.4 104.69 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 110.173 -179.819 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 15.8 mtpt -89.75 159.06 17.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.518 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -155.83 154.31 31.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -104.42 152.02 39.24 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.587 1.309 . . . . 0.0 110.608 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.403 HG13 ' H3 ' ' A' ' 1' ' ' VAL . 20.5 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.277 0.56 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.637 ' CE2' ' CD ' ' A' ' 34' ' ' LYS . 3.9 m-85 -90.46 160.52 15.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' CG1' ' C ' ' A' ' 2' ' ' PHE . 5.7 mt -145.84 168.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -99.68 20.95 13.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.3 124.92 22.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 2.6 ptmt -68.6 77.03 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.438 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 6' ' ' LYS . 4.2 p -50.68 -178.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 109.969 179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -129.88 -37.66 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.375 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -146.92 -52.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.86 -54.85 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.185 -1.185 . . . . 0.0 111.222 -179.854 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.15 -37.1 96.96 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.279 1.147 . . . . 0.0 111.478 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 pm0 -58.76 -27.47 65.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.975 -1.078 . . . . 0.0 110.464 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -67.75 -37.24 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.548 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -49.46 -56.77 14.5 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 110.478 -180.0 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -58.73 -41.79 59.87 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.316 1.167 . . . . 0.0 109.686 179.418 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -49.3 77.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.792 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 21' ' ' ILE . 75.5 m -58.81 -35.57 73.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -62.33 -37.57 86.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.855 . . . . 0.0 110.038 179.766 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.73 -17.79 57.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 109.921 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.45 -43.39 5.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 17' ' ' CYS . 11.5 tt -111.59 -25.75 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.958 . . . . 0.0 110.169 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 69.81 37.58 75.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.75 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HG23 ' A' ' 21' ' ' ILE . 7.0 tttp -130.04 -2.64 4.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -1.207 . . . . 0.0 110.314 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 48.82 57.46 6.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.34 119.33 6.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.025 -1.047 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . 149.69 172.2 18.96 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -141.73 -168.16 2.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -1.018 . . . . 0.0 110.005 179.794 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -102.08 150.56 23.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.746 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.53 73.38 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -179.605 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.5 m120 51.93 30.04 6.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 139.78 -31.37 2.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -106.32 -175.81 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.902 -1.351 . . . . 0.0 110.35 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.8 t -120.76 155.25 34.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.009 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' CD ' ' CE2' ' A' ' 2' ' ' PHE . 6.0 mtmt -136.38 88.94 2.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.648 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 19.4 m -80.17 139.65 36.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.903 . . . . 0.0 109.751 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.47 140.98 52.27 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.149 -0.97 . . . . 0.0 110.36 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.561 1.295 . . . . 0.0 110.503 179.653 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 37' ' ' PRO . 57.9 t . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 2.7 m-85 -140.41 144.21 36.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 0.0 109.881 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 33' ' ' CYS . 2.7 pt -138.89 139.65 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.936 . . . . 0.0 110.569 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' ALA . 15.7 p-10 -56.41 -43.65 79.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.802 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . 37.78 -141.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.606 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.3 50.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.473 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 25.4 p -57.73 146.42 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.4 0.619 . . . . 0.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -111.63 -11.36 14.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.368 -0.833 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -144.29 -71.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.59 -54.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 110.523 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -60.27 -20.66 63.46 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.326 1.172 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 33.9 mm-40 -74.84 -17.77 60.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -68.33 -26.43 65.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.345 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.6 mt -59.02 -58.42 19.66 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.95 -49.95 10.1 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.373 1.196 . . . . 0.0 110.175 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -43.42 74.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.853 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 1.7 m -75.82 -38.06 58.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.963 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -28.43 43.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -101.65 -19.02 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 110.329 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.98 -50.66 9.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.237 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 23' ' ' LYS . 5.9 pt -106.06 -36.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 110.34 21.29 6.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -127.35 -139.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -1.2 . . . . 0.0 109.937 179.688 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 14' ' ' LEU . . . 179.61 50.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.0 -1.062 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.34 100.24 3.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 27' ' ' LYS . . . 173.67 -176.63 46.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 25.2 mtmm -143.99 -172.23 3.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -1.218 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -100.26 159.08 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -0.82 . . . . 0.0 109.941 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.494 ' HG3' ' HE3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -146.08 98.74 3.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.033 . . . . 0.0 111.137 -179.711 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 51.78 29.8 6.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 101.07 19.98 15.31 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 mttp -131.28 164.5 25.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -1.205 . . . . 0.0 109.824 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.9 t -112.4 131.71 55.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.039 -1.038 . . . . 0.0 111.296 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -113.3 93.03 4.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.687 -0.633 . . . . 0.0 109.426 179.279 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 1' ' ' VAL . 83.0 m -115.86 164.62 14.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.975 -1.078 . . . . 0.0 110.696 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -102.36 155.83 36.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.321 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' HG21 ' A' ' 1' ' ' VAL . 2.8 Cg_endo . . . . . 0 C--N 1.311 -1.446 0 O-C-N 123.772 1.406 . . . . 0.0 110.46 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 5' ' ' ALA . 1.6 pt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.181 0.515 . . . . 0.0 109.864 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' ALA . 10.5 p30 -67.67 -13.91 62.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 110.389 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 3' ' ' ILE . . . -44.25 104.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.02 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.27 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 5' ' ' ALA . 26.3 p -75.57 153.58 37.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -128.8 -9.54 4.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.039 -1.038 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.98 131.0 4.72 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.154 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.604 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -49.4 -49.23 72.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 110.952 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.63 -21.02 70.19 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.303 1.159 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -75.63 -30.94 59.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 109.599 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -68.0 -22.0 65.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -64.14 -58.9 12.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.8 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.76 -32.19 96.53 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.362 1.191 . . . . 0.0 109.354 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -56.14 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.494 -0.754 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -50.33 -47.38 55.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -58.75 -34.47 71.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.245 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.8 tm-20 -82.36 -16.12 50.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 109.363 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 21' ' ' ILE . . . -88.1 -58.42 2.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.189 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -105.3 -28.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.274 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 -15.27 5.07 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.037 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 8.7 mmmt -118.81 144.6 46.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.235 . . . . 0.0 110.508 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 14' ' ' LEU . . . -90.09 64.22 6.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.39 103.99 7.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.83 178.38 45.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.34 -175.64 4.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -1.178 . . . . 0.0 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.2 t -126.55 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.428 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 13.1 mtp -150.15 160.82 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 110.308 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 51.05 24.78 2.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.314 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 69.16 41.57 79.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 26.4 mttm -156.98 161.65 39.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -1.135 . . . . 0.0 110.023 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -99.36 134.0 42.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.179 -0.95 . . . . 0.0 110.194 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HD2' ' HB2' ' A' ' 29' ' ' MET . 8.6 mtpt -107.0 86.07 2.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.9 m -91.54 135.65 33.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.85 113.8 65.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.229 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.268 1.141 . . . . 0.0 110.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.308 0.575 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' ALA . 21.8 p30 -106.89 -10.58 15.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.33 116.07 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.833 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.65 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 0.0 110.378 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 27.3 p -60.35 151.67 27.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -110.64 -22.21 11.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.962 . . . . 0.0 110.595 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.37 153.51 24.49 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.07 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -65.18 -48.24 69.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.474 -1.015 . . . . 0.0 111.207 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.77 -20.92 72.44 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.34 1.179 . . . . 0.0 111.103 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 tt0 -75.18 -37.13 61.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 109.807 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -67.48 -23.32 65.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.854 . . . . 0.0 110.132 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.1 mm? -59.38 -59.06 15.06 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.993 . . . . 0.0 109.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.4 -47.95 15.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.277 1.146 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 1.7 mtpt -64.53 -53.5 46.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -0.801 . . . . 0.0 110.176 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 1.025 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.4 t -55.16 -36.49 65.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 tttm -62.87 -42.93 99.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.38 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -74.39 -15.85 60.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -0.998 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 19' ' ' GLU . . . -93.64 -34.52 13.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.025 HG22 ' O ' ' A' ' 17' ' ' CYS . 9.3 tt -110.91 -15.17 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 110.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 99.22 -14.71 60.99 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.824 ' H ' HG23 ' A' ' 21' ' ' ILE . 4.3 tptt -138.84 125.8 21.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.129 -1.218 . . . . 0.0 110.378 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -65.53 77.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -131.79 67.23 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -159.6 -173.65 28.35 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -162.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.5 t -130.96 118.35 20.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.445 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -150.66 162.55 40.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 48.77 23.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 69.32 26.52 74.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 15.7 mtpt -136.34 175.2 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.987 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -112.81 116.98 30.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.015 . . . . 0.0 110.381 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -96.9 151.07 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 109.499 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 34' ' ' LYS . 97.1 m -149.88 154.49 38.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 110.654 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.53 129.79 21.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.367 1.193 . . . . 0.0 110.588 -179.82 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.1 pt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.36 0.6 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.7 p30 -76.31 1.95 14.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.307 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.0 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.237 -0.914 . . . . 0.0 110.095 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -47.57 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.32 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 5' ' ' ALA . 12.1 p -78.72 -173.43 3.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.171 -0.956 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' OE1' ' A' ' 12' ' ' GLU . 3.0 mmt180 -112.04 -27.1 8.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.2 -173.62 33.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -70.27 -46.94 20.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.521 -0.988 . . . . 0.0 111.866 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.72 -9.92 15.34 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.127 1.067 . . . . 0.0 111.493 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -87.06 -20.41 27.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.981 -1.074 . . . . 0.0 109.536 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -36.97 83.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.441 -0.787 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.683 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -47.56 -58.71 6.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.13 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.63 -42.25 55.95 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.352 1.185 . . . . 0.0 109.918 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 16' ' ' LYS . 6.2 mptt -65.21 -51.18 62.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.3 m -57.06 -45.84 82.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.182 -0.949 . . . . 0.0 109.893 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.5 ttpt -61.96 -33.0 73.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.8 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.02 -11.62 43.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.56 -49.44 8.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.069 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 pt -125.61 -33.96 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.75 27.09 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' HD2' ' OXT' ' A' ' 37' ' ' PRO . 4.0 mmtm -126.97 -156.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.378 -1.072 . . . . 0.0 109.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -160.88 44.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 110.066 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.37 101.01 6.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 176.72 171.91 40.84 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -138.72 -176.44 4.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.564 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -132.24 134.12 44.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.051 -1.03 . . . . 0.0 110.411 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -144.06 146.39 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 29' ' ' MET . 78.6 m-20 57.61 14.06 2.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 89.29 32.27 10.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.6 OUTLIER -141.69 143.9 33.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -1.22 . . . . 0.0 109.767 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.9 t -94.36 147.78 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.852 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -132.85 99.9 4.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.205 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 6.4 m -101.5 174.88 5.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.132 -0.98 . . . . 0.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 21.2 m-85 -141.98 161.49 50.89 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' OXT' ' HD2' ' A' ' 23' ' ' LYS . 3.0 Cg_endo . . . . . 0 C--N 1.31 -1.462 0 O-C-N 123.701 1.369 . . . . 0.0 110.497 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.495 HG13 ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.573 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 50.2 p30 -118.91 68.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 110.389 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . . . -79.78 6.2 11.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 65.98 51.25 1.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.4 p -71.48 166.88 20.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.83 -8.44 5.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 110.478 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.67 170.2 31.79 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.147 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -66.12 -48.29 59.86 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.946 . . . . 0.0 111.465 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.4 -10.64 16.64 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.321 1.169 . . . . 0.0 111.157 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -84.3 -47.12 11.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.128 -0.982 . . . . 0.0 109.631 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 53.2 t -67.93 -23.84 65.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.787 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.84 -59.44 11.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 109.566 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -58.98 -43.51 42.42 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.364 1.192 . . . . 0.0 109.359 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 13.8 mmtp -57.15 -39.8 75.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 109.779 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 52.2 m -69.31 -42.93 74.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 -35.99 49.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 109.723 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -12.26 32.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -81.09 -64.06 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 23' ' ' LYS . 13.4 pt -109.97 -33.09 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.26 1.93 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' HD11 ' A' ' 21' ' ' ILE . 28.1 mmtm -142.29 114.34 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.69 62.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.404 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -143.01 102.57 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 110.11 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.93 -176.77 43.51 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.83 -170.58 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.063 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 43.1 t -128.8 111.8 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.441 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -133.13 150.58 52.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.31 26.04 2.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.31 40.76 80.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 17.1 mtpp -141.68 159.3 42.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.136 . . . . 0.0 110.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG13 ' A' ' 3' ' ' ILE . 48.6 t -101.97 115.47 30.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 0.0 110.506 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -102.2 123.83 46.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.709 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -107.14 148.39 28.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.967 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 47.8 m-85 -133.11 149.3 72.35 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.523 -0.736 . . . . 0.0 109.808 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 O-C-N 123.661 1.348 . . . . 0.0 110.548 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.387 0.613 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ALA . 9.5 p30 -72.69 0.87 9.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.887 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.97 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.26 -164.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -40.08 1.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.337 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -156.86 -53.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.583 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 170.32 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.194 . . . . 0.0 110.7 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -59.85 -13.07 20.8 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.26 1.137 . . . . 0.0 110.709 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 26.1 mt-10 -92.5 -19.99 21.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -38.31 71.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.385 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -50.04 -56.0 20.61 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.67 -38.12 74.16 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.291 1.153 . . . . 0.0 109.781 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -64.41 -53.77 43.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.701 ' O ' HG22 ' A' ' 21' ' ' ILE . 85.4 m -53.95 -38.87 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.451 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -56.56 -44.94 81.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.863 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -78.32 -8.88 58.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.98 -51.18 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.378 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 23' ' ' LYS . 16.1 tt -99.66 -26.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 18' ' ' LYS . . . 122.53 -28.64 5.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.781 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -130.95 147.68 52.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.145 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.82 95.17 6.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.23 50.85 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 110.153 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -143.76 -178.88 19.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 39.0 mtmt -139.44 179.73 6.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.444 -1.033 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 t -107.98 118.36 36.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.775 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.487 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.34 152.96 39.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.465 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 14.6 m-20 50.45 23.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.79 79.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -132.83 166.05 23.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 t -101.61 121.12 41.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 29' ' ' MET . 6.8 mtpm? -97.63 90.34 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.953 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 13.2 m -87.48 139.3 30.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 3.3 m-30 -88.45 150.36 46.42 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.162 -0.962 . . . . 0.0 110.397 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 O-C-N 123.686 1.361 . . . . 0.0 110.532 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 15.7 pt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.27 0.557 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.72 75.44 9.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 110.47 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.4 15.21 20.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.907 . . . . 0.0 109.992 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 48.81 59.3 4.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 110.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 12.1 p -56.56 147.82 21.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 3.9 mmt-85 -99.03 -30.06 12.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.11 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.15 149.46 20.86 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -51.76 -54.56 38.66 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.231 -1.158 . . . . 0.0 110.656 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.93 -40.16 64.81 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.384 1.202 . . . . 0.0 110.312 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.2 mm-40 -64.94 -24.69 67.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.31 -31.23 70.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -51.95 -58.68 10.35 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.65 -48.62 14.32 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.398 1.21 . . . . 0.0 110.034 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -60.58 -41.07 93.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 t -55.66 -39.71 71.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -44.53 80.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.991 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.03 -14.01 62.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.1 -65.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 110.283 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.37 -25.08 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.93 13.23 10.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -119.1 111.69 18.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.157 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.2 55.92 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.164 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.75 108.69 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -179.16 152.22 10.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.9 -162.09 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 110.145 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 27.9 t -143.34 131.88 22.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.111 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtt -148.23 137.11 21.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.493 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.86 17.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.503 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 94.95 -1.06 64.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 38.3 mmtt -105.66 159.77 15.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.0 t -107.53 134.62 50.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.698 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -99.14 83.66 2.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.51 137.53 37.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.421 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -109.25 117.99 52.0 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.271 1.143 . . . . 0.0 110.534 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 33' ' ' CYS . 29.6 pt . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.331 0.586 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -82.7 71.02 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.843 . . . . 0.0 110.364 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -110.97 23.65 13.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 5' ' ' ALA . 3.3 pttm 33.18 62.63 0.37 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.59 0.709 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 28.2 p -57.6 168.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.717 -0.614 . . . . 0.0 110.422 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB2' ' OE2' ' A' ' 12' ' ' GLU . 3.3 mmt-85 -122.77 -25.11 4.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -150.67 148.66 20.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -45.82 -50.95 32.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 111.137 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -62.06 -17.86 58.55 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.327 1.172 . . . . 0.0 110.934 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 3.1 tt0 -70.68 -26.21 63.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.126 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -75.17 -27.64 59.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.16 -54.54 49.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.81 -1.181 . . . . 0.0 109.595 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.6 Cg_endo -64.41 -49.36 3.52 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.344 1.181 . . . . 0.0 110.54 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -69.34 -52.45 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.0 111.062 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.955 ' O ' HG22 ' A' ' 21' ' ' ILE . 32.9 t -55.26 -48.17 74.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 110.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -58.96 -35.38 73.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.987 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.32 9.01 42.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.59 -17.69 7.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.955 HG22 ' O ' ' A' ' 17' ' ' CYS . 8.4 tt -130.02 -26.02 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.053 -1.03 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.82 3.12 28.54 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.678 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -141.25 133.49 28.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.0 110.239 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -73.99 55.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -134.63 96.52 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.91 156.53 28.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -129.73 -176.17 3.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.381 -1.07 . . . . 0.0 110.003 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -132.89 116.25 16.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.972 -1.08 . . . . 0.0 110.828 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 43.6 tpp -150.36 152.0 33.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.84 . . . . 0.0 110.121 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 29' ' ' MET . 3.7 m-80 61.19 13.01 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.04 23.71 56.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 49.7 mttt -132.33 161.46 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -1.141 . . . . 0.0 109.925 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' HG12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -104.44 122.61 45.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.748 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -89.63 155.11 19.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HB3' HD12 ' A' ' 21' ' ' ILE . 11.4 m -147.62 162.28 39.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 110.534 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.87 159.73 49.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.816 . . . . 0.0 109.89 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 O-C-N 123.729 1.384 . . . . 0.0 110.611 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.171 0.51 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -113.71 59.31 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.98 . . . . 0.0 109.85 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.53 10.69 26.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 110.6 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 54.06 44.12 29.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.08 -1.012 . . . . 0.0 110.099 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 6' ' ' LYS . 16.6 p -44.14 170.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.466 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.41 -22.03 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -0.839 . . . . 0.0 110.253 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.65 166.46 26.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.17 -50.0 1.41 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.331 -1.099 . . . . 0.0 111.058 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.7 -25.41 68.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.355 1.187 . . . . 0.0 110.704 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -70.88 -34.87 72.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.035 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -65.43 -25.82 67.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.599 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.42 -59.9 9.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.92 . . . . 0.0 109.928 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.22 -49.04 13.49 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.311 1.164 . . . . 0.0 109.53 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.97 -37.67 74.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 24.7 t -70.37 -36.82 74.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.935 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 2.5 tttp -56.59 -44.16 80.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.942 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -17.89 48.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 110.184 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -54.03 7.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 110.426 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 22' ' ' GLY . 12.1 pt -112.41 -34.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -0.918 . . . . 0.0 110.387 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 116.87 26.35 3.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -123.53 -147.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -1.09 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.56 48.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.235 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.81 68.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.106 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -126.12 161.85 20.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 -165.0 1.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -1.165 . . . . 0.0 110.345 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' MET . 43.3 t -137.98 114.09 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 1.2 mmt -146.92 145.51 29.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.038 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.35 33.43 23.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.129 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.55 35.2 88.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' C ' ' A' ' 31' ' ' GLY . 10.5 mttt -142.09 159.19 42.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.59 122.54 37.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.131 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.479 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 3.1 mtmt -99.38 94.09 6.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.827 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.5 m -84.5 147.17 27.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 110.652 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -136.7 91.47 15.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.309 -1.51 0 O-C-N 123.689 1.363 . . . . 0.0 110.606 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.255 0.55 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 5' ' ' ALA . 1.2 p-10 -75.17 -0.65 20.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -42.5 116.86 0.91 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.099 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.6 ttmm -64.35 69.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 4.2 p -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -76.43 -15.57 59.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . 152.64 -23.96 0.83 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.67 -55.83 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.27 . . . . 0.0 110.927 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.13 -14.25 18.64 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.283 1.149 . . . . 0.0 110.652 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' OE1' ' HG3' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -97.48 -29.56 13.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.765 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.4 t -74.34 -33.58 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -59.95 -57.68 25.0 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.7 -50.53 9.04 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 109.464 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG3' ' OE1' ' A' ' 12' ' ' GLU . 2.2 mttm -52.87 -34.38 54.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.101 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 5.0 t -68.22 -43.57 77.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -54.63 -32.59 59.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.666 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.49 -16.08 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.782 . . . . 0.0 109.961 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.18 -50.6 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.389 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.48 -9.29 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 82.69 32.17 27.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -144.63 103.99 3.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 110.064 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 65.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -134.44 88.75 2.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 177.52 -175.64 47.67 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 20.2 mttp -151.14 177.02 10.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.6 t -112.16 139.28 47.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.288 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' A' ' 29' ' ' MET . 3.9 ppp? -150.86 131.56 14.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 t30 58.1 41.65 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.747 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.62 30.07 76.57 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -137.39 155.8 48.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -1.214 . . . . 0.0 109.784 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.8 t -110.86 129.94 55.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.3 mtpt -100.88 144.81 29.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.346 -0.846 . . . . 0.0 109.751 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m -149.38 143.2 25.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.364 -0.835 . . . . 0.0 110.55 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -89.52 123.87 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 O-C-N 123.313 1.165 . . . . 0.0 110.529 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.34 0.59 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 5' ' ' ALA . 2.8 p-10 -74.57 -10.11 59.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -43.95 110.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.3 tttp -59.85 94.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -71.04 152.38 43.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.687 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -8.1 8.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.031 . . . . 0.0 110.74 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -155.7 135.39 4.56 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.188 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -52.45 -50.2 81.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -1.083 . . . . 0.0 110.698 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.79 -16.29 48.01 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.427 1.225 . . . . 0.0 110.576 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 11.9 tt0 -82.48 -39.43 22.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 0.0 109.726 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -66.96 -20.31 65.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.833 . . . . 0.0 109.993 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.608 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.8 mp -63.64 -59.65 11.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -59.84 -32.67 95.73 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.369 1.194 . . . . 0.0 109.92 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 1.7 mmtp -64.07 -54.95 26.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 110.351 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 85.9 m -56.8 -39.88 74.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.053 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 5.9 tttt -59.22 -46.23 89.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.23 -16.74 62.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.93 -43.58 10.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 4.1 pt -115.83 -34.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 131.03 -14.0 5.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -126.65 145.11 50.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.242 . . . . 0.0 110.466 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.49 60.61 4.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.82 84.35 2.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -165.84 179.56 40.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 177.03 8.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -1.131 . . . . 0.0 110.298 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 29' ' ' MET . 1.5 t -123.27 114.04 19.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.833 . . . . 0.0 109.637 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -144.26 157.71 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.92 24.53 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.369 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 68.87 39.31 85.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -145.81 167.99 21.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -1.157 . . . . 0.0 110.035 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.4 t -109.88 123.4 49.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.696 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -107.49 91.88 3.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.364 -0.835 . . . . 0.0 110.202 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 18.4 m -91.48 141.22 28.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.11 -0.994 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.415 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 4.5 m-85 -113.32 138.13 22.31 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.415 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.514 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.495 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.1 pt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.083 0.468 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 19.4 p-10 -86.33 30.2 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -75.08 101.91 4.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 0.0 109.959 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 7.1 ptpp? -39.56 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.757 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' ALA . 25.4 p -78.42 146.33 34.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.912 . . . . 0.0 110.1 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -20.58 13.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -167.14 154.85 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -46.39 -50.23 40.6 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.4 -1.059 . . . . 0.0 111.03 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.35 -20.43 68.22 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.346 1.182 . . . . 0.0 110.968 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 tp10 -78.59 -39.67 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.944 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 30.1 t -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.046 -1.034 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -49.32 -59.09 7.16 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.026 -1.046 . . . . 0.0 109.768 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.45 -40.57 65.68 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.418 1.22 . . . . 0.0 109.898 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 2.1 mmtp -57.8 -46.04 85.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.965 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' ILE . 66.1 m -65.43 -45.61 83.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -23.76 62.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.041 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.26 -12.17 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.41 -65.65 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.846 HD13 ' HB3' ' A' ' 35' ' ' CYS . 11.8 pt -86.47 -21.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.95 18.5 26.96 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -145.99 119.58 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 110.158 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 64.71 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.32 76.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.938 . . . . 0.0 110.207 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -166.28 168.31 39.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 19.2 mtmt -132.7 -175.31 3.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -1.082 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 7' ' ' CYS . 11.3 t -100.97 147.33 26.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 0.0 109.791 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.43 93.9 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.002 -1.061 . . . . 0.0 110.814 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.4 m120 61.56 9.54 2.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.45 -0.781 . . . . 0.0 111.097 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 122.66 10.38 5.94 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 6.3 mttt -121.23 154.73 35.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.258 . . . . 0.0 110.227 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -96.43 120.22 36.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 22.3 mtmt -97.49 78.14 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.932 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.846 ' HB3' HD13 ' A' ' 21' ' ' ILE . 53.8 m -80.71 156.12 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.363 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.56 75.45 68.97 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.852 . . . . 0.0 110.153 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 O-C-N 123.611 1.322 . . . . 0.0 110.553 -179.891 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.188 0.518 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -87.16 67.53 9.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.476 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -93.94 28.72 2.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 36.4 48.8 0.62 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.0 110.95 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 27.4 p -53.44 138.55 33.15 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.518 -0.739 . . . . 0.0 109.966 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -9.72 13.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.63 147.16 15.92 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.09 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -61.22 -43.97 91.92 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 111.613 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.0 -21.85 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 122.875 0.934 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.431 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 tt0 -78.64 -34.03 46.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.6 -26.62 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.621 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -57.19 -57.71 22.98 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 109.898 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.58 -41.37 48.39 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.38 1.2 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -62.49 -50.97 69.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.5 m -54.76 -36.52 64.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 109.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -67.11 -51.43 54.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.709 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.13 -5.09 33.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.719 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -57.01 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.15 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 pt -116.91 -32.5 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.61 17.16 2.16 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.233 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -144.68 125.43 14.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.974 -1.309 . . . . 0.0 110.058 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -72.34 81.32 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.442 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -146.9 119.46 8.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 150.35 177.95 24.79 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -148.13 -170.02 3.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.158 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.5 132.51 55.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.228 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 tpt -149.64 143.95 25.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 50.2 30.42 4.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 70.68 24.97 76.47 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 mttt -127.48 155.46 43.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 110.298 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 t -105.42 123.1 47.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.1 mtpm? -109.49 105.8 15.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 36.0 m -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.493 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -125.59 158.82 63.45 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 109.994 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.389 0 O-C-N 123.707 1.372 . . . . 0.0 110.587 -179.751 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.4 pt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.195 0.521 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -88.84 65.54 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.647 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.536 ' HB1' ' HE3' ' A' ' 16' ' ' LYS . . . -81.54 1.1 35.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 68.46 52.47 0.61 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 28.8 p -55.54 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.393 -0.817 . . . . 0.0 109.952 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -141.45 -33.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 110.663 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -159.97 -40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 168.11 -53.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.267 -1.137 . . . . 0.0 110.473 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.53 -11.1 18.53 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.281 1.148 . . . . 0.0 110.507 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 tp10 -91.86 -47.47 7.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.913 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -67.03 -16.02 64.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 mt -72.83 -58.37 2.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.46 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -59.49 -46.55 20.43 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.314 1.166 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -60.8 -38.46 85.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 31.9 t -65.22 -44.96 86.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 27.7 ttpp -54.97 -41.89 71.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.04 -16.87 59.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.96 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.57 -55.14 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 110.333 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 37' ' ' PRO . 1.5 tt -86.58 -17.7 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.71 -33.8 5.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -137.05 133.19 35.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -1.196 . . . . 0.0 110.159 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . . . -67.3 91.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.182 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HB3' ' HG2' ' A' ' 37' ' ' PRO . . . -139.82 66.59 1.39 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.375 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -158.56 -168.23 20.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -141.26 171.58 13.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -1.187 . . . . 0.0 110.117 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -110.57 142.51 42.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.95 . . . . 0.0 109.883 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -150.32 117.0 5.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.68 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 25.8 m-20 57.26 35.04 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.971 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 80.5 24.04 59.44 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.349 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -126.18 152.68 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.181 -1.188 . . . . 0.0 109.835 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.4 t -107.74 119.21 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 110.234 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 11.4 mtmt -108.39 117.23 33.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 26' ' ' GLY . 97.3 m -120.56 141.57 50.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 m-85 -79.39 -53.16 1.08 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 110.939 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.926 ' O ' HD11 ' A' ' 21' ' ' ILE . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.327 0 O-C-N 123.25 1.131 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.442 HG13 ' HB3' ' A' ' 33' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.189 0.518 . . . . 0.0 109.692 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -90.81 46.78 1.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.57 8.1 8.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 34.5 mmtt 51.77 51.3 16.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 27.1 p -55.87 150.72 12.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.838 . . . . 0.0 110.234 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -111.49 -24.13 10.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 150.79 22.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.36 -47.93 95.19 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.074 . . . . 0.0 111.241 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -64.5 -39.44 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.301 1.159 . . . . 0.0 110.72 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -60.38 -26.48 66.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.145 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -29.62 68.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.5 mp -54.0 -58.94 11.26 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.73 -47.27 19.24 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.346 1.182 . . . . 0.0 110.017 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -60.85 -47.83 84.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 109.89 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 21' ' ' ILE . 19.1 t -59.75 -37.21 78.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.465 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -58.21 -47.87 82.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.13 -25.67 60.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.42 60.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.68 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.593 HD11 ' SG ' ' A' ' 17' ' ' CYS . 7.3 pt -124.31 -31.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 0.0 110.58 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 113.43 18.62 7.01 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' CE ' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -145.12 125.29 13.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.147 . . . . 0.0 110.181 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.7 7.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.35 68.19 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.336 -0.852 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -156.54 152.04 23.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.3 mtmt -114.52 179.84 3.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -1.178 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 32.0 t -120.75 138.88 53.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.454 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -148.06 116.36 6.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.94 . . . . 0.0 110.489 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 66.33 7.23 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.623 179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 106.76 16.0 15.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 24.0 mmtt -123.24 142.66 50.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -1.194 . . . . 0.0 109.894 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.9 t -93.34 127.54 38.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.373 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 24.2 mtpt -101.08 80.93 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -86.28 147.5 26.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.044 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.4 m-85 -79.26 -60.32 0.55 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 110.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 36' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.366 0 O-C-N 123.213 1.112 . . . . 0.0 110.52 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 33' ' ' CYS . 20.7 pt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.225 0.536 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -79.43 16.1 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 111.244 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' ASN . . . -46.88 171.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.93 -1.106 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 2.7 tppt? -116.32 69.3 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.564 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LYS . 5.0 p -49.12 175.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 109.703 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.48 -10.02 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.116 -0.99 . . . . 0.0 110.777 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -161.42 -74.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.595 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 175.88 -58.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 110.545 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.0 Cg_endo -57.94 -15.63 22.98 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.293 1.154 . . . . 0.0 110.287 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 mt-10 -87.55 -15.55 37.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.08 -40.41 68.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.58 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 tp -50.09 -54.29 34.8 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -60.5 -55.86 1.29 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.396 1.208 . . . . 0.0 110.254 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -62.11 -31.62 72.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.81 ' O ' HG22 ' A' ' 21' ' ' ILE . 35.8 t -71.89 -46.11 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -58.11 -45.14 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.71 -21.41 60.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.424 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.96 -51.39 8.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 23' ' ' LYS . 2.5 tt -101.94 -24.19 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 104.2 -6.74 46.93 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.908 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -117.39 115.34 25.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.133 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -70.8 67.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.68 103.51 3.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 170.66 178.67 41.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.6 mttp -147.78 -176.12 5.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -1.076 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.6 t -107.91 128.62 54.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -145.95 126.9 14.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.47 -0.769 . . . . 0.0 109.788 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.2 m120 62.68 42.58 8.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 62.43 23.88 65.14 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 20.2 mttm -134.03 175.99 8.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -1.183 . . . . 0.0 109.922 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.5 ' HB3' HG12 ' A' ' 3' ' ' ILE . 1.9 t -118.47 129.25 55.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 1.9 mmmm -99.92 92.47 5.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 110.148 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.87 142.81 27.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.394 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -96.47 133.92 24.1 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.451 1.237 . . . . 0.0 110.548 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 33' ' ' CYS . 1.3 pt . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.87 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.362 0.601 . . . . 0.0 111.074 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -144.55 88.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.214 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 6.3 mmtp -36.01 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.373 0.606 . . . . 0.0 110.897 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 5' ' ' ALA . 23.8 p -78.71 139.57 38.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.349 -0.845 . . . . 0.0 110.352 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 -15.19 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.265 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -154.27 151.4 23.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -60.09 -50.98 83.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -1.149 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.16 -11.98 21.21 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.422 1.222 . . . . 0.0 110.841 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -80.51 -34.82 35.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 2.0 t -67.1 -27.19 67.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -53.72 -59.08 10.51 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 0.0 109.723 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.21 -41.97 54.73 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.362 1.19 . . . . 0.0 109.785 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -50.31 64.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 59.6 m -56.48 -45.93 80.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.112 -0.992 . . . . 0.0 109.822 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -39.78 69.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.712 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -78.97 -13.42 59.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.53 -15.69 25.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 17' ' ' CYS . 2.0 pt -148.52 -37.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.352 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -9.13 10.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 126.55 52.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 110.263 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -76.57 74.11 3.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.361 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 110.12 4.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 109.865 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 177.6 171.16 40.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.37 -168.73 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -1.118 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.77 133.04 55.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.27 141.62 23.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.0 110.968 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.14 22.3 0.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.33 -0.856 . . . . 0.0 110.621 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 82.2 13.84 78.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 7.6 mttt -117.69 160.17 21.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -1.174 . . . . 0.0 109.618 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.578 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -97.04 128.16 43.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.856 -1.152 . . . . 0.0 110.146 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 36.7 mtpt -96.88 117.38 30.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.8 m -123.34 134.98 53.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.978 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' OH ' ' CE ' ' A' ' 34' ' ' LYS . 23.6 m-85 -108.38 151.28 41.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 O-C-N 123.655 1.345 . . . . 0.0 110.359 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 ' CB ' ' A' ' 33' ' ' CYS . 36.0 pt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.237 0.541 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.423 ' HA ' ' CE ' ' A' ' 32' ' ' LYS . 27.9 p-10 -79.34 48.09 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.399 -0.813 . . . . 0.0 110.47 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -95.09 90.77 6.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -0.952 . . . . 0.0 109.81 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -45.76 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.437 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 10.3 p -73.11 -167.68 0.42 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.135 -0.978 . . . . 0.0 110.367 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.31 -17.38 6.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.213 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.69 150.29 22.35 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.609 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -58.84 -51.0 84.96 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -1.093 . . . . 0.0 111.163 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.44 -24.73 78.84 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.39 1.205 . . . . 0.0 111.217 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 39.4 tp10 -58.88 -26.51 64.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -70.96 -23.05 62.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.613 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -58.05 -57.39 26.22 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.4 -45.0 19.94 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.424 1.223 . . . . 0.0 109.864 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -49.05 79.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 m -61.78 -42.55 99.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.726 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 12.2 ttpp -55.99 -30.1 61.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.04 -20.11 23.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.55 -57.88 2.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 35' ' ' CYS . 10.0 pt -100.9 -41.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.09 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 103.01 32.79 4.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 19.9 mmtt -129.69 -2.27 4.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -1.178 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.62 60.33 1.64 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.742 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 36' ' ' TYR . . . -150.22 82.37 1.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.0 -175.2 33.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 5.3 mttp -150.0 -176.92 5.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -1.068 . . . . 0.0 109.948 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.1 t -121.97 127.54 50.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 110.585 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.531 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -144.11 155.27 43.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 109.823 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.87 18.21 1.54 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.127 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 78.06 43.3 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 3.9 mttt -153.07 160.33 42.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.132 -1.216 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.636 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -91.26 134.2 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 0.0 109.96 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.531 ' CD ' ' HB2' ' A' ' 29' ' ' MET . 0.4 OUTLIER -120.89 99.68 6.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.547 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HB3' HD13 ' A' ' 21' ' ' ILE . 57.1 m -87.74 156.4 19.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.101 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 32.6 m-85 -140.33 141.24 25.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 0.0 110.23 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.7 Cg_endo . . . . . 0 C--N 1.313 -1.314 0 O-C-N 123.508 1.268 . . . . 0.0 110.451 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 5' ' ' ALA . 3.8 pt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.348 0.594 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 6' ' ' LYS . 12.3 p-10 -62.6 -9.77 10.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.464 -0.773 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . -41.2 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.86 . . . . 0.0 110.265 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' ASN . 10.5 mmtm -49.04 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 110.345 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . 16.9 p -76.07 149.36 37.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -122.38 -10.67 8.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.01 143.84 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -49.75 -50.26 68.37 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.338 -1.095 . . . . 0.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.14 -9.35 16.88 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.368 1.194 . . . . 0.0 110.776 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -87.8 -35.63 17.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 8.4 t -73.24 -39.92 65.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -44.56 -55.65 9.89 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.059 -1.026 . . . . 0.0 109.845 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -62.54 -47.76 8.77 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.367 1.193 . . . . 0.0 110.119 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 20.0 mttt -54.01 -44.14 70.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 60.6 m -62.65 -39.34 93.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.856 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.631 ' CD ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 tttt -61.92 -26.96 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -32.49 21.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.475 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.63 -18.02 21.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.119 -0.988 . . . . 0.0 110.325 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.593 ' CD1' ' CB ' ' A' ' 35' ' ' CYS . 37.0 mt -128.92 -45.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 97.18 35.76 5.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -134.78 1.39 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -1.226 . . . . 0.0 110.338 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . . . 39.16 46.28 1.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.463 -0.773 . . . . 0.0 110.442 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.84 106.85 7.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 110.237 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 173.49 178.99 43.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -146.58 -165.36 2.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.011 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 t -126.71 122.56 35.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 tpt -150.02 134.96 17.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER 62.15 31.01 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.261 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.76 33.88 88.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 18.3 mttt -136.36 150.87 49.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.221 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.547 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.45 118.16 30.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 109.846 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -101.22 103.73 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.454 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.593 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 9.8 m -111.76 166.74 10.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.89 157.4 42.0 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.423 0 O-C-N 123.69 1.363 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.503 HG13 ' HB3' ' A' ' 33' ' ' CYS . 17.9 pt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.434 0.635 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 32' ' ' LYS . 14.6 p-10 -101.34 60.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.283 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.71 4.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 47.65 79.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.51 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -70.42 -165.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 0.0 109.982 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -126.45 -18.0 4.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.01 . . . . 0.0 110.63 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -154.3 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.622 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 168.65 -55.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.095 -1.238 . . . . 0.0 111.309 -179.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.9 Cg_exo -56.15 -11.95 6.76 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.309 1.163 . . . . 0.0 111.69 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.85 -31.2 64.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 109.533 179.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.1 t -69.12 -28.65 66.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.506 -0.746 . . . . 0.0 110.633 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 tp -59.36 -56.5 35.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.581 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.26 -46.44 18.41 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.405 1.213 . . . . 0.0 110.291 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -62.58 -32.6 73.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.857 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.0 m -64.24 -52.33 59.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 ttpt -57.94 -35.84 71.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 mm-40 -76.05 -18.17 59.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.95 -9.94 12.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.857 HG22 ' O ' ' A' ' 17' ' ' CYS . 5.8 tt -131.06 -28.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.65 -38.0 3.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.73 ' H ' HG23 ' A' ' 21' ' ' ILE . 3.5 mtpt -124.0 132.92 53.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.339 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.85 90.61 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' TYR . . . -141.42 89.55 2.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 27' ' ' LYS . . . 177.7 -175.42 47.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 15.1 mtmm -150.15 175.03 12.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -1.094 . . . . 0.0 109.584 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 18.4 t -109.44 130.71 55.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.927 -1.108 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.55 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 1.6 ttt -130.51 138.6 50.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 61.24 11.93 3.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 95.63 17.48 35.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 2.1 mttt -131.24 143.29 50.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.917 -1.343 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.7 t -84.47 145.51 28.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 0.0 110.638 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HE2' ' CB ' ' A' ' 29' ' ' MET . 2.4 mtmp? -133.24 100.84 4.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.742 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.6 m -81.93 168.4 17.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.519 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 5.4 m-85 -122.08 159.6 51.07 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.004 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 0.0 110.554 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.293 0.568 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -108.14 42.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -96.15 27.78 3.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.581 -0.699 . . . . 0.0 110.278 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 3.1 ptmm? 36.06 72.57 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.582 0.706 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.9 p -51.82 134.46 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.63 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -94.26 -15.58 24.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 0.0 109.845 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -160.1 156.98 28.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.605 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.43 -50.02 89.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.13 -11.44 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.425 1.224 . . . . 0.0 110.857 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.5 mm-40 -81.7 -33.72 31.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.3 t -67.03 -21.01 65.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -59.65 -59.36 14.1 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.068 -1.02 . . . . 0.0 109.314 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -57.94 -37.98 94.01 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.3 1.158 . . . . 0.0 109.697 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 18.5 mttp -69.81 -38.31 76.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' HG12 ' A' ' 21' ' ' ILE . 62.6 m -75.65 -34.82 60.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.902 . . . . 0.0 109.703 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -67.78 -36.24 80.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.83 -18.29 27.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.188 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -75.04 -55.33 5.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.338 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 17' ' ' CYS . 18.1 pt -108.34 -35.03 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.14 11.02 3.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -135.52 135.92 40.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.281 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -85.73 76.64 9.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 93.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -164.79 178.45 39.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 3.6 mtmp? -142.71 -175.16 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -1.107 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 5.8 t -132.18 119.7 21.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 110.168 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.13 145.35 30.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.829 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.83 28.28 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.817 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.82 75.7 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -126.57 159.39 33.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -1.154 . . . . 0.0 110.344 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.5 119.78 40.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.974 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.3 mtmt -105.36 125.78 51.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.41 ' SG ' HD11 ' A' ' 3' ' ' ILE . 40.0 m -119.11 142.14 48.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -110.2 125.1 31.73 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 110.148 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.401 1.211 . . . . 0.0 110.516 179.983 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.7 pt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.317 0.58 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.493 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 31.5 p-10 -101.0 68.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.86 11.16 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 4' ' ' ASN . 4.4 mttt 50.64 60.86 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 23.7 p -71.97 159.07 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 110.409 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.54 -17.13 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.01 151.78 22.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -52.9 -48.0 93.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.392 -1.063 . . . . 0.0 111.529 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.01 -25.9 78.09 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.201 1.106 . . . . 0.0 111.684 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.3 tp10 -52.33 -29.58 24.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.806 -1.184 . . . . 0.0 110.095 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 5.6 t -69.35 -35.59 76.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.499 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.741 HD12 ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -44.62 -57.5 6.63 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.947 -1.096 . . . . 0.0 109.816 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -61.49 -48.4 9.51 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.392 1.206 . . . . 0.0 109.323 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.779 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 5.1 t -61.6 -48.73 79.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 4.5 ttmt -66.16 -19.81 65.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.885 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.54 -12.98 30.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.98 -69.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.365 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 22' ' ' GLY . 6.2 pt -84.78 -29.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 110.204 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 112.67 18.1 7.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -149.99 122.88 8.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -1.225 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -81.48 82.33 7.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.84 92.17 2.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . 171.13 -159.36 31.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.5 mtmp? -147.73 -163.37 1.75 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -1.092 . . . . 0.0 109.859 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -138.86 127.71 23.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.884 -1.135 . . . . 0.0 110.682 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 29.5 ttm -141.91 166.19 25.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 109.657 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 48.92 22.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.965 . . . . 0.0 109.892 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 73.6 34.97 56.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.2 mttp -148.19 147.05 28.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -83.4 139.44 32.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -115.55 149.57 37.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.845 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.05 147.83 37.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.566 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -123.13 104.05 35.62 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.024 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 O-C-N 123.457 1.241 . . . . 0.0 110.594 -179.715 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.561 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.9 pt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.148 0.499 . . . . 0.0 109.67 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 24.8 p-10 -100.24 55.31 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.817 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.79 15.15 17.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 4.7 mmtp 46.63 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.343 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 8' ' ' ARG . 19.6 p -69.7 -168.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 3.5 mmt85 -140.37 -34.89 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -138.45 -65.19 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.105 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER 169.9 -55.85 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.119 -1.224 . . . . 0.0 110.88 -179.691 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -57.92 -26.67 75.55 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.377 1.199 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt-10 -61.2 -23.12 65.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -69.64 -31.01 68.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.941 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.6 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -53.58 -58.43 12.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.072 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.66 -51.93 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.367 1.193 . . . . 0.0 109.976 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -60.27 -46.65 89.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.1 t -62.61 -44.43 96.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -58.54 -28.3 65.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -105.25 1.58 28.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.17 -62.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 22' ' ' GLY . 4.4 tt -90.34 -39.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 110.03 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 21' ' ' ILE . . . 109.38 26.68 5.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -147.79 127.66 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.539 -0.977 . . . . 0.0 109.828 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -76.28 50.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 110.779 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -137.16 110.97 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.046 -1.034 . . . . 0.0 109.837 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 179.26 173.36 44.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -150.04 -172.39 4.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.136 . . . . 0.0 110.302 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.1 t -122.54 122.12 38.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 3.6 tmm? -146.91 137.07 23.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 63.94 10.75 5.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 110.343 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.79 22.8 37.97 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 27.8 mttt -124.97 162.44 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -1.153 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -108.64 106.81 17.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 108.726 179.736 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.9 mtpm? -89.4 152.96 21.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.018 . . . . 0.0 111.003 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 23.7 m -144.23 136.71 26.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.689 . . . . 0.0 109.751 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -97.22 154.03 38.24 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.942 . . . . 0.0 110.464 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.732 1.385 . . . . 0.0 110.639 179.862 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.8 pt . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.181 0.515 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 4' ' ' ASN . 16.0 p-10 -79.84 75.44 6.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 0.0 110.087 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -108.36 15.95 23.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 23.6 tptp 44.51 44.0 6.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 26.8 p -45.65 154.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -101.79 -31.19 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.36 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 176.54 31.67 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.122 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.637 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -69.27 -47.39 28.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.991 . . . . 0.0 111.369 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -60.84 -21.97 72.27 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.175 1.092 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.9 mm-40 -84.03 -35.76 23.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 42.1 t -69.3 -31.55 70.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.67 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -51.83 -59.07 8.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 109.839 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.13 -45.44 31.66 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.292 1.154 . . . . 0.0 109.684 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -52.85 -41.21 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.9 m -69.66 -27.77 65.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.577 179.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 2.0 ttpm? -71.06 -22.02 62.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.787 . . . . 0.0 109.73 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.77 -26.03 18.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.146 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.52 -45.16 17.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 23' ' ' LYS . 5.4 pt -123.27 -32.62 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 96.25 36.36 5.2 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -121.82 -9.22 8.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.509 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 41.21 47.22 2.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.767 . . . . 0.0 110.4 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.94 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -151.62 -178.11 26.06 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 mttp -143.0 172.11 13.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -1.106 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.7 t -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.334 -0.854 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.414 ' HB3' ' CD ' ' A' ' 34' ' ' LYS . 46.7 tpp -135.94 127.3 28.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 110.501 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.05 23.65 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.75 3.98 76.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 150.97 24.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.918 -1.342 . . . . 0.0 110.36 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -95.82 126.31 40.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -104.75 84.69 2.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.694 -179.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -85.17 148.79 25.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.101 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.86 108.37 28.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 109.994 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 O-C-N 123.469 1.247 . . . . 0.0 110.624 -179.791 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.378 0.609 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 20.6 p30 -87.26 67.91 9.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.37 4.5 42.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 56.49 57.62 4.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -65.56 166.73 10.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -107.31 -9.52 16.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.46 156.02 27.38 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.15 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -63.41 -42.58 75.06 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.964 . . . . 0.0 112.074 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.7 Cg_exo -60.12 -13.49 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 122.848 0.92 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -75.54 -22.04 57.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.036 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' SER . 1.3 m -71.8 -26.25 62.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.57 -0.706 . . . . 0.0 110.147 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -58.65 -57.78 24.08 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.15 -45.7 22.2 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.326 1.172 . . . . 0.0 109.97 179.156 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -62.09 -50.29 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.838 ' O ' HG22 ' A' ' 21' ' ' ILE . 49.9 m -54.27 -36.99 64.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.021 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -60.88 -52.35 65.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -76.42 -4.55 42.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.042 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.75 -47.69 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 17' ' ' CYS . 6.9 tt -116.92 -28.16 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.11 38.65 9.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -138.08 2.2 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.292 . . . . 0.0 110.706 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.55 48.24 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.42 108.82 4.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.06 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -178.11 -178.0 47.26 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.112 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -146.92 175.08 10.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.957 . . . . 0.0 109.448 179.664 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.83 128.87 41.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 110.267 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.1 tpp -143.38 154.08 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 110.111 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.56 20.88 6.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.069 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 77.55 29.7 54.91 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.6 mttt -141.73 153.76 44.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -1.189 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.448 ' C ' ' CG ' ' A' ' 34' ' ' LYS . 9.9 t -93.01 154.81 17.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.84 . . . . 0.0 110.827 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' CG ' ' C ' ' A' ' 33' ' ' CYS . 23.8 mtmm -148.68 99.67 3.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.035 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 58.1 m -81.81 173.85 11.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.199 -0.938 . . . . 0.0 110.386 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.5 m-85 -108.58 140.43 21.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.291 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.509 1.268 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.9 pt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.212 0.529 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 44.5 p30 -98.05 75.59 2.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.945 . . . . 0.0 110.572 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 15.16 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.875 . . . . 0.0 109.872 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER 48.51 55.25 9.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 -179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 22.0 p -61.12 144.19 54.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.29 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -26.64 13.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -137.31 152.7 21.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.11 -46.22 96.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.397 -1.061 . . . . 0.0 111.67 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.6 Cg_exo -61.58 -16.7 49.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.064 1.033 . . . . 0.0 111.429 -179.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -73.99 -32.56 63.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.938 -1.101 . . . . 0.0 109.699 179.464 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 1.9 t -68.2 -24.8 64.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.624 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -55.1 -59.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 179.765 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.04 -44.43 29.76 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.365 1.192 . . . . 0.0 109.878 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -64.83 -39.11 93.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 110.247 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 55.9 m -66.0 -25.18 66.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 110.409 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -77.91 -41.36 36.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 110.509 -179.752 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.0 -24.53 47.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 110.668 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.35 -23.6 23.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 35' ' ' CYS . 8.1 mt -131.06 -29.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 110.48 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 112.37 -19.15 22.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.03 119.93 38.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -1.144 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -68.63 79.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.004 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -149.24 127.91 12.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 157.9 -175.22 35.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -146.7 -170.33 3.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 31.2 t -132.73 111.86 11.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -122.36 125.59 46.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 -179.883 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 65.16 16.14 10.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 179.805 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.64 18.76 54.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 4.0 mmtp -112.8 144.98 41.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.333 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -93.88 114.53 26.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.133 -179.709 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -109.96 116.37 31.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.042 179.836 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 17.3 m -111.06 144.56 39.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 27.2 m-85 -93.32 149.95 38.22 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 O-C-N 123.754 1.397 . . . . 0.0 110.522 -179.725 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.0 pt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.295 0.569 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 5' ' ' ALA . 14.7 p30 -64.13 -7.52 9.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 110.894 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.39 113.62 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 110.436 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.25 79.99 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.922 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.0 p -75.09 172.33 12.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -132.41 -27.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.948 . . . . 0.0 110.876 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.04 141.79 16.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.9 -52.7 70.49 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.385 -1.068 . . . . 0.0 110.771 179.887 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 2.9 Cg_endo -62.32 -35.68 71.92 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.387 1.204 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt-10 -62.36 -26.14 68.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -67.93 -38.05 82.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.991 179.794 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -44.77 -58.55 5.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.774 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -57.75 -55.46 2.36 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.426 1.224 . . . . 0.0 109.805 179.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 22.5 mmmt -52.68 -39.06 61.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.251 179.233 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.0 t -67.97 -43.14 79.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 tttp -55.0 -25.05 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.699 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.85 -21.44 18.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.795 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.3 -43.35 12.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.457 HG12 ' HD3' ' A' ' 23' ' ' LYS . 8.8 tt -113.87 -33.34 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.099 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 89.64 40.8 5.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HD3' HG12 ' A' ' 21' ' ' ILE . 1.6 mptp? -139.16 4.73 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -1.163 . . . . 0.0 110.663 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . 40.37 45.57 1.87 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.434 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.97 86.83 1.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.144 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -162.95 176.4 39.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 4.7 mtmp? -142.04 174.97 10.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 109.828 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 35.8 t -117.63 119.17 34.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.3 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.475 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -150.57 151.22 32.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.314 -179.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.96 18.14 3.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 110.466 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 81.33 20.21 65.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.28 169.37 17.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.246 -1.149 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 1.8 t -107.82 125.4 51.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 110.35 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 1.5 mtpt -94.44 101.42 13.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.919 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 142.01 33.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 110.369 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.35 168.71 12.18 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.89 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.614 1.323 . . . . 0.0 110.508 179.741 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.359 0.6 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.82 47.14 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 110.032 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.86 13.03 4.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER 50.76 67.72 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.016 -179.874 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 p -55.6 176.05 0.07 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.58 -40.9 6.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.049 -1.032 . . . . 0.0 110.784 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -166.46 -41.96 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.093 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.58 -55.23 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.11 -1.229 . . . . 0.0 110.863 -179.659 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.26 -12.44 16.35 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.413 1.217 . . . . 0.0 110.955 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.6 mp0 -96.74 -21.54 17.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -75.05 -49.02 21.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.511 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -42.42 -52.88 9.8 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 110.446 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -62.37 -57.06 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.348 1.183 . . . . 0.0 109.905 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 9.7 mmtp -50.99 -37.28 43.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.4 t -67.88 -37.48 81.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.639 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 7.4 tttm -61.39 -27.59 68.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.759 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 14.4 mt-10 -94.68 -24.99 16.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -47.6 42.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.379 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 17' ' ' CYS . 11.6 pt -115.61 -28.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -0.951 . . . . 0.0 110.413 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 109.92 16.19 10.98 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 37' ' ' PRO . 7.5 ttpt -139.94 119.74 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.242 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -70.74 67.92 0.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.05 68.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.96 170.18 29.35 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 29.7 mtmt -142.91 171.69 13.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.3 t -110.4 132.86 53.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 109.618 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -150.09 133.52 16.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.1 m120 61.49 13.0 4.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 90.68 28.49 16.13 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.1 mtpp -139.88 167.49 21.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -1.163 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.37 118.45 36.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 110.053 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 29' ' ' MET . 14.1 mtpt -111.11 103.58 12.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.536 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 96.8 m -98.82 165.7 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -147.91 95.55 4.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.1 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.518 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.552 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.4 mm . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -110.81 42.16 1.66 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.417 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.72 15.86 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt 45.17 59.12 3.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.622 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 16.1 p -45.21 134.18 6.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.471 -0.768 . . . . 0.0 110.735 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.4 -24.54 15.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.24 144.25 15.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.57 -50.69 85.79 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -1.104 . . . . 0.0 110.841 -179.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -62.91 -19.24 68.38 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.461 1.243 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.45 -32.06 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.775 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 4.0 t -66.36 -29.95 70.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -50.89 -59.56 7.27 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.556 179.375 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -56.64 -44.51 44.74 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.345 1.182 . . . . 0.0 109.486 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 8.0 mmtt -58.31 -33.05 69.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 108.989 178.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.7 -39.45 80.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.579 -0.701 . . . . 0.0 109.724 179.472 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -69.05 -20.78 64.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 110.137 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -103.82 -10.52 18.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.7 -54.06 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.124 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.595 HG21 ' SG ' ' A' ' 17' ' ' CYS . 14.9 tt -105.12 -12.69 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.94 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.84 89.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ALA . 15.7 tptt -135.24 1.75 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 110.316 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.6 46.87 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 110.487 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.08 88.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.336 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -153.53 175.61 31.84 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 2.0 mtmp? -146.11 -168.45 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -1.118 . . . . 0.0 110.461 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 38.0 t -125.21 105.87 9.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 tpt -128.34 137.42 51.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.24 28.01 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.396 179.79 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . 69.73 37.44 76.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -139.3 150.97 46.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.328 -1.101 . . . . 0.0 110.015 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.4 104.69 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 110.173 -179.819 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 15.8 mtpt -89.75 159.06 17.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.518 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -155.83 154.31 31.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -104.42 152.02 39.24 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.587 1.309 . . . . 0.0 110.608 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE . 5.7 mt . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.29 0.567 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -99.68 20.95 13.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.3 124.92 22.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 2.6 ptmt -68.6 77.03 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.438 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 6' ' ' LYS . 4.2 p -50.68 -178.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 109.969 179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -129.88 -37.66 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.375 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -146.92 -52.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.86 -54.85 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.185 -1.185 . . . . 0.0 111.222 -179.854 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.15 -37.1 96.96 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.279 1.147 . . . . 0.0 111.478 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 pm0 -58.76 -27.47 65.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.975 -1.078 . . . . 0.0 110.464 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -67.75 -37.24 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.548 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -49.46 -56.77 14.5 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 110.478 -180.0 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -58.73 -41.79 59.87 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.316 1.167 . . . . 0.0 109.686 179.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -49.3 77.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.792 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 21' ' ' ILE . 75.5 m -58.81 -35.57 73.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -62.33 -37.57 86.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.855 . . . . 0.0 110.038 179.766 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.73 -17.79 57.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 109.921 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.45 -43.39 5.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 17' ' ' CYS . 11.5 tt -111.59 -25.75 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.958 . . . . 0.0 110.169 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 69.81 37.58 75.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HG23 ' A' ' 21' ' ' ILE . 7.0 tttp -130.04 -2.64 4.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -1.207 . . . . 0.0 110.314 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 48.82 57.46 6.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.34 119.33 6.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.025 -1.047 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . 149.69 172.2 18.96 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -141.73 -168.16 2.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -1.018 . . . . 0.0 110.005 179.794 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -102.08 150.56 23.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.746 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.53 73.38 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -179.605 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.5 m120 51.93 30.04 6.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 139.78 -31.37 2.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -106.32 -175.81 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.902 -1.351 . . . . 0.0 110.35 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.8 t -120.76 155.25 34.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.009 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -136.38 88.94 2.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.648 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 19.4 m -80.17 139.65 36.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.903 . . . . 0.0 109.751 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.47 140.98 52.27 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.149 -0.97 . . . . 0.0 110.36 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.561 1.295 . . . . 0.0 110.503 179.653 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 33' ' ' CYS . 2.7 pt . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.248 0.547 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' ALA . 15.7 p-10 -56.41 -43.65 79.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.802 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . 37.78 -141.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.606 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.3 50.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.473 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 25.4 p -57.73 146.42 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.4 0.619 . . . . 0.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -111.63 -11.36 14.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.368 -0.833 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -144.29 -71.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.59 -54.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 110.523 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -60.27 -20.66 63.46 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.326 1.172 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 33.9 mm-40 -74.84 -17.77 60.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -68.33 -26.43 65.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.345 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.6 mt -59.02 -58.42 19.66 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.95 -49.95 10.1 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.373 1.196 . . . . 0.0 110.175 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -43.42 74.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.853 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 1.7 m -75.82 -38.06 58.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.963 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -28.43 43.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -101.65 -19.02 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 110.329 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.98 -50.66 9.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.237 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 23' ' ' LYS . 5.9 pt -106.06 -36.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 110.34 21.29 6.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -127.35 -139.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -1.2 . . . . 0.0 109.937 179.688 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 14' ' ' LEU . . . 179.61 50.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.0 -1.062 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.34 100.24 3.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 27' ' ' LYS . . . 173.67 -176.63 46.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 25.2 mtmm -143.99 -172.23 3.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -1.218 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -100.26 159.08 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -0.82 . . . . 0.0 109.941 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.494 ' HG3' ' HE3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -146.08 98.74 3.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.033 . . . . 0.0 111.137 -179.711 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 51.78 29.8 6.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 101.07 19.98 15.31 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 mttp -131.28 164.5 25.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -1.205 . . . . 0.0 109.824 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.9 t -112.4 131.71 55.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.039 -1.038 . . . . 0.0 111.296 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HE3' ' HG3' ' A' ' 29' ' ' MET . 0.0 OUTLIER -113.3 93.03 4.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.687 -0.633 . . . . 0.0 109.426 179.279 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.0 m -115.86 164.62 14.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.975 -1.078 . . . . 0.0 110.696 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -102.36 155.83 36.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.321 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.311 -1.446 0 O-C-N 123.772 1.406 . . . . 0.0 110.46 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 2' ' ' PHE . 9.0 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.123 0.487 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 11.4 m-85 -122.85 169.98 10.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.703 HG13 ' HB3' ' A' ' 5' ' ' ALA . 1.6 pt -130.12 144.33 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' ALA . 10.5 p30 -67.67 -13.91 62.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -0.849 . . . . 0.0 110.389 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.703 ' HB3' HG13 ' A' ' 3' ' ' ILE . . . -44.25 104.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.02 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.27 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.468 ' N ' ' O ' ' A' ' 5' ' ' ALA . 26.3 p -75.57 153.58 37.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -128.8 -9.54 4.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.039 -1.038 . . . . 0.0 110.791 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.98 131.0 4.72 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.154 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.604 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -49.4 -49.23 72.33 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.359 -1.083 . . . . 0.0 110.952 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.63 -21.02 70.19 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.303 1.159 . . . . 0.0 110.806 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -75.63 -30.94 59.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.132 -0.98 . . . . 0.0 109.599 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -68.0 -22.0 65.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.794 . . . . 0.0 110.038 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -64.14 -58.9 12.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.151 -0.968 . . . . 0.0 109.8 179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.76 -32.19 96.53 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.362 1.191 . . . . 0.0 109.354 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -56.14 7.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.494 -0.754 . . . . 0.0 110.094 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.5 m -50.33 -47.38 55.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.968 . . . . 0.0 108.992 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -58.75 -34.47 71.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.245 178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.8 tm-20 -82.36 -16.12 50.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.799 . . . . 0.0 109.363 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 21' ' ' ILE . . . -88.1 -58.42 2.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.417 -0.802 . . . . 0.0 110.189 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.573 HD13 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -105.3 -28.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.274 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 -15.27 5.07 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.037 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 8.7 mmmt -118.81 144.6 46.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.235 . . . . 0.0 110.508 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 14' ' ' LEU . . . -90.09 64.22 6.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.39 103.99 7.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.229 -0.919 . . . . 0.0 110.253 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 175.83 178.38 45.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.34 -175.64 4.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.197 -1.178 . . . . 0.0 109.923 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 18.2 t -126.55 117.26 22.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 0.0 110.337 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.428 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 13.1 mtp -150.15 160.82 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 110.308 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 51.05 24.78 2.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.314 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' O ' ' CG ' ' A' ' 32' ' ' LYS . . . 69.16 41.57 79.62 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 31' ' ' GLY . 26.4 mttm -156.98 161.65 39.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -1.135 . . . . 0.0 110.023 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB3' HG12 ' A' ' 3' ' ' ILE . 4.3 t -99.36 134.0 42.86 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.179 -0.95 . . . . 0.0 110.194 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HA ' ' CD2' ' A' ' 2' ' ' PHE . 8.6 mtpt -107.0 86.07 2.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 110.26 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.9 m -91.54 135.65 33.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -103.85 113.8 65.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.261 -0.899 . . . . 0.0 110.229 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.257 0 O-C-N 123.268 1.141 . . . . 0.0 110.431 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.839 HG21 HD12 ' A' ' 21' ' ' ILE . 10.5 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.375 0.607 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 1' ' ' VAL . 27.4 m-85 -150.59 152.98 34.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.019 -1.05 . . . . 0.0 110.66 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.04 164.36 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -0.916 . . . . 0.0 109.701 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.434 ' O ' ' C ' ' A' ' 5' ' ' ALA . 21.8 p30 -106.89 -10.58 15.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.333 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.33 116.07 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.833 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -58.65 80.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 0.0 110.378 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 27.3 p -60.35 151.67 27.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 110.0 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -110.64 -22.21 11.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -0.962 . . . . 0.0 110.595 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.37 153.51 24.49 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.07 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -65.18 -48.24 69.92 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.474 -1.015 . . . . 0.0 111.207 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.77 -20.92 72.44 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.34 1.179 . . . . 0.0 111.103 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 tt0 -75.18 -37.13 61.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 109.807 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -67.48 -23.32 65.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.854 . . . . 0.0 110.132 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.1 mm? -59.38 -59.06 15.06 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.112 -0.993 . . . . 0.0 109.993 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.4 -47.95 15.15 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.277 1.146 . . . . 0.0 110.043 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' O ' ' CG ' ' A' ' 19' ' ' GLU . 1.7 mtpt -64.53 -53.5 46.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.418 -0.801 . . . . 0.0 110.176 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 1.025 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.4 t -55.16 -36.49 65.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 9.1 tttm -62.87 -42.93 99.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.38 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -74.39 -15.85 60.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.103 -0.998 . . . . 0.0 110.223 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' N ' ' HG3' ' A' ' 19' ' ' GLU . . . -93.64 -34.52 13.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 110.4 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.025 HG22 ' O ' ' A' ' 17' ' ' CYS . 9.3 tt -110.91 -15.17 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 110.362 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 99.22 -14.71 60.99 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.824 ' H ' HG23 ' A' ' 21' ' ' ILE . 4.3 tptt -138.84 125.8 21.13 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.129 -1.218 . . . . 0.0 110.378 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -65.53 77.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -131.79 67.23 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -159.6 -173.65 28.35 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.15 -162.12 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.5 t -130.96 118.35 20.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.445 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -150.66 162.55 40.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 48.77 23.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.227 -0.92 . . . . 0.0 109.948 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 69.32 26.52 74.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 15.7 mtpt -136.34 175.2 9.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.987 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -112.81 116.98 30.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.015 . . . . 0.0 110.381 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -96.9 151.07 20.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 0.0 109.499 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 34' ' ' LYS . 97.1 m -149.88 154.49 38.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 110.654 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -132.53 129.79 21.54 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.356 -0.84 . . . . 0.0 109.834 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.285 0 O-C-N 123.367 1.193 . . . . 0.0 110.588 -179.82 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.304 0.573 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 5.9 m-30 -99.19 145.25 27.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.86 . . . . 0.0 110.036 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 16.1 pt -122.62 137.75 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.7 p30 -76.31 1.95 14.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 110.307 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -43.0 94.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.237 -0.914 . . . . 0.0 110.095 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -47.57 91.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.399 -0.813 . . . . 0.0 110.32 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 5' ' ' ALA . 12.1 p -78.72 -173.43 3.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.171 -0.956 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' OE1' ' A' ' 12' ' ' GLU . 3.0 mmt180 -112.04 -27.1 8.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.2 -173.62 33.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -70.27 -46.94 20.69 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.521 -0.988 . . . . 0.0 111.866 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.72 -9.92 15.34 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.127 1.067 . . . . 0.0 111.493 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -87.06 -20.41 27.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.981 -1.074 . . . . 0.0 109.536 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.94 -36.97 83.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.441 -0.787 . . . . 0.0 110.169 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.683 ' CD1' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -47.56 -58.71 6.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.244 -0.91 . . . . 0.0 110.13 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.63 -42.25 55.95 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.352 1.185 . . . . 0.0 109.918 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 16' ' ' LYS . 6.2 mptt -65.21 -51.18 62.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.3 m -57.06 -45.84 82.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.182 -0.949 . . . . 0.0 109.893 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 8.5 ttpt -61.96 -33.0 73.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.8 . . . . 0.0 109.956 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.02 -11.62 43.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.824 . . . . 0.0 110.202 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.56 -49.44 8.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.069 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 pt -125.61 -33.96 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.75 27.09 1.64 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' HD2' ' OXT' ' A' ' 37' ' ' PRO . 4.0 mmtm -126.97 -156.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.378 -1.072 . . . . 0.0 109.876 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.683 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -160.88 44.47 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.13 -0.981 . . . . 0.0 110.066 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.37 101.01 6.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.074 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 176.72 171.91 40.84 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -138.72 -176.44 4.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 109.564 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -132.24 134.12 44.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.051 -1.03 . . . . 0.0 110.411 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -144.06 146.39 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 29' ' ' MET . 78.6 m-20 57.61 14.06 2.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.783 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 89.29 32.27 10.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.6 OUTLIER -141.69 143.9 33.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -1.22 . . . . 0.0 109.767 179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 9.9 t -94.36 147.78 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -0.941 . . . . 0.0 110.852 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.1 OUTLIER -132.85 99.9 4.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.393 -0.817 . . . . 0.0 110.205 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 6.4 m -101.5 174.88 5.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.132 -0.98 . . . . 0.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 21.2 m-85 -141.98 161.49 50.89 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.0 110.135 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' OXT' ' HD2' ' A' ' 23' ' ' LYS . 3.0 Cg_endo . . . . . 0 C--N 1.31 -1.462 0 O-C-N 123.701 1.369 . . . . 0.0 110.497 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 21' ' ' ILE . 27.7 m . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.27 0.557 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 1.6 m-85 -121.61 144.93 48.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.886 . . . . 0.0 110.216 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.495 HG13 ' HB3' ' A' ' 33' ' ' CYS . 37.3 pt -145.23 164.77 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 110.095 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 50.2 p30 -118.91 68.83 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 110.389 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' LYS . . . -79.78 6.2 11.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 65.98 51.25 1.36 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.247 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.4 p -71.48 166.88 20.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.83 -8.44 5.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 110.478 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.67 170.2 31.79 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.147 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -66.12 -48.29 59.86 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.946 . . . . 0.0 111.465 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.4 -10.64 16.64 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.321 1.169 . . . . 0.0 111.157 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -84.3 -47.12 11.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.128 -0.982 . . . . 0.0 109.631 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 53.2 t -67.93 -23.84 65.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -0.887 . . . . 0.0 109.787 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -55.84 -59.44 11.53 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 109.566 179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -58.98 -43.51 42.42 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.364 1.192 . . . . 0.0 109.359 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 13.8 mmtp -57.15 -39.8 75.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 109.779 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 52.2 m -69.31 -42.93 74.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 109.9 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.08 -35.99 49.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.352 -0.842 . . . . 0.0 109.723 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 -12.26 32.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -81.09 -64.06 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 23' ' ' LYS . 13.4 pt -109.97 -33.09 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.34 30.26 1.93 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' HD11 ' A' ' 21' ' ' ILE . 28.1 mmtm -142.29 114.34 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.0 110.172 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.69 62.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 0.0 110.404 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -143.01 102.57 4.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 110.11 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . -174.93 -176.77 43.51 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.83 -170.58 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -1.152 . . . . 0.0 110.063 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 43.1 t -128.8 111.8 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 110.228 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.441 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -133.13 150.58 52.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.215 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.31 26.04 2.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 110.152 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.31 40.76 80.48 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.467 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 17.1 mtpp -141.68 159.3 42.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -1.136 . . . . 0.0 110.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' HG13 ' A' ' 3' ' ' ILE . 48.6 t -101.97 115.47 30.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 0.0 110.506 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -102.2 123.83 46.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -0.875 . . . . 0.0 109.709 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -107.14 148.39 28.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.957 . . . . 0.0 110.967 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 47.8 m-85 -133.11 149.3 72.35 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.523 -0.736 . . . . 0.0 109.808 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 O-C-N 123.661 1.348 . . . . 0.0 110.548 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 1' ' ' VAL . 41.7 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.195 0.521 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.552 ' CE2' ' HG2' ' A' ' 34' ' ' LYS . 12.7 m-30 -107.24 158.42 17.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.167 -0.958 . . . . 0.0 110.422 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -139.4 154.5 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ALA . 9.5 p30 -72.69 0.87 9.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.887 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.97 104.52 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.061 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.4 99.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.451 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.6 p -70.26 -164.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 -40.08 1.4 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.261 -0.899 . . . . 0.0 110.337 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -156.86 -53.45 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.583 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 170.32 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.171 -1.194 . . . . 0.0 110.7 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -59.85 -13.07 20.8 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.26 1.137 . . . . 0.0 110.709 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 26.1 mt-10 -92.5 -19.99 21.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.091 -1.006 . . . . 0.0 110.075 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.42 -38.31 71.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.385 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -50.04 -56.0 20.61 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 109.979 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.67 -38.12 74.16 Favored 'Trans proline' 0 C--N 1.315 -1.232 0 O-C-N 123.291 1.153 . . . . 0.0 109.781 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -64.41 -53.77 43.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.341 -0.849 . . . . 0.0 109.902 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.701 ' O ' HG22 ' A' ' 21' ' ' ILE . 85.4 m -53.95 -38.87 65.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.451 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -56.56 -44.94 81.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.863 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -78.32 -8.88 58.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.98 -51.18 3.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 110.378 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 23' ' ' LYS . 16.1 tt -99.66 -26.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 110.274 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 18' ' ' LYS . . . 122.53 -28.64 5.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.781 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -130.95 147.68 52.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.145 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.82 95.17 6.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.23 50.85 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 110.153 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -143.76 -178.88 19.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 39.0 mtmt -139.44 179.73 6.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.444 -1.033 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 t -107.98 118.36 36.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.775 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.487 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.34 152.96 39.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 110.465 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 14.6 m-20 50.45 23.35 1.24 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.79 79.53 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -132.83 166.05 23.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -1.118 . . . . 0.0 109.926 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.6 t -101.61 121.12 41.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HG2' ' CE2' ' A' ' 2' ' ' PHE . 6.8 mtpm? -97.63 90.34 4.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 110.953 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 13.2 m -87.48 139.3 30.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 3.3 m-30 -88.45 150.36 46.42 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.162 -0.962 . . . . 0.0 110.397 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 O-C-N 123.686 1.361 . . . . 0.0 110.532 179.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.407 HG22 ' H3 ' ' A' ' 1' ' ' VAL . 11.9 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.198 0.523 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.623 ' CE2' ' CG ' ' A' ' 34' ' ' LYS . 25.2 m-85 -121.99 148.86 44.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 0.0 110.43 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 15.7 pt -133.65 137.55 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.21 -0.931 . . . . 0.0 109.917 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -86.72 75.44 9.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 110.47 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.4 15.21 20.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.907 . . . . 0.0 109.992 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 48.81 59.3 4.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 110.095 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 12.1 p -56.56 147.82 21.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 110.375 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 8' ' ' ARG . 3.9 mmt-85 -99.03 -30.06 12.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 0.0 110.11 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.15 149.46 20.86 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -51.76 -54.56 38.66 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.231 -1.158 . . . . 0.0 110.656 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.93 -40.16 64.81 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.384 1.202 . . . . 0.0 110.312 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.2 mm-40 -64.94 -24.69 67.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.725 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.31 -31.23 70.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -51.95 -58.68 10.35 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.267 -0.896 . . . . 0.0 109.912 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.65 -48.62 14.32 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.398 1.21 . . . . 0.0 110.034 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -60.58 -41.07 93.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 t -55.66 -39.71 71.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.146 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -44.53 80.05 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.991 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -67.03 -14.01 62.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.1 -65.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.835 . . . . 0.0 110.283 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.37 -25.08 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.214 -0.929 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.93 13.23 10.35 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -119.1 111.69 18.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.232 -1.157 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.2 55.92 0.45 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.164 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.75 108.69 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 110.272 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -179.16 152.22 10.95 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.9 -162.09 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -1.109 . . . . 0.0 110.145 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 27.9 t -143.34 131.88 22.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.111 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mtt -148.23 137.11 21.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.917 . . . . 0.0 110.493 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.86 17.87 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 110.503 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 94.95 -1.06 64.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 38.3 mmtt -105.66 159.77 15.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.246 . . . . 0.0 110.017 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 6.0 t -107.53 134.62 50.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -0.97 . . . . 0.0 110.698 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.623 ' CG ' ' CE2' ' A' ' 2' ' ' PHE . 0.5 OUTLIER -99.14 83.66 2.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.2 m -79.51 137.53 37.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.247 -0.908 . . . . 0.0 110.421 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -109.25 117.99 52.0 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.308 -0.87 . . . . 0.0 109.916 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.271 1.143 . . . . 0.0 110.534 -179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 1' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.268 0.556 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 9.1 m-30 -97.92 153.8 18.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.945 . . . . 0.0 110.261 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 33' ' ' CYS . 29.6 pt -105.72 144.05 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.238 -0.914 . . . . 0.0 109.835 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -82.7 71.02 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.843 . . . . 0.0 110.364 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -110.97 23.65 13.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 5' ' ' ALA . 3.3 pttm 33.18 62.63 0.37 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.59 0.709 . . . . 0.0 110.843 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 28.2 p -57.6 168.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.717 -0.614 . . . . 0.0 110.422 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB2' ' OE2' ' A' ' 12' ' ' GLU . 3.3 mmt-85 -122.77 -25.11 4.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -150.67 148.66 20.07 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -45.82 -50.95 32.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.0 111.137 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -62.06 -17.86 58.55 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.327 1.172 . . . . 0.0 110.934 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 3.1 tt0 -70.68 -26.21 63.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.126 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -75.17 -27.64 59.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 110.5 179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.16 -54.54 49.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.81 -1.181 . . . . 0.0 109.595 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.6 Cg_endo -64.41 -49.36 3.52 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 O-C-N 123.344 1.181 . . . . 0.0 110.54 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -69.34 -52.45 27.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.399 -0.813 . . . . 0.0 111.062 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.955 ' O ' HG22 ' A' ' 21' ' ' ILE . 32.9 t -55.26 -48.17 74.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.026 . . . . 0.0 110.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -58.96 -35.38 73.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.376 -0.828 . . . . 0.0 109.987 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -96.32 9.01 42.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.331 -0.856 . . . . 0.0 110.113 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.59 -17.69 7.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.955 HG22 ' O ' ' A' ' 17' ' ' CYS . 8.4 tt -130.02 -26.02 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.053 -1.03 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.82 3.12 28.54 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.678 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -141.25 133.49 28.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.0 110.239 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -73.99 55.7 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -134.63 96.52 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.228 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.91 156.53 28.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -129.73 -176.17 3.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.381 -1.07 . . . . 0.0 110.003 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.2 t -132.89 116.25 16.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.972 -1.08 . . . . 0.0 110.828 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 43.6 tpp -150.36 152.0 33.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.355 -0.84 . . . . 0.0 110.121 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 29' ' ' MET . 3.7 m-80 61.19 13.01 4.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.216 -0.927 . . . . 0.0 110.219 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.04 23.71 56.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 49.7 mttt -132.33 161.46 33.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -1.141 . . . . 0.0 109.925 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.508 ' HB3' HG12 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -104.44 122.61 45.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.174 -0.954 . . . . 0.0 109.748 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -89.63 155.11 19.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.18 -0.95 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HB3' HD12 ' A' ' 21' ' ' ILE . 11.4 m -147.62 162.28 39.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 110.534 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.87 159.73 49.31 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.816 . . . . 0.0 109.89 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 O-C-N 123.729 1.384 . . . . 0.0 110.611 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 70.0 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.177 0.513 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 22.1 m-30 -121.1 144.39 48.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 110.549 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.11 163.78 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.346 -0.846 . . . . 0.0 109.633 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -113.71 59.31 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.98 . . . . 0.0 109.85 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.53 10.69 26.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.415 -0.803 . . . . 0.0 110.6 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER 54.06 44.12 29.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.08 -1.012 . . . . 0.0 110.099 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 6' ' ' LYS . 16.6 p -44.14 170.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 110.466 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.41 -22.03 4.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.358 -0.839 . . . . 0.0 110.253 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.65 166.46 26.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.589 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -79.17 -50.0 1.41 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.331 -1.099 . . . . 0.0 111.058 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.7 -25.41 68.75 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.355 1.187 . . . . 0.0 110.704 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -70.88 -34.87 72.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.035 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -65.43 -25.82 67.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.91 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.599 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -55.42 -59.9 9.88 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.229 -0.92 . . . . 0.0 109.928 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.599 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.22 -49.04 13.49 Favored 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.311 1.164 . . . . 0.0 109.53 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.97 -37.67 74.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.449 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 24.7 t -70.37 -36.82 74.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.935 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 2.5 tttp -56.59 -44.16 80.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.942 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -17.89 48.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.368 -0.833 . . . . 0.0 110.184 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -54.03 7.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.0 110.426 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 22' ' ' GLY . 12.1 pt -112.41 -34.21 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.231 -0.918 . . . . 0.0 110.387 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 116.87 26.35 3.06 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -123.53 -147.5 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.347 -1.09 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.56 48.36 0.06 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.235 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.81 68.67 1.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 110.106 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -126.12 161.85 20.42 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 -165.0 1.43 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -1.165 . . . . 0.0 110.345 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' MET . 43.3 t -137.98 114.09 10.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 110.036 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 1.2 mmt -146.92 145.51 29.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.038 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.35 33.43 23.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.14 -0.975 . . . . 0.0 110.129 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.55 35.2 88.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' HG3' ' C ' ' A' ' 31' ' ' GLY . 10.5 mttt -142.09 159.19 42.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 0.0 110.111 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.59 122.54 37.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 110.131 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 3.1 mtmt -99.38 94.09 6.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.376 -0.827 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.5 m -84.5 147.17 27.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.291 -0.88 . . . . 0.0 110.652 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -136.7 91.47 15.66 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.369 -0.832 . . . . 0.0 110.202 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.309 -1.51 0 O-C-N 123.689 1.363 . . . . 0.0 110.606 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 1' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.189 0.518 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 8.8 m-30 -90.3 154.12 19.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.3 pt -113.22 151.54 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.883 . . . . 0.0 110.042 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 5' ' ' ALA . 1.2 p-10 -75.17 -0.65 20.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.918 . . . . 0.0 110.64 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -42.5 116.86 0.91 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.169 -0.957 . . . . 0.0 110.099 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.6 ttmm -64.35 69.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' ALA . 4.2 p -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.246 -0.909 . . . . 0.0 110.023 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -76.43 -15.57 59.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . 152.64 -23.96 0.83 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.67 -55.83 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.041 -1.27 . . . . 0.0 110.927 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.13 -14.25 18.64 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.283 1.149 . . . . 0.0 110.652 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' OE1' ' HG3' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -97.48 -29.56 13.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.765 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 3.4 t -74.34 -33.58 63.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -59.95 -57.68 25.0 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.206 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -58.7 -50.53 9.04 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.448 1.236 . . . . 0.0 109.464 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG3' ' OE1' ' A' ' 12' ' ' GLU . 2.2 mttm -52.87 -34.38 54.33 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.383 -0.823 . . . . 0.0 109.101 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 5.0 t -68.22 -43.57 77.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.541 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -54.63 -32.59 59.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.361 -0.837 . . . . 0.0 109.666 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.49 -16.08 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.448 -0.782 . . . . 0.0 109.961 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.18 -50.6 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.874 . . . . 0.0 110.389 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.48 -9.29 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.652 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 82.69 32.17 27.98 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' ALA . 0.5 OUTLIER -144.63 103.99 3.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -1.108 . . . . 0.0 110.064 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.65 65.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.396 -0.815 . . . . 0.0 110.158 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -134.44 88.75 2.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 110.049 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 177.52 -175.64 47.67 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 20.2 mttp -151.14 177.02 10.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -1.132 . . . . 0.0 110.333 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.6 t -112.16 139.28 47.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.288 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' A' ' 29' ' ' MET . 3.9 ppp? -150.86 131.56 14.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.242 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 3.1 t30 58.1 41.65 23.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.23 -0.918 . . . . 0.0 110.747 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.62 30.07 76.57 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -137.39 155.8 48.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -1.214 . . . . 0.0 109.784 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.8 t -110.86 129.94 55.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.0 110.809 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' O ' ' HA3' ' A' ' 26' ' ' GLY . 3.3 mtpt -100.88 144.81 29.38 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.346 -0.846 . . . . 0.0 109.751 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.4 m -149.38 143.2 25.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.364 -0.835 . . . . 0.0 110.55 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -89.52 123.87 65.66 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 O-C-N 123.313 1.165 . . . . 0.0 110.529 179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.608 ' O ' HG22 ' A' ' 1' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.202 0.525 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 19.9 m-30 -93.24 -178.98 4.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 110.222 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.72 148.79 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.267 -0.896 . . . . 0.0 109.981 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 5' ' ' ALA . 2.8 p-10 -74.57 -10.11 59.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -43.95 110.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.848 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.3 tttp -59.85 94.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.868 . . . . 0.0 110.392 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -71.04 152.38 43.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.687 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.31 -8.1 8.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.05 -1.031 . . . . 0.0 110.74 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . -155.7 135.39 4.56 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.188 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -52.45 -50.2 81.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -1.083 . . . . 0.0 110.698 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.79 -16.29 48.01 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.427 1.225 . . . . 0.0 110.576 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 11.9 tt0 -82.48 -39.43 22.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 0.0 109.726 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -66.96 -20.31 65.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.833 . . . . 0.0 109.993 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.608 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.8 mp -63.64 -59.65 11.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -59.84 -32.67 95.73 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 123.369 1.194 . . . . 0.0 109.92 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 1.7 mmtp -64.07 -54.95 26.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 110.351 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 21' ' ' ILE . 85.9 m -56.8 -39.88 74.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.392 -0.817 . . . . 0.0 110.053 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.449 ' HA ' ' N ' ' A' ' 23' ' ' LYS . 5.9 tttt -59.22 -46.23 89.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.173 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.23 -16.74 62.51 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 110.127 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.93 -43.58 10.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.491 ' CG1' ' O ' ' A' ' 17' ' ' CYS . 4.1 pt -115.83 -34.56 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 131.03 -14.0 5.47 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.449 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -126.65 145.11 50.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.242 . . . . 0.0 110.466 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.49 60.61 4.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.245 -0.909 . . . . 0.0 110.203 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.82 84.35 2.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -165.84 179.56 40.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.07 177.03 8.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -1.131 . . . . 0.0 110.298 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 29' ' ' MET . 1.5 t -123.27 114.04 19.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.368 -0.833 . . . . 0.0 109.637 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -144.26 157.71 44.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.92 24.53 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.369 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 68.87 39.31 85.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -145.81 167.99 21.87 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -1.157 . . . . 0.0 110.035 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.4 t -109.88 123.4 49.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.0 110.696 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.554 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 1.5 mtmm -107.49 91.88 3.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.364 -0.835 . . . . 0.0 110.202 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 18.4 m -91.48 141.22 28.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.11 -0.994 . . . . 0.0 110.237 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.415 ' O ' ' OXT' ' A' ' 37' ' ' PRO . 4.5 m-85 -113.32 138.13 22.31 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.234 -0.916 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.415 ' OXT' ' O ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.313 -1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.514 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.538 HG11 ' HG2' ' A' ' 37' ' ' PRO . 2.5 p . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.221 0.534 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 9.0 m-85 -123.97 -178.82 4.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.507 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.495 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.1 pt -136.62 160.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.387 -0.821 . . . . 0.0 109.745 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 19.4 p-10 -86.33 30.2 0.71 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -75.08 101.91 4.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 0.0 109.959 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 7.1 ptpp? -39.56 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.561 -0.712 . . . . 0.0 110.757 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 5' ' ' ALA . 25.4 p -78.42 146.33 34.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.24 -0.912 . . . . 0.0 110.1 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -20.58 13.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -167.14 154.85 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -46.39 -50.23 40.6 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.4 -1.059 . . . . 0.0 111.03 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.35 -20.43 68.22 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.346 1.182 . . . . 0.0 110.968 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.9 tp10 -78.59 -39.67 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.03 -1.044 . . . . 0.0 109.944 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.446 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 30.1 t -66.77 -32.27 73.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.046 -1.034 . . . . 0.0 110.143 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.1 mp -49.32 -59.09 7.16 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.026 -1.046 . . . . 0.0 109.768 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.45 -40.57 65.68 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 O-C-N 123.418 1.22 . . . . 0.0 109.898 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 2.1 mmtp -57.8 -46.04 85.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.965 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.404 ' O ' HG12 ' A' ' 21' ' ' ILE . 66.1 m -65.43 -45.61 83.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -23.76 62.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.041 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.26 -12.17 18.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 110.067 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.41 -65.65 0.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.846 HD13 ' HB3' ' A' ' 35' ' ' CYS . 11.8 pt -86.47 -21.4 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.95 18.5 26.96 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -145.99 119.58 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 110.158 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.94 64.71 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.32 76.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.198 -0.938 . . . . 0.0 110.207 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.605 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -166.28 168.31 39.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 19.2 mtmt -132.7 -175.31 3.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -1.082 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 7' ' ' CYS . 11.3 t -100.97 147.33 26.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.868 . . . . 0.0 109.791 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.467 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -139.43 93.9 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.002 -1.061 . . . . 0.0 110.814 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.4 m120 61.56 9.54 2.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.45 -0.781 . . . . 0.0 111.097 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 122.66 10.38 5.94 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.076 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 6.3 mttt -121.23 154.73 35.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.258 . . . . 0.0 110.227 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -96.43 120.22 36.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 22.3 mtmt -97.49 78.14 2.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.932 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.846 ' HB3' HD13 ' A' ' 21' ' ' ILE . 53.8 m -80.71 156.12 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.236 -0.915 . . . . 0.0 110.363 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.56 75.45 68.97 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.852 . . . . 0.0 110.153 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' HG2' HG11 ' A' ' 1' ' ' VAL . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.436 0 O-C-N 123.611 1.322 . . . . 0.0 110.553 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.278 0.561 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.41 ' C ' HG23 ' A' ' 3' ' ' ILE . 4.1 m-30 -95.96 139.28 32.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 110.196 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.41 HG23 ' C ' ' A' ' 2' ' ' PHE . 12.1 pt -148.32 145.9 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -87.16 67.53 9.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.476 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.526 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -93.94 28.72 2.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.151 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER 36.4 48.8 0.62 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.618 -0.676 . . . . 0.0 110.95 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 27.4 p -53.44 138.55 33.15 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.518 -0.739 . . . . 0.0 109.966 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -9.72 13.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.63 147.16 15.92 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.09 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.0 OUTLIER -61.22 -43.97 91.92 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.378 -1.072 . . . . 0.0 111.613 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.0 -21.85 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 O-C-N 122.875 0.934 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.431 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 tt0 -78.64 -34.03 46.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.523 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.6 -26.62 63.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.366 -0.834 . . . . 0.0 110.08 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.621 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -57.19 -57.71 22.98 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.979 . . . . 0.0 109.898 179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.58 -41.37 48.39 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.38 1.2 . . . . 0.0 109.801 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -62.49 -50.97 69.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 110.101 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.5 m -54.76 -36.52 64.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 109.826 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -67.11 -51.43 54.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.709 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -72.13 -5.09 33.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 109.719 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -57.01 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.381 -0.824 . . . . 0.0 110.15 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 pt -116.91 -32.5 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.882 . . . . 0.0 110.351 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.61 17.16 2.16 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.233 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -144.68 125.43 14.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.974 -1.309 . . . . 0.0 110.058 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -72.34 81.32 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.17 -0.956 . . . . 0.0 110.442 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -146.9 119.46 8.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 110.288 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 150.35 177.95 24.79 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' CD ' ' C ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -148.13 -170.02 3.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.158 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.5 t -119.5 132.51 55.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.228 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.3 tpt -149.64 143.95 25.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 50.2 30.42 4.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 110.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 70.68 24.97 76.47 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 mttt -127.48 155.46 43.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 110.298 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.9 t -105.42 123.1 47.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.943 . . . . 0.0 110.434 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.51 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.1 mtpm? -109.49 105.8 15.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.286 -0.884 . . . . 0.0 110.017 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 36.0 m -104.51 151.51 23.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.493 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -125.59 158.82 63.45 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 109.994 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.389 0 O-C-N 123.707 1.372 . . . . 0.0 110.587 -179.751 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 1' ' ' VAL . 77.9 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.236 0.541 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.62 ' CE2' ' CD ' ' A' ' 34' ' ' LYS . 8.7 m-30 -107.87 149.91 27.69 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.302 -0.874 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.4 pt -128.72 136.15 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -88.84 65.54 7.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.647 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.536 ' HB1' ' HE3' ' A' ' 16' ' ' LYS . . . -81.54 1.1 35.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER 68.46 52.47 0.61 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.335 -0.853 . . . . 0.0 110.464 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 28.8 p -55.54 -162.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.393 -0.817 . . . . 0.0 109.952 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -141.45 -33.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.104 -0.998 . . . . 0.0 110.663 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -159.97 -40.37 0.02 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 168.11 -53.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.267 -1.137 . . . . 0.0 110.473 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.53 -11.1 18.53 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.281 1.148 . . . . 0.0 110.507 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 tp10 -91.86 -47.47 7.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.913 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -67.03 -16.02 64.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.803 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.4 mt -72.83 -58.37 2.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.157 -0.964 . . . . 0.0 110.46 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -59.49 -46.55 20.43 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.314 1.166 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' HB1' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -60.8 -38.46 85.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 31.9 t -65.22 -44.96 86.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 110.073 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.688 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 27.7 ttpp -54.97 -41.89 71.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.04 -16.87 59.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.96 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.57 -55.14 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 110.333 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 37' ' ' PRO . 1.5 tt -86.58 -17.7 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 110.337 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.71 -33.8 5.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -137.05 133.19 35.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.167 -1.196 . . . . 0.0 110.159 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.688 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . . . -67.3 91.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.923 . . . . 0.0 110.182 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HB3' ' HG2' ' A' ' 37' ' ' PRO . . . -139.82 66.59 1.39 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.375 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -158.56 -168.23 20.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -141.26 171.58 13.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -1.187 . . . . 0.0 110.117 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -110.57 142.51 42.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.95 . . . . 0.0 109.883 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -150.32 117.0 5.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.68 -179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 25.8 m-20 57.26 35.04 25.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.308 -0.87 . . . . 0.0 110.971 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 80.5 24.04 59.44 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.349 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -126.18 152.68 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.181 -1.188 . . . . 0.0 109.835 179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 49.4 t -107.74 119.21 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.253 -0.905 . . . . 0.0 110.234 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' CD ' ' CE2' ' A' ' 2' ' ' PHE . 11.4 mtmt -108.39 117.23 33.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 26' ' ' GLY . 97.3 m -120.56 141.57 50.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 109.963 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 m-85 -79.39 -53.16 1.08 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.1 -1.0 . . . . 0.0 110.939 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.926 ' O ' HD11 ' A' ' 21' ' ' ILE . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.327 0 O-C-N 123.25 1.131 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.232 0.539 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.565 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 20.8 m-85 -119.79 162.85 18.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.143 -0.973 . . . . 0.0 110.453 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.442 HG13 ' HB3' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -136.0 149.78 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -90.81 46.78 1.35 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 0.0 110.297 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.57 8.1 8.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.186 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 34.5 mmtt 51.77 51.3 16.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.973 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 27.1 p -55.87 150.72 12.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.838 . . . . 0.0 110.234 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -111.49 -24.13 10.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.206 -0.934 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.89 150.79 22.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.36 -47.93 95.19 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.074 . . . . 0.0 111.241 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -64.5 -39.44 28.3 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.301 1.159 . . . . 0.0 110.72 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -60.38 -26.48 66.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.229 -0.919 . . . . 0.0 110.145 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -29.62 68.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.5 mp -54.0 -58.94 11.26 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.73 -47.27 19.24 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.346 1.182 . . . . 0.0 110.017 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -60.85 -47.83 84.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.367 -0.833 . . . . 0.0 109.89 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 21' ' ' ILE . 19.1 t -59.75 -37.21 78.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 109.974 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.465 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -58.21 -47.87 82.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.13 -25.67 60.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 109.946 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.22 -45.42 60.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 110.68 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.593 HD11 ' SG ' ' A' ' 17' ' ' CYS . 7.3 pt -124.31 -31.01 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.171 -0.955 . . . . 0.0 110.58 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 113.43 18.62 7.01 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' CE ' ' HG3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -145.12 125.29 13.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.147 . . . . 0.0 110.181 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.65 80.7 7.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.35 68.19 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.336 -0.852 . . . . 0.0 110.204 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 34' ' ' LYS . . . -156.54 152.04 23.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.3 mtmt -114.52 179.84 3.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -1.178 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 32.0 t -120.75 138.88 53.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.238 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.454 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -148.06 116.36 6.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.94 . . . . 0.0 110.489 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 66.33 7.23 4.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.623 179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 106.76 16.0 15.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 24.0 mmtt -123.24 142.66 50.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -1.194 . . . . 0.0 109.894 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.9 t -93.34 127.54 38.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.183 -0.948 . . . . 0.0 110.373 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG2' ' CD2' ' A' ' 2' ' ' PHE . 24.2 mtpt -101.08 80.93 2.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.087 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.3 m -86.28 147.5 26.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.044 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.4 m-85 -79.26 -60.32 0.55 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 110.864 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 36' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.366 0 O-C-N 123.213 1.112 . . . . 0.0 110.52 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 1' ' ' VAL . 44.4 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.247 0.546 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.562 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 12.1 m-30 -97.05 164.33 12.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.407 -0.808 . . . . 0.0 110.284 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 33' ' ' CYS . 20.7 pt -130.34 144.71 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.869 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -79.43 16.1 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 111.244 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' ASN . . . -46.88 171.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.93 -1.106 . . . . 0.0 109.804 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 2.7 tppt? -116.32 69.3 0.74 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 110.564 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LYS . 5.0 p -49.12 175.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 0.0 109.703 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -125.48 -10.02 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.116 -0.99 . . . . 0.0 110.777 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -161.42 -74.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.595 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 0.5 OUTLIER 175.88 -58.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 110.545 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 3.0 Cg_endo -57.94 -15.63 22.98 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.293 1.154 . . . . 0.0 110.287 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 mt-10 -87.55 -15.55 37.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.876 . . . . 0.0 110.273 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' N ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -72.08 -40.41 68.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 110.432 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.58 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.4 tp -50.09 -54.29 34.8 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.098 -1.001 . . . . 0.0 110.523 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -60.5 -55.86 1.29 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.396 1.208 . . . . 0.0 110.254 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -62.11 -31.62 72.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 110.064 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.81 ' O ' HG22 ' A' ' 21' ' ' ILE . 35.8 t -71.89 -46.11 58.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 22' ' ' GLY . 9.1 tttm -58.11 -45.14 87.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 0.0 110.169 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -73.71 -21.41 60.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 110.424 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.96 -51.39 8.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -0.92 . . . . 0.0 110.348 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 23' ' ' LYS . 2.5 tt -101.94 -24.19 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 104.2 -6.74 46.93 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.908 ' H ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -117.39 115.34 25.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -1.163 . . . . 0.0 110.133 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 18' ' ' LYS . . . -70.8 67.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 110.222 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.68 103.51 3.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 170.66 178.67 41.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 3.6 mttp -147.78 -176.12 5.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.372 -1.076 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 6.6 t -107.91 128.62 54.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 0.0 110.307 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' CYS . 0.4 OUTLIER -145.95 126.9 14.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.47 -0.769 . . . . 0.0 109.788 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.2 m120 62.68 42.58 8.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 62.43 23.88 65.14 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 20.2 mttm -134.03 175.99 8.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -1.183 . . . . 0.0 109.922 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.5 ' HB3' HG12 ' A' ' 3' ' ' ILE . 1.9 t -118.47 129.25 55.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.562 ' HD2' ' CE2' ' A' ' 2' ' ' PHE . 1.9 mmmm -99.92 92.47 5.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 110.148 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.87 142.81 27.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 110.394 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -96.47 133.92 24.1 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 110.145 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.313 -1.322 0 O-C-N 123.451 1.237 . . . . 0.0 110.548 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.554 ' C ' ' CD1' ' A' ' 2' ' ' PHE . 8.0 p . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.21 0.529 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.633 ' CE2' ' CG ' ' A' ' 34' ' ' LYS . 13.6 m-85 -132.65 157.84 43.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 110.666 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 33' ' ' CYS . 1.3 pt -125.78 137.8 56.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.426 -0.796 . . . . 0.0 109.227 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -63.87 82.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.362 0.601 . . . . 0.0 111.074 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -144.55 88.61 1.93 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.418 -0.801 . . . . 0.0 109.214 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 6.3 mmtp -36.01 92.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.373 0.606 . . . . 0.0 110.897 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 5' ' ' ALA . 23.8 p -78.71 139.57 38.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.349 -0.845 . . . . 0.0 110.352 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 -15.19 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 110.265 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -154.27 151.4 23.09 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.608 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -60.09 -50.98 83.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.246 -1.149 . . . . 0.0 110.917 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -61.16 -11.98 21.21 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.422 1.222 . . . . 0.0 110.841 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -80.51 -34.82 35.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.613 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 2.0 t -67.1 -27.19 67.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.881 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.5 OUTLIER -53.72 -59.08 10.51 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.09 -1.006 . . . . 0.0 109.723 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -59.21 -41.97 54.73 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.362 1.19 . . . . 0.0 109.785 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.23 -50.31 64.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.419 -0.801 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA3' ' A' ' 26' ' ' GLY . 59.6 m -56.48 -45.93 80.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.112 -0.992 . . . . 0.0 109.822 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.0 -39.78 69.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.712 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -78.97 -13.42 59.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.87 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.53 -15.69 25.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.331 -0.855 . . . . 0.0 110.352 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 17' ' ' CYS . 2.0 pt -148.52 -37.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.224 -0.922 . . . . 0.0 110.352 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.64 -9.13 10.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 126.55 52.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 110.263 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -76.57 74.11 3.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.361 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 110.12 4.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 0.0 109.865 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 177.6 171.16 40.78 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -145.37 -168.73 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -1.118 . . . . 0.0 110.222 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.77 133.04 55.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -150.27 141.62 23.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.0 110.968 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.14 22.3 0.92 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.33 -0.856 . . . . 0.0 110.621 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 82.2 13.84 78.1 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 7.6 mttt -117.69 160.17 21.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.205 -1.174 . . . . 0.0 109.618 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.578 ' HB3' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -97.04 128.16 43.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.856 -1.152 . . . . 0.0 110.146 -179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' CG ' ' CE2' ' A' ' 2' ' ' PHE . 36.7 mtpt -96.88 117.38 30.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 110.242 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 1' ' ' VAL . 85.8 m -123.34 134.98 53.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.978 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' OH ' ' CE ' ' A' ' 34' ' ' LYS . 23.6 m-85 -108.38 151.28 41.44 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 110.324 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 3.0 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 O-C-N 123.655 1.345 . . . . 0.0 110.359 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.195 0.521 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 10.5 m-30 -104.78 170.16 8.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.925 . . . . 0.0 110.247 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 ' CB ' ' A' ' 33' ' ' CYS . 36.0 pt -133.35 134.36 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.359 -0.838 . . . . 0.0 109.84 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.423 ' HA ' ' CE ' ' A' ' 32' ' ' LYS . 27.9 p-10 -79.34 48.09 0.86 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.399 -0.813 . . . . 0.0 110.47 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 7' ' ' CYS . . . -95.09 90.77 6.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.176 -0.952 . . . . 0.0 109.81 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -45.76 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 110.437 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.528 ' N ' ' O ' ' A' ' 5' ' ' ALA . 10.3 p -73.11 -167.68 0.42 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.135 -0.978 . . . . 0.0 110.367 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.31 -17.38 6.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 110.213 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.69 150.29 22.35 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.609 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -58.84 -51.0 84.96 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -1.093 . . . . 0.0 111.163 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -61.44 -24.73 78.84 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.39 1.205 . . . . 0.0 111.217 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 39.4 tp10 -58.88 -26.51 64.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 t -70.96 -23.05 62.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.613 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -58.05 -57.39 26.22 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.4 -45.0 19.94 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 O-C-N 123.424 1.223 . . . . 0.0 109.864 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -49.05 79.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.0 m -61.78 -42.55 99.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.726 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 12.2 ttpp -55.99 -30.1 61.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 109.807 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -90.04 -20.11 23.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.408 -0.808 . . . . 0.0 110.271 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.55 -57.88 2.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 35' ' ' CYS . 10.0 pt -100.9 -41.29 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 110.09 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 103.01 32.79 4.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 19.9 mmtt -129.69 -2.27 4.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.197 -1.178 . . . . 0.0 110.306 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.62 60.33 1.64 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.742 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 36' ' ' TYR . . . -150.22 82.37 1.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 110.131 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -163.0 -175.2 33.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 5.3 mttp -150.0 -176.92 5.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -1.068 . . . . 0.0 109.948 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 1.1 t -121.97 127.54 50.45 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.1 -1.0 . . . . 0.0 110.585 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.531 ' HB2' ' CD ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -144.11 155.27 43.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 109.823 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 53.87 18.21 1.54 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.247 -0.908 . . . . 0.0 110.127 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 78.06 43.3 14.03 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 3.9 mttt -153.07 160.33 42.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.132 -1.216 . . . . 0.0 110.378 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.636 ' CB ' HD11 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -91.26 134.2 34.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.351 -0.843 . . . . 0.0 109.96 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.4 OUTLIER -120.89 99.68 6.65 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.189 -0.945 . . . . 0.0 110.547 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HB3' HD13 ' A' ' 21' ' ' ILE . 57.1 m -87.74 156.4 19.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.101 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 32.6 m-85 -140.33 141.24 25.35 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.155 -0.966 . . . . 0.0 110.23 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.7 Cg_endo . . . . . 0 C--N 1.313 -1.314 0 O-C-N 123.508 1.268 . . . . 0.0 110.451 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 1' ' ' VAL . 40.1 t . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.164 0.507 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 16.2 m-30 -105.07 175.19 5.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' A' ' 5' ' ' ALA . 3.8 pt -141.74 150.92 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.177 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 6' ' ' LYS . 12.3 p-10 -62.6 -9.77 10.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.464 -0.773 . . . . 0.0 110.666 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . -41.2 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.323 -0.86 . . . . 0.0 110.265 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' ASN . 10.5 mmtm -49.04 96.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.895 . . . . 0.0 110.345 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 5' ' ' ALA . 16.9 p -76.07 149.36 37.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.2 mtm105 -122.38 -10.67 8.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.955 . . . . 0.0 110.247 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.01 143.84 8.93 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -49.75 -50.26 68.37 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.338 -1.095 . . . . 0.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -63.14 -9.35 16.88 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.368 1.194 . . . . 0.0 110.776 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -87.8 -35.63 17.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 8.4 t -73.24 -39.92 65.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 110.393 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.609 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -44.56 -55.65 9.89 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.059 -1.026 . . . . 0.0 109.845 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -62.54 -47.76 8.77 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.367 1.193 . . . . 0.0 110.119 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 20.0 mttt -54.01 -44.14 70.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 60.6 m -62.65 -39.34 93.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.844 . . . . 0.0 109.856 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.631 ' CD ' ' HB2' ' A' ' 24' ' ' ALA . 10.6 tttt -61.92 -26.96 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.355 -0.841 . . . . 0.0 109.974 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -32.49 21.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.475 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.63 -18.02 21.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.119 -0.988 . . . . 0.0 110.325 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.593 ' CD1' ' CB ' ' A' ' 35' ' ' CYS . 37.0 mt -128.92 -45.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.07 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 97.18 35.76 5.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -134.78 1.39 3.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -1.226 . . . . 0.0 110.338 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.631 ' HB2' ' CD ' ' A' ' 18' ' ' LYS . . . 39.16 46.28 1.2 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.463 -0.773 . . . . 0.0 110.442 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.84 106.85 7.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 110.237 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 173.49 178.99 43.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -146.58 -165.36 2.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.366 -1.079 . . . . 0.0 110.011 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 t -126.71 122.56 35.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 2.1 tpt -150.02 134.96 17.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 110.161 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 0.9 OUTLIER 62.15 31.01 17.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 0.0 110.261 179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.76 33.88 88.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 18.3 mttt -136.36 150.87 49.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.221 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.547 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.45 118.16 30.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.141 -0.974 . . . . 0.0 109.846 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.6 OUTLIER -101.22 103.73 14.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 110.454 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.593 ' CB ' ' CD1' ' A' ' 21' ' ' ILE . 9.8 m -111.76 166.74 10.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.032 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -113.89 157.4 42.0 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.207 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.423 0 O-C-N 123.69 1.363 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 1' ' ' VAL . 49.8 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.353 0.597 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 3.2 m-30 -90.44 165.7 13.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.288 -0.883 . . . . 0.0 110.102 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.503 HG13 ' HB3' ' A' ' 33' ' ' CYS . 17.9 pt -147.73 135.34 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 0.0 110.235 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' CB ' ' HD3' ' A' ' 32' ' ' LYS . 14.6 p-10 -101.34 60.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.283 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.34 15.71 4.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 47.65 79.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.51 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 p -70.42 -165.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.101 -0.999 . . . . 0.0 109.982 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -126.45 -18.0 4.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.01 . . . . 0.0 110.63 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -154.3 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.587 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.622 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 168.65 -55.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.095 -1.238 . . . . 0.0 111.309 -179.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.9 Cg_exo -56.15 -11.95 6.76 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.309 1.163 . . . . 0.0 111.69 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.437 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.85 -31.2 64.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.892 -1.13 . . . . 0.0 109.533 179.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 14.1 t -69.12 -28.65 66.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.506 -0.746 . . . . 0.0 110.633 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 tp -59.36 -56.5 35.35 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 110.581 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -60.26 -46.44 18.41 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.405 1.213 . . . . 0.0 110.291 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -62.58 -32.6 73.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.857 ' O ' HG22 ' A' ' 21' ' ' ILE . 20.0 m -64.24 -52.33 59.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' NZ ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 ttpt -57.94 -35.84 71.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 18.4 mm-40 -76.05 -18.17 59.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.95 -9.94 12.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.857 HG22 ' O ' ' A' ' 17' ' ' CYS . 5.8 tt -131.06 -28.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.005 -1.06 . . . . 0.0 110.622 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.65 -38.0 3.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.73 ' H ' HG23 ' A' ' 21' ' ' ILE . 3.5 mtpt -124.0 132.92 53.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -1.145 . . . . 0.0 110.339 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.85 90.61 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.218 -0.926 . . . . 0.0 110.236 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' TYR . . . -141.42 89.55 2.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' C ' ' CG ' ' A' ' 27' ' ' LYS . . . 177.7 -175.42 47.54 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' CG ' ' C ' ' A' ' 26' ' ' GLY . 15.1 mtmm -150.15 175.03 12.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.341 -1.094 . . . . 0.0 109.584 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 18.4 t -109.44 130.71 55.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.927 -1.108 . . . . 0.0 110.578 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.55 ' CB ' ' HE2' ' A' ' 34' ' ' LYS . 1.6 ttt -130.51 138.6 50.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.903 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' MET . 0.8 OUTLIER 61.24 11.93 3.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 95.63 17.48 35.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 2.1 mttt -131.24 143.29 50.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.917 -1.343 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.503 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.7 t -84.47 145.51 28.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.432 -0.792 . . . . 0.0 110.638 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HE2' ' CB ' ' A' ' 29' ' ' MET . 2.4 mtmp? -133.24 100.84 4.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.742 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.6 m -81.93 168.4 17.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.519 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 5.4 m-85 -122.08 159.6 51.07 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.004 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 0.0 110.554 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.413 HG22 ' H3 ' ' A' ' 1' ' ' VAL . 18.8 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.289 0.566 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 14.3 m-30 -104.08 165.78 10.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 0.4 OUTLIER -116.72 156.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -108.14 42.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . -96.15 27.78 3.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.581 -0.699 . . . . 0.0 110.278 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 3.1 ptmm? 36.06 72.57 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.582 0.706 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 32' ' ' LYS . 26.9 p -51.82 134.46 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 110.63 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -94.26 -15.58 24.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 0.0 109.845 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -160.1 156.98 28.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.605 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.43 -50.02 89.43 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.238 -1.154 . . . . 0.0 110.923 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -63.13 -11.44 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.425 1.224 . . . . 0.0 110.857 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.5 mm-40 -81.7 -33.72 31.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.3 t -67.03 -21.01 65.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD12 ' HB1' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -59.65 -59.36 14.1 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.068 -1.02 . . . . 0.0 109.314 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_exo -57.94 -37.98 94.01 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.3 1.158 . . . . 0.0 109.697 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 18.5 mttp -69.81 -38.31 76.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 0.0 109.902 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' HG12 ' A' ' 21' ' ' ILE . 62.6 m -75.65 -34.82 60.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.902 . . . . 0.0 109.703 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -67.78 -36.24 80.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -88.83 -18.29 27.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.188 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 16' ' ' LYS . . . -75.04 -55.33 5.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 110.338 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 17' ' ' CYS . 18.1 pt -108.34 -35.03 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.14 11.02 3.24 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -135.52 135.92 40.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.281 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -85.73 76.64 9.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.819 . . . . 0.0 110.171 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.26 93.06 1.94 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.192 -0.943 . . . . 0.0 109.893 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -164.79 178.45 39.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 3.6 mtmp? -142.71 -175.16 4.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -1.107 . . . . 0.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 10' ' ' SER . 5.8 t -132.18 119.7 21.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.2 -0.938 . . . . 0.0 110.168 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.475 ' HG2' ' HE2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -146.13 145.35 30.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 109.829 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.83 28.28 15.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.817 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.82 75.7 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -126.57 159.39 33.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -1.154 . . . . 0.0 110.344 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -107.5 119.78 40.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.465 -0.772 . . . . 0.0 109.974 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 3.3 mtmt -105.36 125.78 51.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.41 ' SG ' HD11 ' A' ' 3' ' ' ILE . 40.0 m -119.11 142.14 48.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -110.2 125.1 31.73 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.177 -0.952 . . . . 0.0 110.148 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.314 -1.256 0 O-C-N 123.401 1.211 . . . . 0.0 110.516 179.983 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.524 HG21 ' HD3' ' A' ' 37' ' ' PRO . 33.7 m . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.594 0.712 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 2.6 m-85 -109.67 148.2 31.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.631 -0.668 . . . . 0.0 110.032 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 16' ' ' LYS . 1.7 pt -128.31 141.02 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.101 -0.999 . . . . 0.0 110.043 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.493 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 31.5 p-10 -101.0 68.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.493 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.86 11.16 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.205 -0.934 . . . . 0.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HE3' ' O ' ' A' ' 4' ' ' ASN . 4.4 mttt 50.64 60.86 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.319 -0.863 . . . . 0.0 109.992 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 12' ' ' GLU . 23.7 p -71.97 159.07 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 110.409 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.54 -17.13 17.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.065 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' HD2' ' A' ' 11' ' ' PRO . . . -140.01 151.78 22.33 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -52.9 -48.0 93.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.392 -1.063 . . . . 0.0 111.529 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -62.01 -25.9 78.09 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.201 1.106 . . . . 0.0 111.684 -178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.3 tp10 -52.33 -29.58 24.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.806 -1.184 . . . . 0.0 110.095 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 5.6 t -69.35 -35.59 76.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.499 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.741 HD12 ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -44.62 -57.5 6.63 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.947 -1.096 . . . . 0.0 109.816 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.612 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.5 Cg_endo -61.49 -48.4 9.51 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.392 1.206 . . . . 0.0 109.323 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 0.4 OUTLIER -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -0.755 . . . . 0.0 110.099 179.779 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 5.1 t -61.6 -48.73 79.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 4.5 ttmt -66.16 -19.81 65.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.885 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -92.54 -12.98 30.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 110.12 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.98 -69.36 0.8 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -0.887 . . . . 0.0 110.365 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.424 HG13 ' N ' ' A' ' 22' ' ' GLY . 6.2 pt -84.78 -29.8 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.0 110.204 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' N ' HG13 ' A' ' 21' ' ' ILE . . . 112.67 18.1 7.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' N ' ' HA ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -149.99 122.88 8.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.118 -1.225 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' HD12 ' A' ' 14' ' ' LEU . . . -81.48 82.33 7.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.84 92.17 2.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . 171.13 -159.36 31.27 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.5 mtmp? -147.73 -163.37 1.75 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -1.092 . . . . 0.0 109.859 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -138.86 127.71 23.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.884 -1.135 . . . . 0.0 110.682 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 29.5 ttm -141.91 166.19 25.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.433 -0.792 . . . . 0.0 109.657 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 48.92 22.64 0.59 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.965 . . . . 0.0 109.892 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 73.6 34.97 56.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.2 mttp -148.19 147.05 28.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -1.127 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.432 ' HB3' HG13 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -83.4 139.44 32.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.256 -179.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -115.55 149.57 37.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.845 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.7 m -142.05 147.83 37.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.892 . . . . 0.0 110.566 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -123.13 104.05 35.62 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 110.024 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HD3' HG21 ' A' ' 1' ' ' VAL . 3.0 Cg_exo . . . . . 0 C--N 1.314 -1.267 0 O-C-N 123.457 1.241 . . . . 0.0 110.594 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.248 0.547 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 17.1 m-30 -116.59 163.44 16.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.509 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.561 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.9 pt -110.39 154.02 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.345 -0.847 . . . . 0.0 109.67 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 24.8 p-10 -100.24 55.31 0.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.817 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.79 15.15 17.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 109.72 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 4.7 mmtp 46.63 85.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 0.0 110.343 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 8' ' ' ARG . 19.6 p -69.7 -168.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 3.5 mmt85 -140.37 -34.89 0.52 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.023 -1.048 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -138.45 -65.19 0.04 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.105 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.3 OUTLIER 169.9 -55.85 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.119 -1.224 . . . . 0.0 110.88 -179.691 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -57.92 -26.67 75.55 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.377 1.199 . . . . 0.0 110.921 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt-10 -61.2 -23.12 65.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.94 . . . . 0.0 109.934 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -69.64 -31.01 68.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.941 179.742 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.6 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -53.58 -58.43 12.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.072 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -59.66 -51.93 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.367 1.193 . . . . 0.0 109.976 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -60.27 -46.65 89.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 110.18 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.1 t -62.61 -44.43 96.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.141 -0.974 . . . . 0.0 110.112 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -58.54 -28.3 65.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.057 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -105.25 1.58 28.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 110.28 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.17 -62.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.497 HG23 ' N ' ' A' ' 22' ' ' GLY . 4.4 tt -90.34 -39.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 110.03 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 21' ' ' ILE . . . 109.38 26.68 5.04 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' N ' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -147.79 127.66 13.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.539 -0.977 . . . . 0.0 109.828 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CD1' ' A' ' 14' ' ' LEU . . . -76.28 50.32 0.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 110.779 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -137.16 110.97 8.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.046 -1.034 . . . . 0.0 109.837 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 34' ' ' LYS . . . 179.26 173.36 44.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -150.04 -172.39 4.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -1.136 . . . . 0.0 110.302 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.1 t -122.54 122.12 38.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.311 -0.868 . . . . 0.0 109.947 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 3.6 tmm? -146.91 137.07 23.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 110.163 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.9 OUTLIER 63.94 10.75 5.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 110.343 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.79 22.8 37.97 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 27.8 mttt -124.97 162.44 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -1.153 . . . . 0.0 110.269 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.1 OUTLIER -108.64 106.81 17.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.295 -0.878 . . . . 0.0 108.726 179.736 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 3.9 mtpm? -89.4 152.96 21.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.071 -1.018 . . . . 0.0 111.003 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' ALA . 23.7 m -144.23 136.71 26.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.597 -0.689 . . . . 0.0 109.751 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -97.22 154.03 38.24 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.942 . . . . 0.0 110.464 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 O-C-N 123.732 1.385 . . . . 0.0 110.639 179.862 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.239 0.543 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 20.1 m-30 -105.85 140.96 38.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.433 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 4.8 pt -135.98 138.77 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -0.844 . . . . 0.0 110.208 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 4' ' ' ASN . 16.0 p-10 -79.84 75.44 6.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.942 . . . . 0.0 110.087 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 6' ' ' LYS . . . -108.36 15.95 23.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.372 -0.83 . . . . 0.0 110.173 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 23.6 tptp 44.51 44.0 6.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 26.8 p -45.65 154.73 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.088 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -101.79 -31.19 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.36 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 176.54 31.67 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.122 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.637 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -69.27 -47.39 28.02 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.516 -0.991 . . . . 0.0 111.369 179.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.4 Cg_exo -60.84 -21.97 72.27 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.175 1.092 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 10.9 mm-40 -84.03 -35.76 23.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.758 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 42.1 t -69.3 -31.55 70.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 0.0 109.67 179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -51.83 -59.07 8.95 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.252 -0.905 . . . . 0.0 109.839 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.0 Cg_endo -58.13 -45.44 31.66 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.292 1.154 . . . . 0.0 109.684 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -52.85 -41.21 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.9 m -69.66 -27.77 65.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.577 179.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 2.0 ttpm? -71.06 -22.02 62.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.787 . . . . 0.0 109.73 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -91.77 -26.03 18.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 110.146 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.52 -45.16 17.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.294 -0.879 . . . . 0.0 110.263 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 23' ' ' LYS . 5.4 pt -123.27 -32.62 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 96.25 36.36 5.2 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HB2' HD12 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -121.82 -9.22 8.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -1.196 . . . . 0.0 110.509 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.607 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 41.21 47.22 2.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.767 . . . . 0.0 110.4 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.94 71.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 110.299 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -151.62 -178.11 26.06 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 8.4 mttp -143.0 172.11 13.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -1.106 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.7 t -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.334 -0.854 . . . . 0.0 109.811 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.414 ' HB3' ' CD ' ' A' ' 34' ' ' LYS . 46.7 tpp -135.94 127.3 28.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -0.998 . . . . 0.0 110.501 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 55.05 23.65 5.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 110.317 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.75 3.98 76.46 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 150.97 24.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.918 -1.342 . . . . 0.0 110.36 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -95.82 126.31 40.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -104.75 84.69 2.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 0.0 110.694 -179.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -85.17 148.79 25.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 110.101 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -124.86 108.37 28.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 109.994 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.311 -1.396 0 O-C-N 123.469 1.247 . . . . 0.0 110.624 -179.791 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 1' ' ' VAL . 57.6 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 3' ' ' ILE . 8.3 m-30 -90.35 -179.23 5.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.154 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 2' ' ' PHE . 1.6 pt -158.82 137.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.474 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 20.6 p30 -87.26 67.91 9.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.37 4.5 42.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER 56.49 57.62 4.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 -179.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -65.56 166.73 10.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -107.31 -9.52 16.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.09 -1.006 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.46 156.02 27.38 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.15 -179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -63.41 -42.58 75.06 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.964 . . . . 0.0 112.074 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.7 Cg_exo -60.12 -13.49 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 122.848 0.92 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -75.54 -22.04 57.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.036 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 10' ' ' SER . 1.3 m -71.8 -26.25 62.33 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.57 -0.706 . . . . 0.0 110.147 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.8 OUTLIER -58.65 -57.78 24.08 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.202 -0.936 . . . . 0.0 109.882 179.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -60.15 -45.7 22.2 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 O-C-N 123.326 1.172 . . . . 0.0 109.97 179.156 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -62.09 -50.29 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.838 ' O ' HG22 ' A' ' 21' ' ' ILE . 49.9 m -54.27 -36.99 64.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 110.021 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -60.88 -52.35 65.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 110.019 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -76.42 -4.55 42.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.821 . . . . 0.0 110.042 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -105.75 -47.69 3.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 17' ' ' CYS . 6.9 tt -116.92 -28.16 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 0.0 110.141 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.11 38.65 9.02 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -138.08 2.2 2.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.292 . . . . 0.0 110.706 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 41.55 48.24 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 0.0 110.286 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.42 108.82 4.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 110.06 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . -178.11 -178.0 47.26 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.112 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -146.92 175.08 10.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.573 -0.957 . . . . 0.0 109.448 179.664 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.83 128.87 41.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.943 -1.098 . . . . 0.0 110.267 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.1 tpp -143.38 154.08 43.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 0.0 110.111 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 57.56 20.88 6.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -0.894 . . . . 0.0 110.069 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 77.55 29.7 54.91 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 41.6 mttt -141.73 153.76 44.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -1.189 . . . . 0.0 110.209 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.448 ' C ' ' CG ' ' A' ' 34' ' ' LYS . 9.9 t -93.01 154.81 17.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.84 . . . . 0.0 110.827 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 23.8 mtmm -148.68 99.67 3.02 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 110.035 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 58.1 m -81.81 173.85 11.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.199 -0.938 . . . . 0.0 110.386 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 5.5 m-85 -108.58 140.43 21.78 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 110.291 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 36' ' ' TYR . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.367 0 O-C-N 123.509 1.268 . . . . 0.0 110.587 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 1' ' ' VAL . 3.0 p . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.316 0.579 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 12.7 m-85 -140.76 163.57 32.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 0.0 110.089 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 36.9 pt -124.33 145.44 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.143 -0.973 . . . . 0.0 110.058 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 44.5 p30 -98.05 75.59 2.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.945 . . . . 0.0 110.572 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 15.16 28.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.875 . . . . 0.0 109.872 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER 48.51 55.25 9.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.108 -179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 31' ' ' GLY . 22.0 p -61.12 144.19 54.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.307 -0.871 . . . . 0.0 110.29 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.52 -26.64 13.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.275 -0.89 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -137.31 152.7 21.6 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.11 -46.22 96.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.397 -1.061 . . . . 0.0 111.67 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.6 Cg_exo -61.58 -16.7 49.76 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.064 1.033 . . . . 0.0 111.429 -179.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -73.99 -32.56 63.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.938 -1.101 . . . . 0.0 109.699 179.464 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 1.9 t -68.2 -24.8 64.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.102 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.624 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -55.1 -59.44 10.86 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.561 179.765 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.04 -44.43 29.76 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.365 1.192 . . . . 0.0 109.878 178.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -64.83 -39.11 93.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.854 . . . . 0.0 110.247 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 13' ' ' CYS . 55.9 m -66.0 -25.18 66.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 110.409 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -77.91 -41.36 36.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.192 -0.943 . . . . 0.0 110.509 -179.752 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.0 -24.53 47.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 110.668 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.35 -23.6 23.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.491 -179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 35' ' ' CYS . 8.1 mt -131.06 -29.37 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.152 -0.968 . . . . 0.0 110.48 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 18' ' ' LYS . . . 112.37 -19.15 22.49 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.03 119.93 38.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -1.144 . . . . 0.0 110.282 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -68.63 79.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 110.004 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 35' ' ' CYS . . . -149.24 127.91 12.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . 157.9 -175.22 35.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -146.7 -170.33 3.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.196 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 31.2 t -132.73 111.86 11.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.45 ' O ' ' CB ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -122.36 125.59 46.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.95 . . . . 0.0 110.293 -179.883 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' CB ' ' O ' ' A' ' 29' ' ' MET . 0.7 OUTLIER 65.16 16.14 10.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 179.805 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 88.64 18.76 54.13 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 4.0 mmtp -112.8 144.98 41.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.934 -1.333 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -93.88 114.53 26.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 110.133 -179.709 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 0.7 OUTLIER -109.96 116.37 31.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.401 -0.812 . . . . 0.0 110.042 179.836 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 21' ' ' ILE . 17.3 m -111.06 144.56 39.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 110.49 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 27.2 m-85 -93.32 149.95 38.22 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.974 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.31 -1.493 0 O-C-N 123.754 1.397 . . . . 0.0 110.522 -179.725 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.108 0.48 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 9.3 m-85 -123.02 155.89 35.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.226 -0.921 . . . . 0.0 110.342 -179.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 13.0 pt -112.01 138.53 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.903 . . . . 0.0 109.985 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 5' ' ' ALA . 14.7 p30 -64.13 -7.52 9.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.494 -0.754 . . . . 0.0 110.894 -179.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 4' ' ' ASN . . . -41.39 113.62 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.162 -0.961 . . . . 0.0 110.436 -179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -70.25 79.99 0.53 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 110.445 -179.922 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.0 p -75.09 172.33 12.54 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.075 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -132.41 -27.69 1.74 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -0.948 . . . . 0.0 110.876 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.04 141.79 16.18 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.5 OUTLIER -60.9 -52.7 70.49 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.385 -1.068 . . . . 0.0 110.771 179.887 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' SER . 2.9 Cg_endo -62.32 -35.68 71.92 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.387 1.204 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt-10 -62.36 -26.14 68.29 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.217 -0.927 . . . . 0.0 110.247 -179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -67.93 -38.05 82.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 109.991 179.794 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.2 mp -44.77 -58.55 5.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.132 -0.98 . . . . 0.0 109.774 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -57.75 -55.46 2.36 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.426 1.224 . . . . 0.0 109.805 179.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 22.5 mmmt -52.68 -39.06 61.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.251 179.233 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' ILE . 38.0 t -67.97 -43.14 79.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.396 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 2.5 tttp -55.0 -25.05 27.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 0.0 109.699 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.85 -21.44 18.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.795 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.3 -43.35 12.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.457 HG12 ' HD3' ' A' ' 23' ' ' LYS . 8.8 tt -113.87 -33.34 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.099 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 89.64 40.8 5.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HD3' HG12 ' A' ' 21' ' ' ILE . 1.6 mptp? -139.16 4.73 2.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -1.163 . . . . 0.0 110.663 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . . . 40.37 45.57 1.87 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 110.434 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.97 86.83 1.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.287 -0.883 . . . . 0.0 110.144 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 14' ' ' LEU . . . -162.95 176.4 39.22 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 4.7 mtmp? -142.04 174.97 10.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -1.148 . . . . 0.0 109.828 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 35.8 t -117.63 119.17 34.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.3 -179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.475 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -150.57 151.22 32.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.208 -0.933 . . . . 0.0 110.314 -179.992 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 t30 56.96 18.14 3.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 110.466 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 81.33 20.21 65.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.28 169.37 17.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.246 -1.149 . . . . 0.0 110.071 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 1.8 t -107.82 125.4 51.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 110.35 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HA ' ' CD2' ' A' ' 2' ' ' PHE . 1.5 mtpt -94.44 101.42 13.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.919 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.5 m -101.41 142.01 33.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 110.369 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -143.35 168.71 12.18 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.89 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--N 1.312 -1.376 0 O-C-N 123.614 1.323 . . . . 0.0 110.508 179.741 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.78 ' O ' HG12 ' A' ' 1' ' ' VAL . 50.5 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.281 0.563 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.566 ' CZ ' ' HE2' ' A' ' 34' ' ' LYS . 7.6 m-30 -108.15 146.64 32.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.203 -0.935 . . . . 0.0 109.954 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 mt -117.1 164.15 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.147 -0.971 . . . . 0.0 110.181 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.82 47.14 1.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.515 -0.741 . . . . 0.0 110.032 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.86 13.03 4.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 110.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.5 OUTLIER 50.76 67.72 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.016 -179.874 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 p -55.6 176.05 0.07 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.58 -40.9 6.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.049 -1.032 . . . . 0.0 110.784 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -166.46 -41.96 0.02 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.093 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER 169.58 -55.23 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.11 -1.229 . . . . 0.0 110.863 -179.659 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -59.26 -12.44 16.35 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 O-C-N 123.413 1.217 . . . . 0.0 110.955 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.6 mp0 -96.74 -21.54 17.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 110.436 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -75.05 -49.02 21.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.511 -179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -42.42 -52.88 9.8 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.982 . . . . 0.0 110.446 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.8 Cg_endo -62.37 -57.06 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.348 1.183 . . . . 0.0 109.905 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 9.7 mmtp -50.99 -37.28 43.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.135 -0.978 . . . . 0.0 109.413 179.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.435 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.4 t -67.88 -37.48 81.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.639 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' O ' ' HA2' ' A' ' 22' ' ' GLY . 7.4 tttm -61.39 -27.59 68.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 109.759 179.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 14.4 mt-10 -94.68 -24.99 16.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.22 -47.6 42.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.379 -179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 17' ' ' CYS . 11.6 pt -115.61 -28.7 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.178 -0.951 . . . . 0.0 110.413 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 109.92 16.19 10.98 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 37' ' ' PRO . 7.5 ttpt -139.94 119.74 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.242 . . . . 0.0 110.274 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.559 ' HB1' HD23 ' A' ' 14' ' ' LEU . . . -70.74 67.92 0.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.05 68.44 1.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.96 170.18 29.35 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HG3' ' C ' ' A' ' 26' ' ' GLY . 29.7 mtmt -142.91 171.69 13.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -1.178 . . . . 0.0 110.019 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.3 t -110.4 132.86 53.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 109.618 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -150.09 133.52 16.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 29' ' ' MET . 1.1 m120 61.49 13.0 4.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.59 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 90.68 28.49 16.13 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 6.1 mtpp -139.88 167.49 21.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -1.163 . . . . 0.0 110.047 -179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.37 118.45 36.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.0 110.053 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HE2' ' CZ ' ' A' ' 2' ' ' PHE . 14.1 mtpt -111.11 103.58 12.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 0.0 110.536 -179.642 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 96.8 m -98.82 165.7 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 110.244 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.458 ' HH ' ' HZ ' ' A' ' 2' ' ' PHE . 15.7 m-85 -147.91 95.55 4.17 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 110.1 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 2.9 Cg_endo . . . . . 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.518 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 1' ' ' VAL . 2.1 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.362 0.601 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 2.8 m-30 -102.39 169.82 8.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.901 . . . . 0.0 110.22 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.552 ' CG1' ' HB3' ' A' ' 33' ' ' CYS . 3.4 mm -98.97 164.68 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.262 179.353 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -110.81 42.16 1.66 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.417 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.72 15.86 20.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.576 -0.703 . . . . 0.0 110.483 -179.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt 45.17 59.12 3.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 0.0 109.622 -179.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' SG ' ' A' ' 28' ' ' CYS . 16.1 p -45.21 134.18 6.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.471 -0.768 . . . . 0.0 110.735 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.4 -24.54 15.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.634 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.24 144.25 15.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.596 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -59.57 -50.69 85.79 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -1.104 . . . . 0.0 110.841 -179.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.2 Cg_exo -62.91 -19.24 68.38 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.461 1.243 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -70.45 -32.06 69.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.775 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' LYS . 4.0 t -66.36 -29.95 70.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' CB ' ' CD ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -50.89 -59.56 7.27 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.556 179.375 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.592 ' CD ' ' CB ' ' A' ' 14' ' ' LEU . 3.1 Cg_exo -56.64 -44.51 44.74 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 O-C-N 123.345 1.182 . . . . 0.0 109.486 178.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 8.0 mmtt -58.31 -33.05 69.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 108.989 178.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.7 -39.45 80.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.579 -0.701 . . . . 0.0 109.724 179.472 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -69.05 -20.78 64.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.853 . . . . 0.0 110.137 179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -103.82 -10.52 18.18 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 110.34 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.7 -54.06 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.183 -0.948 . . . . 0.0 110.124 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.595 HG21 ' SG ' ' A' ' 17' ' ' CYS . 14.9 tt -105.12 -12.69 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.94 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.59 41.84 89.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 24' ' ' ALA . 15.7 tptt -135.24 1.75 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -1.188 . . . . 0.0 110.316 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . 39.6 46.87 1.57 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.354 -0.841 . . . . 0.0 110.487 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.08 88.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.336 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 34' ' ' LYS . . . -153.53 175.61 31.84 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 13' ' ' CYS . 2.0 mtmp? -146.11 -168.45 3.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.3 -1.118 . . . . 0.0 110.461 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 7' ' ' CYS . 38.0 t -125.21 105.87 9.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.4 -0.813 . . . . 0.0 110.105 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.5 tpt -128.34 137.42 51.91 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.24 28.01 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.893 . . . . 0.0 110.396 179.79 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 32' ' ' LYS . . . 69.73 37.44 76.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -139.3 150.97 46.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.328 -1.101 . . . . 0.0 110.015 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -91.4 104.69 17.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.92 . . . . 0.0 110.173 -179.819 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 2' ' ' PHE . 15.8 mtpt -89.75 159.06 17.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -0.874 . . . . 0.0 110.518 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -155.83 154.31 31.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.38 -0.825 . . . . 0.0 110.268 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -104.42 152.02 39.24 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 110.027 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.312 -1.392 0 O-C-N 123.587 1.309 . . . . 0.0 110.608 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.403 HG13 ' H3 ' ' A' ' 1' ' ' VAL . 20.5 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.277 0.56 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.637 ' CE2' ' CD ' ' A' ' 34' ' ' LYS . 3.9 m-85 -90.46 160.52 15.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' CG1' ' C ' ' A' ' 2' ' ' PHE . 5.7 mt -145.84 168.79 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -99.68 20.95 13.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.3 124.92 22.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 2.6 ptmt -68.6 77.03 0.29 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.438 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.436 ' O ' ' O ' ' A' ' 6' ' ' LYS . 4.2 p -50.68 -178.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.353 -0.842 . . . . 0.0 109.969 179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.5 mtt85 -129.88 -37.66 1.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.16 -0.962 . . . . 0.0 110.375 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -146.92 -52.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.86 -54.85 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.185 -1.185 . . . . 0.0 111.222 -179.854 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.3 Cg_exo -58.15 -37.1 96.96 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.279 1.147 . . . . 0.0 111.478 -179.057 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 1.7 pm0 -58.76 -27.47 65.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.975 -1.078 . . . . 0.0 110.464 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -67.75 -37.24 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.548 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -49.46 -56.77 14.5 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 110.478 -180.0 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -58.73 -41.79 59.87 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.316 1.167 . . . . 0.0 109.686 179.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.26 -49.3 77.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.792 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.715 ' O ' HG22 ' A' ' 21' ' ' ILE . 75.5 m -58.81 -35.57 73.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.105 -0.997 . . . . 0.0 109.645 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -62.33 -37.57 86.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.855 . . . . 0.0 110.038 179.766 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.73 -17.79 57.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.922 . . . . 0.0 109.921 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.45 -43.39 5.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -0.915 . . . . 0.0 110.314 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 17' ' ' CYS . 11.5 tt -111.59 -25.75 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.168 -0.958 . . . . 0.0 110.169 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 18' ' ' LYS . . . 69.81 37.58 75.63 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' N ' HG23 ' A' ' 21' ' ' ILE . 7.0 tttp -130.04 -2.64 4.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -1.207 . . . . 0.0 110.314 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . . . 48.82 57.46 6.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.34 119.33 6.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.025 -1.047 . . . . 0.0 110.375 179.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 35' ' ' CYS . . . 149.69 172.2 18.96 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -141.73 -168.16 2.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.469 -1.018 . . . . 0.0 110.005 179.794 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -102.08 150.56 23.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.28 -0.887 . . . . 0.0 109.677 179.746 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.454 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -113.53 73.38 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -179.605 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.5 m120 51.93 30.04 6.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.273 -0.892 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 139.78 -31.37 2.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' MET . 0.3 OUTLIER -106.32 -175.81 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.902 -1.351 . . . . 0.0 110.35 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 5.8 t -120.76 155.25 34.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.009 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' CD ' ' CE2' ' A' ' 2' ' ' PHE . 6.0 mtmt -136.38 88.94 2.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.648 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 19.4 m -80.17 139.65 36.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.254 -0.903 . . . . 0.0 109.751 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.47 140.98 52.27 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.149 -0.97 . . . . 0.0 110.36 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 C--N 1.314 -1.283 0 O-C-N 123.561 1.295 . . . . 0.0 110.503 179.653 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 37' ' ' PRO . 57.9 t . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 34' ' ' LYS . 2.7 m-85 -140.41 144.21 36.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -0.783 . . . . 0.0 109.881 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.497 HG13 ' HB3' ' A' ' 33' ' ' CYS . 2.7 pt -138.89 139.65 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.202 -0.936 . . . . 0.0 110.569 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' ALA . 15.7 p-10 -56.41 -43.65 79.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -0.836 . . . . 0.0 109.802 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 3' ' ' ILE . . . 37.78 -141.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.603 -0.686 . . . . 0.0 110.606 179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.3 50.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.473 179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 32' ' ' LYS . 25.4 p -57.73 146.42 31.17 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.4 0.619 . . . . 0.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -111.63 -11.36 14.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.368 -0.833 . . . . 0.0 110.013 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 10' ' ' SER . . . -144.29 -71.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER 167.59 -54.93 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.319 -1.106 . . . . 0.0 110.523 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' SER . 3.1 Cg_exo -60.27 -20.66 63.46 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.326 1.172 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 33.9 mm-40 -74.84 -17.77 60.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -68.33 -26.43 65.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.345 -179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 15' ' ' PRO . 1.6 mt -59.02 -58.42 19.66 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.598 ' HD3' ' CB ' ' A' ' 14' ' ' LEU . 2.9 Cg_endo -58.95 -49.95 10.1 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 O-C-N 123.373 1.196 . . . . 0.0 110.175 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.25 -43.42 74.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.853 . . . . 0.0 109.914 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 1.7 m -75.82 -38.06 58.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.963 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -28.43 43.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -101.65 -19.02 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 110.329 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.98 -50.66 9.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.237 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 23' ' ' LYS . 5.9 pt -106.06 -36.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.971 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 21' ' ' ILE . . . 110.34 21.29 6.99 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -127.35 -139.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -1.2 . . . . 0.0 109.937 179.688 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 14' ' ' LEU . . . 179.61 50.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.0 -1.062 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.34 100.24 3.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.266 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 27' ' ' LYS . . . 173.67 -176.63 46.22 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 26' ' ' GLY . 25.2 mtmm -143.99 -172.23 3.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -1.218 . . . . 0.0 110.469 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' LYS . 3.5 t -100.26 159.08 15.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.387 -0.82 . . . . 0.0 109.941 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.494 ' HG3' ' HE3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -146.08 98.74 3.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.033 . . . . 0.0 111.137 -179.711 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 51.78 29.8 6.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.875 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 32' ' ' LYS . . . 101.07 19.98 15.31 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 1.2 mttp -131.28 164.5 25.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.152 -1.205 . . . . 0.0 109.824 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.497 ' HB3' HG13 ' A' ' 3' ' ' ILE . 1.9 t -112.4 131.71 55.41 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.039 -1.038 . . . . 0.0 111.296 -179.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -113.3 93.03 4.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.687 -0.633 . . . . 0.0 109.426 179.279 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 1' ' ' VAL . 83.0 m -115.86 164.62 14.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.975 -1.078 . . . . 0.0 110.696 -179.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -102.36 155.83 36.01 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.321 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' HG21 ' A' ' 1' ' ' VAL . 2.8 Cg_endo . . . . . 0 C--N 1.311 -1.446 0 O-C-N 123.772 1.406 . . . . 0.0 110.46 179.887 . . . . . . . . 1 1 . 1 stop_ save_